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Abstract 
In budding yeast, progression through anaphase and exit from mitosis are controlled 
by the conserved protein phosphatase Cdc14. The activity of Cdc14 is regulated in space 
and time by changes in its subcellular localization. For most of the cell cycle up to 
metaphase, the phosphatase is sequestered in the nucleolus, by binding to a competitive 
inhibitor called Cfi1 (also known as Net1) (Shou et al., 1999; Straight et al., 1999; Visintin 
et al., 1999). During anaphase, Cdc14 is released from its inhibitor by the sequential 
activation of two signaling cascades, the Cdc Fourteen Early Anaphase Release (FEAR) 
network and the Mitotic Exit Network (MEN). Once released Cdc14 spreads throughout 
the nucleus and the cytoplasm, where it reaches its targets and promotes progression 
through and exit from mitosis (Pereira et al., 2002; Shou et al., 1999; Stegmeier et al., 
2002; Visintin et al., 1999; Yoshida et al., 2002). Several in vivo and in vitro observations 
suggest that phosphorylation of Cdc14 and/or Cfi1 is responsible for the dissociation of 
Cdc14 from its inhibitor. Three kinases have been implicated in the process: the polo-like 
kinase Cdc5, the Clb2-Cdk complex and the MEN kinase Dbf2 (Azzam et al., 2004; 
Geymonat et al., 2003; Hu and Elledge, 2002; Hu et al., 2001; Mohl et al., 2009; Pereira et 
al., 2002; Queralt et al., 2006; Stegmeier et al., 2002; Visintin et al., 2003; Yoshida and 
Toh-e, 2002).  
The aim of my project was to assess the contribution of the above-mentioned kinases 
and to identify the molecular mechanisms by which these kinases mediate the release of 
Cdc14 from its inhibitor. By modulating the kinases of interest alone or in mutual 
combination we found that Cdc14 is released from the nucleolus by the combined activity 
of two kinases, Cdc5 always and either Clb-Cdks or Dbf2. Once active, Cdc14 triggers a 
negative feedback loop that, in the presence of stable levels of mitotic cyclins, generates 
periodic cycles of Cdc14 release and sequestration. Similar phenotypes have been 
described for yeast bud formation and centrosome duplication. A common theme emerges 
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where events that must happen only once per cycle, although intrinsically capable of 
oscillations, are limited to one occurrence by their coupling with the cyclin-Cdk cell cycle 
engine.  
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1. Introduction 
 
In the early 1800 it became clear that all living organisms are composed of 
individual units called cells. As growth, development and survival of all living organisms 
rely on the reproduction of those cells, understanding the cell reproduction process is a 
fundamental problem in biology. Understanding cell reproduction is also important for 
understanding human diseases such as cancer that can be defined as a disease of cell 
reproduction. A cell within a tissue acquires a mutation that allows it to grow more rapidly 
than its neighboring cells. Through the acquisition of additional mutations the progeny of 
that cell can form into a tumor that can eventually escape that tissue and result in 
malignant cancer that spreads through the body (Morgan, 2007), Fig.1.1.  
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Fig. 1.1 Evolution of a tumor 
Tumor evolution begins with a mutation that provides a cell with a competitive advantage, by enabling the 
cell to proliferate more rapidly than its neighbors. Over a period of many years, the descendants of that 
mutant cell acquire additional mutations that allow them to overcome the various regulatory barriers that 
restain cell proliferation. From: The Cell Cycle: Principle of Control by David O Morgan. 
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How do cells reproduce? This fundamental question has occupied scientists for 
more than a century. Nearly a century ago, Walter Sutton, observed that during meiotic 
cell division each sperm or egg receives only one chromosome of each type. Sutton had 
been observing grasshopper cells, where chromosomes have quite distinct shapes. He 
published his findings in 1902 and a year later, made an even stronger argument to connect 
Mendel’s laws of heredity and the behavior of chromosomes in his paper The 
Chromosomes in Heredity. In many ways, Sutton reiterated the work of Walther Fleming 
and, later, of Theodor Boveri, a German scientist who in the late 1880s and early 1890s 
observed that chromosome numbers are cut in half as fertilized sea urchin eggs mature, 
and concluded that sperm and egg nuclei have half sets of chromosomes. Boveri further 
described the detrimental effect of unequal segregation of chromosomes on these cells and 
their progeny (Boveri, 1902), Fig. 1.2, and, later, he postulated that such misdistribution of 
chromosomes might be a cause for tumor development and birth defects (Boveri, 1902).
 16 
 
 
 
Figure 1.2 Drawings of mitosis by Walther Flemming 
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Since then, errors in chromosome segregation have been shown to have dire 
consequences, Fig 1.3. Missegregation during meiosis in gamentogenesis can lead to 
chromosomal abnormalities such as Down, Klinefelter, Prader-Willi and Angelman 
syndromes, and are a leading cause of infertility (Bittel et al., 2005; Jiang et al., 2004; 
Lowe et al., 2001; Tempest et al., 2004). Errors during mitosis can cause chromosome 
instability and cancer (for reviews see (Draviam et al., 2004; Storchova et al., 2004)). 
Therefore, a detailed knowledge of the mechanism driving chromosome segregation is 
vital for understanding and preventing these problems. 
 
Fig. 1.3 Chromosomal abnormalities in cancer cells 
Karyotype of a normal (a) and a cancer (b) cell. In the chromosome complement of a cancer cell are present 
extra copies of several chromosomes and translocations between chromosomes, as revealed by the presence 
of chromosomes with multiple colors. 
 
 
 
The eukaryotic cell cycle: an overview 
The mitotic cell cycle is a strictly ordered sequence of events that leads to the 
production of two daughter cells identical to the mother cell, Figure 1.4. A central 
regulatory system dictates the ordering of the steps by initiating each event at the 
appropriate time. Although in part predetermined, the schedule can be adjusted based on 
extemporary needs and incoming problems.  
The goal of the mitotic cell cycle is to replicate the genome and pass identical copies 
to two daughter cells, so as to maintain genomic ploidy (number of chromosomes) from 
one generation to the next.  
Biologists have long been fascinated by the complexity of cell division and mystified 
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by its high fidelity. The most intriguing part of cell division is how cells manage to 
scrupulously make so that all events occur in a tightly regulated manner, at the right time 
and in the appropriate order. Our current understanding of the cell cycle is a synthesis, 
based on work from numerous investigators who studied the cell cycle in flies, frog 
extracts, clam embryos, human cancer cells and yeast cells. Studies in budding yeast cell 
division, in particular, have contributed significantly to our understanding of genes that 
control cell cycle progression. Although the complexity is increased throughout the 
evolution, the molecular mechanisms involved in the key events of the cell cycle and their 
regulation are highly conserved throughout the eukaryotic organisms (Morgan, 2007). The 
universal architecture of the cell division program consists of four fundamental phases: G1 
(“first gap”-unreplicated chromosomes) where the commitment to cell division occurs, S 
(“synthetic”) phase during which the DNA is replicated, G2 (“second gap”-replicated 
chromosomes) where the cell further grows and prepares to divide, and the mitotic phase 
(M phase) during which nuclear division, where duplicated chromosomes are equally 
segregated into the daughter nuclei (mitosis), and cytoplasmic division, when cells 
physically split (cytokinesis), occur, Fig. 1.4. 
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Figure 1.4 Overview of the eukaryotic cell cycle 
The diagram illustrates the division of a hypothetical eukaryotic cell with two chromosomes. The major 
events of the cell cycle are chromosome duplication and chromosome segregation. Chromosome duplication 
occurs during S phase and results in each chromosome consisting of two tightly-associated identical DNA 
molecules (sister-chromatids). Sister-chromatids are next segregated into daughter nuclei during mitosis and 
finally packaged into individual daughter cells during cytokinesis. Mitosis and cytokinesis are collectively 
called M phase. G1 and G2 are gap phases, G1 preceding and G2 following S phase, respectively. G1, S and 
G2 phases are collectively called interphase. Cell growth occurs throughout the cell cycle.   
 
 
Importantly, after completing M phase cells return in G1, hence the division program 
is cyclical. Between the two major stages (S phase and M phase), the “gap phases” provide 
time for the mother cell to grow and to control whether it is ready to enter into the next 
phase. It is intuitive that the alternation of DNA duplication and chromosomes segregation 
as much as directionality for this process (G1!S!G2!M!G1) is instrumental to 
maintain ploidy (Morgan, 2007). Indeed, to prevent cells from backsliding, cell-cycle 
transitions are coordinated by irreversible events that are finely integrated in reaction 
networks (Csikasz-Nagy et al., 2007).  
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Cyclin-dependent kinases (Cdks): the workhorses of the cell cycle 
At the heart of this system are the cyclin-dependent kinases (Cdks) that drive 
progression through the cell cycle (Nigg, 2001). The activity of the Cdk oscillates during 
the cell cycle in response to changes in their association with regulatory cyclin subunits, by 
binding to stoichiometric Cdk inhibitors (CKIs) and by inhibitory tyrosine phosphorylation 
(Keaton et al., 2007; Murray et al., 2004) Fig. 1.5. 
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Figure 1.5 Mechanisms regulating cyclin-dependent kinase (Cdk) activity 
Cdk enzymatic activity is primarly controlled by binding to an activating subunit called cyclin (a). Full 
activation of a Cdk also requires the phosphorylation of a threonin residue in the T-loop of the kinase domain 
by Cdk-activating kinases (CAKs; b). The fully active cyclin-Cdk complex can be inhibited by 
phosphorylation on a tyrosine residue close to the ATP-binding site of the enzyme by Wee1-like kinases, 
while dephosphorylation of this residue by Cdc25-like phosphatases leads to reactivation of the cyclin-Cdk 
complex (c). The activity of cyclin-Cdk complexes is also negatively regulated by binding to Cdk inhibitor 
proteins (CKIs; d). Cyclin ubiquitylation by APC/C or SCF promotes cyclin degradation and Cdk 
inactivation (e). Modified from Alberts, Molecular Biology of the Cell, 2002. 
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Distinct cyclin-Cdk complexes form at specific cell-cycle stages and initiate the events 
of S and M phase and, at each of the irreversible cell-cycle transitions (G1-S, G2-M, M-
G1), one of these Cdk regulators is ubiquitinated and subsequently degraded by the 
proteosome (Reed et al., 2003). Hence there are cyclins associated with G1 (cyclin D in 
vertebrates and Cln1, Cln2 and Cln3 in budding yeast), S phase (Cyclin E and A, Clb5 and 
Clb6 in budding yeast) and mitosis (cyclin B and A and Clb1, Clb2, Clb3 and Clb4 in 
budding yeast), Fig. 1.6.  
 
Figure 1.6 Regulation of cell cycle progression by cyclin-Cdk complexes 
Activation of distinct cyclin-Cdk complexes at different stages of the cell cycle triggers the various cell cycle 
events in simple eukaryotic organisms as budding yeast (a) as well as in higher eukaryotes as mammals (b). 
Unlike budding yeast, higher eukaryotes possess several Cdks. The levels of the three major cyclin types 
oscillate during the cell cycle while the concentrations of Cdks (not shown) do not change and exceed the 
amount of cyclins, thus the activity of cyclin-Cdk complexes raise and fall in parallel with cyclin levels. 
Expression of G1 cyclins is stimulated in response to external factors (nutrient levels in S. cerevisiae, growth 
factors in mammals). G1-Cdk complexes induce the expression of G1/S cyclins thereby promoting the 
formation of active G1/S-Cdk complexes which trigger progression through the Start in late G1. S-Cdk 
complexes form at Start and initiate DNA replication at the beginning of S phase. M-Cdk complexes form 
during G2 and promote progression through the G2/M transition and the early events of mitosis. Exit from 
mitosis requires the inactivation of M-Cdks (both S- and M-Cdks in S. cerevisiae). 
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Rather than differences on substrate specificity, the multiplicity of cyclins account for 
duplication and divergence that enable different family members to perform biological 
functions that are distinct in space and time (Murray et al., 2004). First discovered in early 
embryonic cell cycle (Evans et al., 1983), complexes of Cdk2 with either cyclin E or cyclin 
A coordinate the G1/S transition, DNA replication and possibly initiate nuclear envelope 
breakdown (NBD) (Strausfeld et al., 1996). Once this is complete, Cdk1/cyclin B 
complexes orchestrate mitotic events such as NBD, Golgi fragmentation, centrosome 
separation, chromosome condensation and spindle assembly (Murray et al., 2004). 
Although mainly overlapping the function of their metazoan functional homologues, a 
series of distinct cyclins governs mitosis in budding yeast. The major S‑phase cyclin, Clb5, 
exhibits features that are reminiscent of vertebrate cyclin A: its expression increases in late 
G1, it helps to stimulate chromosome duplication and it appears to have some functions 
during mitosis. Unlike cyclin A, Clb5 is destroyed just before anaphase, together with 
securin (a negative regulator of chromosome segregation). The major mitotic cyclin, Clb2, 
is crucial for spindle assembly and progression to metaphase. Some Clb2 protein is 
destroyed at the same time as Clb5 and securin, but most remains stable until after 
anaphase (Bloom and Cross, 2007).  
Cdk activity drives cell-cycle progression as far as metaphase, but progression into 
anaphase and beyond depends on another major regulatory component, the APC/C, an E3 
ubiquitin ligase which ubiquitinates several regulatory proteins and thereby targets them to 
the proteosome for destruction (Peters, 2006; Thornton et al., 2006). As cells proceed 
through mitosis, the APC/C is activated in two ways: its subunits are phosphorylated and 
its interaction with an activating protein, named Cdc20, increases (Peters, 2002). 
Remarkably, both changes are stimulated by the activation of Cdk1. Leaving mitosis, the 
APC/C remains active but switches from being dependent on Cdc20 to being dependent on 
a related protein known as Cdh1 for its activity (Visintin et al., 1997). Unlike Cdc20, Cdh1 
is inhibited by Cdk1 dependent phosphorylation (Jaspersen et al., 1999; Zachariae et al., 
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1998) and this is one of the reasons why late mitosis and mitotic exit require the timely and 
complete inactivation of Cdk1 and destruction of cyclin B, which is itself ubiquitinated by 
Cdc20-directed APC/C. In this way, Cdks and ubiquitin machinery mutually regulate each 
other, allowing the coupled, oscillating waves of kinase activity and proteolysis to order 
the events of mitosis (Peters, 2006). 
 
Checkpoint 
While phase-specific cyclin activity and regulated proteolysis confer an order to cell 
division events, cell cycle checkpoints render the transition between phases sensitive to the 
completion of key cellular tasks and the presence of errors. The original paradigm for cell 
cycle checkpoint was provided by Weinart and Hartwell in a genetic screen for S. 
cerevisiae mutants with an impaired response to DNA damage (Weinert and Hartwell, 
1988). Whereas wild type yeast cells exposed to low doses of X-ray irradiation arrest in G2 
and do not enter mitosis until genome damage has been resolved, rad9 cells fail to arrest, 
enter mitosis, and show decreased viability. However, rad9 mutants survive irradiation if 
mitosis is prolonged by treatment with the MT depolymerizing agent nocodazole. Notably, 
loss of Rad9 protein does not impact cell cycle progression or cell viability in the absence 
of DNA damage (Hartwell and Weinert, 1989; Weinert and Hartwell, 1989). These results 
suggested that Rad9 is not directly involved in repairing the DNA but that it becomes 
critical under circumstances of severe DNA damage. Thus, early models defined 
checkpoints as non-essential backup systems that monitor but do not participate in the 
underlying cell division process. Formally, the minimal checkpoint requirements are 
thought to consist of a sensor, which detects underlying errors; a transducer, which relays 
and perhaps amplifies the sensed signal and an effector, which halts the cell cycle until 
damage has been repaired. In reality, these tasks may rely on shared components, and 
crosstalk or feedback between them may exist. Additionally, checkpoints may possess a 
shutoff step to ensure that prolonged cell cycle arrest following repair does not impair the 
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health of a cell. 
Since the RAD screen, cell cycle checkpoints that monitor multiple DNA structural 
lesions, replication fork progress, unreplicated DNA, spindle position, and chromosome 
segregation in mitosis and meiosis have been identified (Bartek et al., 2004; Zhou et al., 
2000).  
While many elements of cell cycle checkpoints are conserved in evolution, further 
characterization of yeast and metazoan checkpoints has modified the classical model in 
two broad ways. First, it has become clear that many checkpoints not only alter the cell 
cycle but also actively regulate the appropriate response, i.e. repair or apoptosis. For 
example, budding yeast Rad24 participates in both DNA double strand break (DSB) repair 
and cell cycle arrest (Aylon and Kupiec, 2003). Second, while canonical checkpoint genes 
are non-essential in yeast because they do not contribute to core processes, genetic deletion 
of homologous genes in higher eukaryotes has proven lethal (Basu et al., 1999; Brown et 
al., 2003; Dobles et al., 2000; Kitagawa et al., 1999). At least three non-exclusive models 
can explain these findings. First, the lesions monitored by such checkpoints occur in nearly 
every cell cycle in higher organism and checkpoint activity is made necessary by the 
frequency of its use; unlike with Rad9, a basal level of activity exists in the absence of an 
exogenous insult. Second, any given checkpoint activity is not active in every cell cycle, 
but the survival of a multicellular organism can be compromised by checkpoint failure in a 
few cells of a specific stages of development. Third, a checkpoint protein in higher 
organism may participate in the underlying repair process or contribute directly to cell 
cycle progression. Metazoan checkpoint proteins often have more complex multidomain 
structures than their yeast homologues and serve to integrate arrest and repair functions. 
The requirement for cell cycle checkpoints in the fitness of multicellular organisms is 
illustrated by their frequent disruption in hereditary and acquired cancers (Zhivotovsky et 
al., 2004; Lobrich et al., 2007).  
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Walking through mitosis: chromosome segregation and mitotic exit 
Although mitosis is a continuous process, chromosomal movements and other 
cytological changes allow it to be arbitrarily divided into a series of sub-phases, known as 
prophase, prometaphase, metaphase, anaphase and telophase, Fig. 1.7. 
During prophase the duplicated genomes condense into compacted chromosomes, 
each consisting of a pair of sister chromatids that are held together by cohesin proteins. 
Chromosome compaction is essential for guaranteeing the ease of movements necessary to 
separate the sister chromatids along the mitotic spindle. Next to chromosome 
condensation, other events that characterize this phase include the beginning of mitotic 
spindle formation and nucleolar break down, Fig. 1.7a. Prometaphase starts with the 
break down of the nuclear envelope. This event allows the spindle to invade the nuclear 
region and capture the condensing chromosomes. Spindle fibers or microtubules (MT) 
capture the chromosomes by their kinetochores, large proteinaceous structures that 
assemble on centromeres, Fig. 1.7b. In metaphase, microtubules pull chromosomes to the 
equator of the cell: the so-called metaphase plate. Aligned chromosomes are held in 
position by kinetochore-microtubule interactions, Fig. 1.7c. During anaphase, sister 
chromatids are separated and can now be considered individual chromosomes. Meanwhile, 
spindle fibers shorten, pulling the individual chromosomes to the opposite poles of the cell, 
Fig. 1.7d. 
Finally, in telophase separating chromosomes reach the two opposite poles, Fig. 1.7e. The 
new daughter nuclei and nuclear envelopes start to reform and chromosomes decondense. 
The mitotic spindle breaks down and the cytoplasm begins to divide, a process that is 
completed during cytokinesis and results in the formation of the two daughter cells 
(Morgan, 2007). 
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Figure 1.7 Stages of M phase (mitosis and cytokinesis) in a vertebrate cell 
Schematic representation of the events occurring during mitosis and cytokinesis in vertebrates. Adapted from 
Visintin and Ciliberto, Encyclopedia of System Biology. Images are a courtesy of Dr. Conly Rieder. 
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Proper chromosome segregation requires that duplicated chromosomes (sister 
chromatids) are bi-polarly attached to microtubules (MTs). Bi-polar attachment is achieved 
when sister chromatids bind microtubules emanated by opposite poles. Microtubules are 
hollow filaments approximately 25 nm diameter (Amos and Klug, 1974). Each tubule 
forms from the parallel association of 13 linear tubulin protofilaments, which in turn form 
from GTP-dependent polymerization of !"-tubulin heterodimers (Weisenberg and Deery, 
1976). The asymmetry of the tubulin heterodimer imposes directionality on the MTs. !-
tubulin subunits are exposed at the more stable minus end of the MT and tend to be buried 
in MTOCs. "-tubulin subunits are exposed at the less stable, dynamically growing plus end 
of the MTs. The behavior of individual MTs is characterized by “dynamic instability” 
(Mitchison et al., 1984), meaning that the polymer switches stochastically between phases 
of growth, pauses, and sudden disassembly by a GTP dependent mechanism. Microtubules 
dynamicity directs spindle assembly and contributes to the forces necessary for 
chromosome segregation. When a microtubule encounters (by chance) a specialized 
structure in the chromosome’s primary constriction –the kinetochore– it is captured and 
stabilized. As spindle assembly progresses, kinetochore fibers, which are bundles of 
microtubules that link each kinetochore to opposite spindle poles, form. Concurrently, as a 
result of the stabilization of microtubules by the kinetochores, the initially symmetric array 
of astral microtubules is transformed into a typical spindle-like shape.  
Despite the appealing simplicity of the search-and-capture model, this mechanism 
could not explain mitosis in cells that lack centrosomes, for example plant cells and 
oocytes. A variety of experiments have shown that chromatin plays a key role in spindle 
assembly in acentrosomal cells (Heald et al., 1996). Addition of DNA to Xenopus eggs and 
extracts lacking centrosomes results in microtubule formation near chromatin; 
kinetochores are not required for microtubule assembly under these conditions (Karsenti et 
al., 1984). Further experiments show that the small GTPase Ran, in its active GTP-bound 
form, can stimulate microtubule formation in the absence of centrosomes (Carazo-Salas et 
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al., 1999). GTP–Ran is generated near chromosomes because its exchange factor, Rcc1, 
localizes to chromatin (Carazo-Salas, 1999). Ran promotes spindle assembly by releasing 
spindle-assembly factors and molecular motors from inhibition by importin ! and " (Ems-
McClung et al., 2004; Gruss et al., 2001). A unifying model proposed by Wadsworth and 
Khodjakov suggests that spindle assembly might proceed by a generally conserved 
acentrosomal mechanism in all higher eukaryotes (Wadsworth and Khodjakov, 2004). 
They argued that, where present, the role of centrosome is to integrate preassembled 
spindle components such as kinetochore fibers and microtubule bundles into a common 
spindle, and to position the spindle in the cell. Recent observations in Jan Ellenberg 
laboratory by quantitative high-resolution confocal live-imaging further enrich this model. 
Looking at chromosome segregation driven by the acentrosomal spindle of maturing 
mouse oocytes, Ellenberg and colleagues showed that a microtubule network in prophase 
promotes the formation of multiple microtubules organizing centers (MTOCs) that in turn 
self organize in a fully functional barrel-shaped spindle in a kinesin-5 dependent manner 
(Schuh et al., 2007). 
The terminology that describes the microtubules-kinetochore attachments accounts 
for both kinetochore orientation and the pole of origin of interacting microtubules, Fig. 1.8. 
Monotelic attachment is a normal stage of microtubules-kinetochore attachment and 
chromosome biorientation processes. In this condition only one kinetochore in a sister 
chromatid pair is attached to kinetochore microtubules, while the other is not. In contrast, 
in syntelic attachment, both sister kinetochores face and become attached to the same pole. 
Finally, merotelic attachments occur when either one or both sister kinetochores bind 
microtubules that arise from both poles even though they orient toward opposite poles. 
However, the only kinetochore-microtubule interaction resulting in proper chromosome 
segregation is the amphitelic or bipolar attachment. In the latter case, the sister 
kinetochores face opposite poles and each kinetochore binds only spindle microtubules 
irradiating from the pole it is facing.  
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Figure 1.8 Type of microtubules-kinetochore attachments 
(adapted from (Pinsky and Biggins, 2005)). 
 
Sister chromatids are held together from S-phase through metaphase by cohesin. The 
cohesin complex – composed of two SMC proteins, Smc1 and Smc3, and two non-SMC 
components Scc1 and Scc3 – loads onto DNA during replication (Guacci et al., 1997; 
Nasmyth, 2002; Uhlmann, 2004). The discovery that cohesin’s cleavable "-kleisin subunit 
Scc1 bridges the two heads of V-shaped Smc1/Smc3 heterodimers suggests that cohesin’s 
stable association with chromatin arise from the trapping of double helical DNA molecules 
inside the tripartite ring created by Scc1, Smc1, and Smc3 (Haering et al., 2002; Ivanov et 
al., 2005). 
Once all kinetochores have matured bipolar attachment to the mitotic spindle, the 
cell is defined as being in metaphase. Now, chromosome congress toward the center of the 
spindle to form the metaphase plate and tension is generated at kinetochores. APC/C then 
targets securin Pds1 for degradation (Yamamoto et al., 1996a; Yamamoto et al., 1996b), 
which in turn activates Separase, a protease that cleaves the Scc1 subunit of cohesin, 
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allowing the sisters to separate (Ciosk et al., 1998).  
Metaphase ends with the rapid and almost synchronous separation of all the sister 
chromatids, which begin to segregate to opposite poles of the spindle (anaphase A), 
followed by elongation of the spindle itself. Once each set of sister chromatids has reached 
opposite spindle poles, the chromatids begin to decondense, the nuclear envelope re-forms 
and the mitotic spindle disassembles (telophase). 
 
The Yeast mitosis 
 In most organisms, the accumulation of mitotic Cdk activity is prevented by 
inhibitory phosphorylation on Tyr15 mediated by Wee1 family of kinases. This event 
delays mitotic entry providing time to the cells to continue their growth and preparation for 
cell division (Morgan, 2007). This “Gap time” is called G2 phase. Only when Cdks are 
dephosphorylated by Cdc25 family phosphatase, mitotic Cdks can be activated and cells 
can progress into metaphase. Expression of a mutant version of Cdk, that can no longer be 
tyrosine phosphorylated causes premature mitotic entry in S. pombe (Gould and Nurse, 
1989) or human cells (Krek and Nigg, 1991), but not in budding yeast (Amon et al., 1992). 
The phosphorylation of this specific tyrosine occurs also in budding yeast but its primary 
function is to delay the cell cycle in response to morphogenesis checkpoint activated by 
perturbation of the actin cytosckeleton (Keaton and Lew, 2006). Therefore, budding yeast 
lacks a canonical G2 phase and does not undergo a typical G2/M transition. However, in 
G2/M M-cyclins (CLB1, 2, 3 and 4) expression is switched on. This process depends, at 
least in part, on M-Cdk activity itself. Indeed, the rising M-Cdk activity promotes the 
activation of the gene regulatory factor Mcm1-Fkh1/2-Ndd1 which trigger the expression 
of the CLB2 cluster genes, comprising genes encoding for mitotic regulators. This cluster 
includes genes encoding for M-cyclin Clb1 and Clb2, the APC/C activator Cdc20 and the 
polo-like kinase Cdc5.  
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Mitotic entry 
 In contrast to higher eukaryotes, Saccharomyces cerevisiae undergoes a closed 
mitosis and possess a relatively simple spindle in which the main MTOCs spindle pole 
bodies (SPBs) remain embedded in the nuclear envelope and chromosomes are bound to 
microtubules throughout the cell cycle with the possible exception of a brief period during 
the replication of centromeres (Adams and Kilmartin, 2000). This results in close 
association between chromosomes and SPBs from telophase through prometaphase in 
budding yeast (Guacci et al., 1997). 
 During entry into mitosis sister-chromatids condense into a rod-like structure in 
order to be easily moved and separated. Two sets of microtubles nucleated by the 
duplicated, opposing spindle pole bodies (SPBs) interdigitate in the spindle midzone to 
form a bipolar array of microtubules called mitotic spindle. Next, duplicated spindle pole 
bodies (SPBs) migrate towards the opposite site of the nucleus. Faithful chromosome 
segregation during mitosis requires sister-chromatids to be properly aligned on the mitotic 
spindle prior to cohesion loss. Sister chromatids are aligned in metaphase by the 
microtubule based mitotic spindle, which attaches to individual chromatids via the 
kinetocore, a large protein complex that assembles on centromeric DNA. Unlike 
metazoans, however,  budding yeast chromosomes do not undergo congression per se. S. 
cerevisiae kinetochores do adopt a highly characteristic bilobed metaphase configuration 
analogous to the metaphase plate (Goshima et al., 2000; He et al., 2000). This bilobed 
localization pattern is the result of both transient sister separation caused by tension across 
centromeres and chromosome oscillation and it changes subtly on a timescale of seconds 
as the extent of overlap among microtubules varies (He et al., 2000). Similarly to 
Metazoans, microtubules attachment to kinetocores proceeds through a random “search 
and capture” mechanism, which does not guarantees proper sister-chromatids orientation 
(McIntosh et al., 2002; Walczak and Heald, 2008). Of course, to guarantee the accurate 
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segregation of the duplicated chromosomes, the attachment of all the sister-chromatids to 
the mitotic spindle has to occur in a bipolar manner, with the two chromatids of a pair 
bound to microtubules originating from opposite poles. Dedicated surveillance 
mechanisms exist to monitor and correct improper sister-chromatids orientation. Cells 
determine if sister-chromatids are properly attached and oriented on the spindle by 
monitoring the status of tension at sister-kinetocores. Tension is generated across sister-
kinetocores when cohesin complexes linking sister-chromatids resist pulling forces exerted 
by the microtubules emanating from opposite spindle poles (Dewar et al., 2004; Tanaka et 
al., 2002; Tanaka et al., 2005). Co-oriented sister-chromatids, or those pairs in which only 
one sister is attached to a microtubule, are unable to generate tension. Kinetocore-
microtubule attachments that fail to generate tension are detached by the Aurora family 
kinases Ipl1 (Biggins et al., 2001; Dewar et al., 2004; Tanaka et al., 2002), that activates 
the spindle assembly checkpoint (SAC). The SAC is a surveillance mechanism that 
monitors the segregation of the genetic material during mitosis, and delays the onset of 
anaphase until all the requirements are satisfied. Even if a single kinetocore is not properly 
attached, a “wait” anaphase signal is generated that prevents sister-cromatids separation.  
Once SAC is active it delays the metaphase-anaphase transition until all sister-chromatids 
are properly bi-oriented on the spindle. The uninterrupted destabilization of improper 
kinetocore-microtuble attachment by Ipl1 ensures that all sister-chromatids re-establish a 
correct microtubule attachment now able to generate tension. Only when tension is 
detected across all sister-chromatids, will the SAC be satisfied and metaphase proceed into 
anaphase.  
 The kinases regulating the entry into mitosis are the Clb1-4 mitotic cyclin-Cdks 
whose transcription has already initiated in G2 phase and whose activation is permitted by 
the degradation of their inhibitors Sic1 and Swe1. Sic1 is targeted to proteasomal 
degradation by phosphorylation mediated by the Cln1/Cln2 G1/S-phase cyclins. While 
responsible for Swe1 degradation is the bud neck-localized fraction of the Polo-like kinase 
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Cdc5 that phosphorylates and targets Swe1 for proteosomal degradation via APC/CCdh1.  
 
Exit from Mitosis 
Exit from mitosis is the process by which sister chromatids are abruptly separated 
through the cleavage of the cohesin complex and then pulled towards the opposite poles of 
the spindle, culminating in the splitting of two identical cells. It is initiated by the activation 
of the Anaphase-Promoting Complex or Cyclosome (APC/C) and by the down-regulation 
of Cdk1 complexes. Next, the phosphate groups that Cdk1 added to its targets and allowed 
cells to enter mitosis must be removed so that the cells can exit from mitosis, a process 
taken care of by specific phosphatases (De Wulf et al., 2009; Queralt and Uhlmann, 2008). 
 Within mitotic exit, two major transitions are identified: i) the metaphase-anaphase 
transition and ii) the telophase-G1. 
 
The metaphase-anaphase transition 
 Passage from metaphase to anaphase is triggered by the dissolution of cohesion 
between the sister-chromatids. At anaphase onset, the Scc1/Mcd1 subunit of the cohesin 
complex is cleaved by a CD clan family protease called Separase (Esp1 in S. cerevisiae, 
reviewed in (Nasmyth, 2001)), which unlinks the sister chromatids and allow them to be 
pulled to the opposite poles of the cell (Ciosk et al., 1998; Uhlmann et al., 1999). Prior to 
anaphase, Separase is kept inactive by the binding of Securin (Pds1 in budding yeast) 
(Ciosk et al., 1998; Yamamoto et al., 1996). Pds1 plays two opposing roles in Esp1 
regulation: an activating one promoting the nuclear import of Esp1 (Jensen et al., 2001; 
Agarwal and Cohen-Fix, 2002), and an inhibitory one by keeping Separase inactive 
through the binding (Ciosk et al., 1998). The crucial event that make Separase free is the 
activation at the metaphase-anaphase transition of the anaphase promoting complex 
APC/C in association with its specificity factor Cdc20, that once active targets Psd1 for 
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proteosomal degradation (Ciosk et al., 1998; Cohen-Fix et al., 1996; Peters, 2006), Fig. 
1.9. At this time APC/CCdc20 targets for degradation also S- and M-phase cyclins a process 
that culminates in cyclins full and partial elimination, respectively. 
 
Figure 1.9 APC/C triggers the metaphase-anaphase transition 
In all the eukaryotic organisms APC/CCdc20 ubiquitylates securin (Pds1 in S. cerevisiae) and thereby targets it 
for proteolysis by the proteasome. This process liberates separase (Esp1 in S. cerevisiae) and allows it to 
mediated the proteolytic cleavage of the cohesin subunit Scc1. This event triggers the initiation of sister-
chromatid separation.  
 
 
Telophase-G1 
 The telophase-G1 transition requires the complete inactivation of the Clb-Cdk 
complexes and removal of the phosphate groups that Cdk added to its targets. 
 In contrast to most other eukaryotes in which M-Cdks inactivation is completed at 
the meta-to-anaphase transition, in budding yeast a pool of mitotic Cdk activity persists 
until anaphase spindle elongation is complete (telophase) (Jaspersen et al., 1998; 
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Shirayama et al., 1994; Surana et al., 1993). In this organism, this pool of mitotic Cdk 
activity is primarily inactivated during later stages of anaphase by the APC/C now 
associated with its specificity factor Cdh1, which targets mitotic cyclins for ubiquitin-
mediated proteolysis, Fig. 1.10 (Peters, 2002; Visintin et al., 1997; Zachariae et al., 1998).  
 
Figure 1.10 APC/C promotes exit from mitosis 
In eukaryotic organisms, exit from mitosis requires the inactivation of M-Cdks, which is mainly obtained by 
the degradation of mitotic cyclins (Clb cyclins in S. cerevisiae). In most eukaryotes, mitotic cyclin 
degradation is initiated and completed at the metaphase-anaphase transition by the APC/CCdc20. In contrast, in 
budding yeast a pool of Clb-Cdk activity persists until late anaphase. In this organism, Clb cyclin 
degradation is initiated by APC/CCdc20 at the metaphase-anaphase transition and completed by APC/CCdh1 in 
late anaphase. In all eukaryotes, the APC/CCdh1 maintains mitotic Cdks (Clb-Cdks in S. cerevisiae) inactive in 
G1. 
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Accumulation of the Cdks inhibitor Sic1, which directly binds to, thereby inhibiting, 
the cyclin-Cdk complexes, further ensures the precipitous inactivation of the M-Cdk at the 
end of mitosis (Mendenhall, 1993; Schwob et al., 1994). Responsible for both the 
activation of the APC/CCdh1 and the accumulation of Sic1, is the highly conserved protein 
phosphatase Cdc14 (Visintin et al., 1998), Fig. 1.11.  
 
 
Figure 1.11 The protein phosphatase Cdc14 triggers exit from mitosis in S. cerevisiae 
In the budding yeast S. cerevisiae the protein phosphatase Cdc14 is responsible for triggering Clb-Cdk 
inactivation in late mitosis by promoting both the activation of the APC/CCdh1 and the accumulation of the 
Clb-Cdk inhibitor Sic1.  
 
 Beside cyclin-Cdks inactivation, the fate of the substrates that had been 
phosphorylated by cyclin-Cdks is of equal importance. When the cells have to exit mitosis 
cyclin-Cdks phosphorylation have to be reverted. This further contributes to the resetting 
of the cell cycle to G1. The timing of Cdks substrates dephosphorylation is not dictated 
simply by the time of cyclin-Cdk kinase inactivation (via cyclin degradation) but also by 
the dynamics of specialized phosphatases able to catalyze the reverse reaction. As for the 
Cdk dependent phosphorylation, also the dephopshorylation of Cdks targets occurs in a 
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specific order to guarantee the correct sequence of cell cycle events (De Wulf et al., 2009; 
Sullivan and Morgan, 2007).  
 In budding yeast responsible for this task is the protein phosphatase Cdc14. Indeed 
cell lacking Cdc14 function arrest in late anaphase with high mitotic Cdks activity 
(Visintin et al., 1998; Wan et al., 1992). Conversely, overexpression of CDC14 results in 
inappropriate mitotic Cdks inactivation (Visintin et al., 1998). Cdc14 promotes mitotic 
Cdks inactivation by reversing Cdks phosphorylation events. Cdc14 dephosphorylates 
Cdh1 making it able to bind APC/C, thereby activating the complex (Visintin et al., 1998; 
Zachariae et al., 1998; Jaspersen et al., 1998). This APC/C activation, as previously said, 
induces the degradation of M-cyclins. Furthermore Cdc14 phosphatase dephosphorylates 
the Cdks inhibitor Sic1 and its transcription factor Swi5. Swi5 dephosphorylation induces 
its translocation from the cytoplasm to the nucleus where it triggers SIC1 transcription. 
While dephosphorylation of Sic1 prevents its degradation by the ubiquitin-protein ligase 
SCFCdc4, resulting in Sic1 stabilization (Moll et al., 1991; Knapp et al., 1996; Feldman et 
al., 1997; Skowyra et al., 1997; Visintin et al., 1998; Jaspersen et al., 1999).  Thus, Cdc14 
provides the accumulation of Sic1 and thus the inhibition of M-Cdks. Cdc14 has many 
other substrates in the cell, and it is likely that Cdc14 dephosphorylate many if not all Clb-
Cdks substrates, contributing to the regulation of multiple processes during anaphase.  
 
Regulation of Cdc14 during mitosis in S. cerevisiae 
 The activity of Cdc14 is controlled by changes in its subcellular localization. For 
most of the cell cycle up to metaphase Cdc14 is kept inactive in the nucleolus by the 
binding to its competitive inhibitor Cfi1 (also known as Net1) (Shou et al., 1999; Visintin 
et al., 1999). During anaphase, Cdc14 becomes released from its inhibitor, spreading in the 
nucleus and in the cytoplasm, where it dephosphorylates its substrates. The dissociation of 
Cdc14 from its inhibitor during anaphase is controlled by the sequential activation of two 
regulatory networks (Stegmeier and Amon, 2004). At the onset of anaphase, the Cdc 
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Fourteen Early Anaphase Release (FEAR) network  initiates the release of Cdc14 from its 
inhibitor and the phosphatase spreads throughout the nucleus, while during the later stages 
of anaphase the Mitotic Exit Network (MEN) induces further release of Cdc14 and results 
in Cdc14 being released both in the nucleus and in the cytoplasm and maintains the 
phosphatase in its released state, Fig. 1.12. 
 
 
 
Figure 1.12 Regulation of Cdc14 during the cell cycle 
The activity of Cdc14 is controlled by changes in its intracellular localization. From G1 up to metaphase, 
Cdc14 is sequestered in the nucleolus by binding to its inhibitor Cfi1. During anaphase Cdc14 is released 
from its inhibitor as a consequence of the sequential activation of two signaling networks. The FEAR 
network promotes a transient nuclear release of Cdc14 from the nucleolus during early anaphase. The Mitotic 
Exit Network (MEN) promotes a sustained release of the phosphatase from its inhibitor both in the nucleus 
and into the cytoplasm during later stages of anaphase. When exit from mitosis is completed Cdc14 is 
resequestered in the nucleolus. Concentrations of Cdc14 are shown in different shades of green, where dark 
green corresponds to high amount of Cdc14 and light green corresponds to low amount of Cdc14; nucleus, 
blue; microtubules, red lines. 
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The qualitative difference in Cdc14 release caused by the FEAR network (primarily 
nuclear) and by the MEN (nuclear and cytoplasmic) is at the basis of Cdc14 function 
regulation. Interestingly, two screens aimed to identify loss-of-function mutants able to 
bypass the mitotic exit defect of the MEN mutant identified proteins involved in the 
nuclear-cytoplasmic transport (Asakawa and Toh-e, 2002; Shou and Deshaies, 2002). In 
addition to give rise to a qualitative difference in Cdc14 release, there are quantitative 
differences in the extent that FEAR network and MEN promote exit from mitosis. Indeed, 
the release of Cdc14 induced by the MEN is essential for mitotic exit as MEN mutant 
arrest in late anaphase with high levels of mitotic Cdk activity (Jaspersen et al., 1998; 
Shirayama et al., 1994b; Yoshida et al., 2002). In contrast, the FEAR-dependent release of 
Cdc14 is required for a timely exit from mitosis but it is not essential for this process. This 
is demonstrated by the fact that mutation in FEAR network components delay, but do not 
prevent, exit from mitosis (Pereira et al., 2002; Stegmeier et al., 2002; Yoshida et al., 
2002). Furthermore the Cdc14 release induced by the FEAR network is transient, as in 
absence of MEN signaling Cdc14 is not maintained in its released state but it is re-
sequestered in the nucleolus (Pereira et al., 2002; Shou et al., 1999; Stegmeier et al., 2002; 
Visintin et al., 1999; Yoshida et al., 2002). These observations imply that Cdc14 activated 
by the FEAR network does not lower mitotic Cdks enough to trigger exit from mitosis. 
This inability may be explained by the fact that the FEAR network is not able to direct 
large amount of Cdc14 to the cytoplasm, where its main targets for mitotic exit Cdh1 and 
Swi5 are located, and that the FEAR network activity is restricted to a brief window during 
early anaphase (Nasmyth et al., 1990). Despite qualitative and quantitative differences in 
FEAR network and MEN-mediated Cdc14 activation, the question arises as to why 
budding yeast uses two pathways rather then one to regulate Cdc14 activity. Employing 
multiple pathways may allow for more elaborate regulation of exit from mitosis. Another 
possibility is that the Cdc14 fraction released by the FEAR network performs function 
during mitosis that are different from that of the Cdc14 fraction release by the MEN. A lot 
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of studies underscored this idea. Indeed, Cdc14 released by the FEAR network has been 
implicated in regulating different processes during anaphase, such as chromosomes 
segregation and localization of chromosomal passenger proteins (see below, Pereira et al., 
2003; D’Amurs et al., 2004). A hypothesis is that the levels of Cdc14 activity needed to 
accomplish these tasks are lower than the one needed to promote exit from mitosis. Hence, 
a pathway that activates briefly Cdc14 would allow the phosphatase to accomplish these 
early anaphase events, while a pathway that leads to the complete release and a full 
activation of the Cdc14 would allow the phosphatase to perform its mitotic exit-promoting 
function. Furthermore, the fact that different anaphase events depend on different and 
increasing amounts of Cdc14 activity might help to establish the order by which they occur 
(Bouchoux and Uhlmann, 2011). 
 
Regulation of Cdc14/Cfi1 interaction 
 Although it is clear that the FEAR network and the MEN promote the release of 
Cdc14 from its inhibitor during anaphase, the molecular mechanisms by which they break 
the complex apart are only partially understood. The observation that both Cdc14 and Cfi1 
are phosphorylated during anaphase and that the timing of these phosphorylations correlate 
with the timing or Cdc14 release from the nucleolus, raised the possibility that the complex 
dissociation was regulated by this post-transcriptional modification (Shou et al., 2002; 
Visintin et al., 2003; Yoshida and Toh-e, 2002). Consistent with this notion, the 
phosphorylation of Cfi1 destabilises the complex in vitro (Shou et al., 2002a). Moreover it 
has been demonstrated that the phosphorylation of Cfi1 by the FEAR network is essential 
for the release of Cdc14 during the early stages of anaphase (Azzam et al., 2004).  
 Responsible for the phosphorylation events leading to the dissociation of the 
complex is a combination of specific kinases involved in both the FEAR network and the 
MEN that leads to the dissociation of Cdc14 from its inhibitor in early anaphase  and then 
in late anaphase respectively (see next session). 
 42 
 
The Cdc Fourteen Early Anaphase Release (FEAR) network 
 That a MEN-independent release of Cdc14 existed was first discovered in MEN 
mutants. Indeed, several groups observed Cdc14 is transiently released into the nucleus 
during early anaphase even in the absence of MEN activity (Pereira et al., 2002; Stegmeier 
et al., 2002; Yoshida et al., 2002). Several proteins, collectively referred to as FEAR 
network, are required for the release and thus activation of Cdc14 during the early stages 
of anaphase, Fig 1.13. 
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Figure 1.13 The Cdc Fourteen Early Anaphase Release (FEAR) network 
At anaphase onset, the degradation of securin (Pds1) induced by the APC/CCdc20 leads to the activation of 
separase (Esp1), an essential component of the FEAR network. Separase, together with Slk19, induces the 
downregulation of of the protein phosphatase PP2ACdc55,  a process that requires the Cdc55-interacting 
proteins Zds1 and Zds2. This allows the Clb2-Cdk-dependent phosphorylation of Cfi1 and Spo12, which 
lead to the dissociation of Cdc14 from its inhibitor. Cfi1 phosphorylation by Clb2-Cdk directly promotes the 
dissociation of the Cdc14-Cfi1 complex. Spo12 phosphorylation by Clb2-Cdk induces the protein to inhibit 
Fob1, which inhibits the dissociation of the Cdc14-Cfi1 complex. The activity of the polo-like kinase Cdc5 is 
also required for the release of the phosphatase at this stage of the cell cycle. 
 
 
 The FEAR network is comprised of the separase Esp1, the separase-binding protein 
Slk19, the small nucleolar protein Spo12 and its homologue Bns1, the replication fork 
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(PP2ACdc55), the Clb2-Cdk kinase complex and the Polo-like kinase Cdc5 (Azzam et al., 
2004; Pereira et al., 2002; Queralt et al., 2006; Stegmeier et al., 2002; Sullivan and 
Uhlmann, 2003; Yoshida and Toh-e, 2002). Among all, positive regulators of the FEAR 
are Esp1, Slk19, Spo12, Bns1, Clb2-Cdk and Cdc5, while proteins that regulate the FEAR 
network activity in a negative manner are Fob1 and PP2ACdc55. Epistasis analysis suggests 
that the FEAR network consists of at least two parallel branches, with SPO12, BNS1 and 
FOB1 functioning in one branch of the pathway, and ESP1 and SLK19 in the other 
(Sullivan and Uhlmann, 2003; Visintin et al., 2003). The Polo-like kinase Cdc5 acts 
downstream of, or in parallel to, the ESP1-SLK19 branch. The position of Cdc5 within the 
FEAR is difficult to determine because Cdc5 is also a regulator of the MEN pathway. It is 
however likely that Cdc5 is the ultimate effector of the FEAR network, as its 
overexpression suppresses the defects in Cdc14 release of cells impaired in both SPO12 
and ESP1 branches and it is sufficient to promote ectopic release of Cdc14 in absence of 
MEN and Esp1 activity (Visintin et al., 2008; Visintin et al., 2003). Little is known about 
the relationship among FEAR network components. Slk19 is cleaved by Esp1 at the 
metaphase-anaphase transition (Sullivan et al., 2001) but Slk19 cleavage is not required for 
its mitotic exit function (Stegmeier et al., 2002; Sullivan et al., 2003). Remarkably, Esp1 
promotes the release of Cdc14 independently of its protease function (Buonomo et al., 
2003; Sullivan et al., 2003), but the nature of this protease-independent signalling 
mechanism remains elusive. Rather than Slk19 being regulated by Esp1, it seems that they 
function together to promote Cdc14 release from the nucleolus. Slk19 forms a complex 
with Esp1 targeting Esp1 to kinetocores and the spindle midzone (Sullivan et al., 2003). 
Thus it is possible that Slk19 promotes the protease-independent function of Esp1. 
Importantly, both the protease dependent and independent function of Esp1 are inhibited 
by the securin Pds1, thus enabling securin to restrain both the onset of sister-chromatids 
separation and FEAR-mediated activation of Cdc14 (Sullivan and Uhlman, 2003). A study 
by Azzam and colleagues provided insights into the mechanisms by which the FEAR 
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network promotes the release of Cdc14 from its inhibitor Cfi1. They showed that Cfi1 
phosphorylation by Clb2-Cdk on six Cdk consensus sites is essential for the release of 
Cdc14 from the nucleolus during early anaphase. Indeed mutants carrying mutations of 
these 6 residues into alanine, an amino acid that can no longer be phosphorylated, exibit 
defects in Cdc14 release from the nucleolus during early anaphase (Azzam et al., 2004). 
The FEAR negative regulator PP2ACdc55 initially antagonizes the Clb2-dependent 
phosphorylation of Cfi1 keeping Cfi1 itself in an hypophosphorylated form during 
metaphase (Queralt et al., 2006). At the metaphase-anaphase transition, once securin is 
degraded, Esp1 in complex with Slk19 triggers the downregulation of PP2ACdc55. Although 
the mechanism by which Esp1 promotes PP2ACdc55 inactivation remains unknown, 
PP2ACdc55 inactivation results in an increase of Clb2-Cdk-dependent phosphorylation of 
Cfi1, that culminates in the dissociation of Cdc14 from its inhibitor (Queralt et al., 2006).  
 Cdc5 plays an essential role in Cdc14 release from the nucleolus (Stegmeier et al, 
2002; Yoshida et al., 2002; Visintin et al., 2008). Indeed, cdc5 mutant cells are impaired in 
the release of Cdc14 during both early and late anaphase. When overexpressed, Cdc5 can 
release Cdc14 from the nucleolus in the absence of MEN function (Visintin et al., 2003). 
Moreover inactivation of the kinase is sufficient to induce ectopic re-sequestration of 
Cdc14 in the nucleolus (Visintin et al., 2008). The way through which Cdc5 contributes to 
Cdc14 release from the nucleolus during early anaphase is still unknown. It has been 
observed that the overexpression of CDC5 induces the ectopic release of Cdc14 with a 
concomitant appearance of phosphorylated forms both Cdc14 itself and Cfi1 (Visintin et 
al., 2003). Both Cdc14 (unpublished data) and Cfi1 (Shou et al., 2002) are phosphorylated 
by Cdc5 in vitro and Cfi1 phosphorylation by Cdc5 has been demonstrated to induce the 
dissociation of the complex Cdc14-Cfi1. Thus, Cdc5 could mediate Cdc14 release in early 
anaphase by directly promoting Cdc14 and/or further Cfi1 phosphorylation. Consistent 
with this hypothesis Cdc5 directly interact with Cdc14 in vitro (Rahal and Amon, 2008). 
Furthermore, Cdc5 promotes the release of Cdc14 during early anaphase also in an indirect 
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way. It induces Clb2-Cdk-dependent phosphorylation of Cfi1 through a PP2ACdc55 
independent mechanism (Liang et al., 2009). At anaphase onset, Cdc5 phosphorylates, thus 
promoting its degradation, the M-Cdks inhibitor Swe1. Swe1 degradation results in Clb-
Cdks activation thus leading to a Clb2-Cdk dependent phosphorylation of Cfi1 culminating 
in Cdc14 release from the nucleolus (Liang et al., 2009). 
 Several studies provided insights into the mechanism by which Spo12, together with 
the FEAR inhibitor Fob1, promotes the release of Cdc14 from Cfi1. The replication fork 
block Fob1 directly binds Cfi1, preventing the dissociation of Cdc14 from the complex 
(Stegmeier et al., 2004). Spo12 also binds this multicomplex, and once it is phosphorylated 
by Clb2-Cdk kinase in early anaphase (Tomson et al., 2009), it induces a conformational 
change in Fob1 which reduces its ability to inhibit the dissociation of Cdc14-Cfi1 complex. 
Recently chromatin has also been implicated in regulating the release of Cdc14 
from the nucleolus during early anaphase. More specifically, monoubiquitination of 
histone H2B and methylation of histone H3 seem to be required for Cdc14 release from the 
nucleolus at this cell cycle stage (Hwang et al., 2009). The modified chromatin structure 
would allow the access of the FEAR network components to the Cdc14-Cfi1 complex 
(Hwang et al., 2009). 
 
The Mitotic Exit Network (MEN) 
The Mitotic Exit Network (MEN) was the first signaling network identified to 
regulate the subcellular localization of Cdc14 (Shou et al., 1999; Visintin et al., 1999). The 
MEN resembles a Ras-like signaling cascade and is comprised of the GTPase Tem1, a 
positive regulator Lte1, the two-component GAP (GTPase-activating protein) Bub2-
Bfa1/Byr4, the protein kinases Cdc5, Cdc15 and Dbf2, the Dbf2-associated factor Mob1, 
and the scaffold protein Nud1 (Bardin and Amon, 2001). Inactivation of this signaling 
cascade causes cells to arrest in late telophase with Cdc14 sequestered in the nucleolus 
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(Shou et al., 1999; Visintin et al., 1999). A combination of genetic and biochemical 
investigations suggested the model for MEN signalling outlined in Fig. 1.14. 
 
Figure 1.14 The Mitotic Exit Network (MEN) 
(a) The MEN is a Ras-like signaling cascade which promotes the release of Cdc14 from its inhibitor Cfi1 
during late anaphase. Although the MEN is sufficient to promote the release of Cdc14 from Cfi1, in an 
umperturbed cell cycle FEAR network activity contributes to MEN activation (shown in gray). The GTPase 
Tem1 acts at the top of the MEN and is positively regulated by Lte1 and negatively regulated by the Bub2-
Bfa1 complex. Once activated, Tem1 propagates the signal to the protein kinase Cdc15, which in turn 
activates Dbf2-Mob1. Nud1 acts as a scaffold for Tem1, Cdc15, Dbf2, Bub2 and Bfa1 on the spindle pole 
body (SPB). MEN activation is achieved by: (1) inactivation of Bub2-Bfa1 promoted by Cdc5 activity and 
by separase (Esp1)-dependent downregulation of the protein phosphatase PP2ACdc55; (2) dephosphorylation 
of Cdc15 by the FEAR network-released Cdc14; (3) movement of the Tem1-bearing SPB into the bud, where 
Lte1 is located; (4) inactivation of Kin4, a key component of the spindle position checkpoint (SPOC; shown 
in blue), which prevents MEN activation until the spindle is correctly aligned along the mother-bud axis. 
Active MEN promotes a sustained release of Cdc14 from the nucleolus both in the nucleus and in the 
cytoplasm. Once released Cdc14 further stimulates MEN activity. (b) Terminal phenotype of the cdc15-2 
MEN mutant. cdc15-2 cells arrest in telophase with Cdc14 sequestered in the nucleolus. 
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The activated form of Tem1, which is likely but not proven to be the GTP-bound 
form, is thought to propagate the signal to the downstream protein kinase Cdc15. Cdc15, in 
turn, stimulates Dbf2 kinase activity, a process that requires the Dbf2-associated factor 
Mob1 (Bardin and Amon, 2001). Tem1’s GTPase activity is negatively regulated by the 
GAP complex Bub2-Bfa1 in a GAP dependent and independent manner (Bardin et al., 
2000; Fraschini et al., 2006). The Bub2-Bfa1 complex inhibits Tem1 protein in two ways: 
on one hand by promoting the hydrolysis of GTP to GDP, switching off the protein 
activity, and on the other hand simply by binding. The GAP activity is given by Bub2 
(Geymonat et al., 2003) which carries a GAP TBC (Tre-2, Bub2 and Cdc16; (Neuwald et 
al, 1997)) domain, whereas the Bfa1 subunit is responsible for the physical interaction of 
the GAP complex with Tem1 (Ro et al., 2002). Recent observations suggested that a 
mutant version of the Bub2-Bfa1 complex depleted for its GAP activity towards Tem1, is 
still able to inhibit mitotic exit in response to the activation of the spindle position 
checkpoint (SPOC; Fraschini et al., 2006), thereby suggesting that Bub2-Bfa1 may 
completely inhibit Tem1 through a GAP-independent mechanism. 
Lte1 is a positive regulator of Tem1 which shares homology with the guanosine 
nucleotide exchange domain of the Ras-guanosine nucleotide exchange factor (GEF) 
Cdc25 (Shirayama et al., 1994). Since TEM1 was isolated as a high copy number 
suppressor of the cold sensitivity lte1 mutant, Lte1 was initially proposed to function as a 
GEF for Tem1 (Shirayama et al, 1994; Keng et al., 1994). However recent studies suggests 
that Lte1 does not rely on nucleotide-exchange activity for activating Tem1 and suggest 
that Lte1 regulates Tem1 by influencing the subcellular localization of Bfa1 (Geymonat et 
al., 2009); which appears to be an important factor in regulating MEN activation (Pereira 
et al., 2001; Fraschini et al., 2006; Pereira and Schiebel, 2005; Molk et al, 2004). The polo-
like kinase Cdc5 has long been thought to be a component of the MEN signalling cascade, 
as cells lacking CDC5 exhibit a phanotype similar to that of MEN mutants, arresting in late 
anaphase with Cdc14 sequestered in the nucleolus (Jaspersen et al., 1998; Kitada et al., 
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1993; Lee et al., 2001a). Recent studies, however suggested that Cdc5 is not a core 
component of the MEN signalling cascade. Instead, Cdc5 is essential for exit from mitosis 
because it activates the MEN pathway in multiple ways. Cdc5 phosphorylates Bfa1, which 
results in the inhibition of the Bub2-Bfa1 GAP activity (Geymonat et al., 2003; Hu et al., 
2001; Pereira et al., 2002). Cdc5 may also regulate Lte1 (Lee et al., 2001b). Lastly, Cdc5 
activates Dbf2 in a BUB2-independent manner, at least in part by promoting the FEAR-
dependent release of Cdc14, which results in Cdc15 dephosphorylation and thus activation 
(Jaspersen and Morgan, 2000; Lee et al., 2001a; Stegmeier et al., 2002). Together, these 
MEN activating functions of Cdc5 are likely to account for the complete loss of MEN 
signalling in cdc5 mutants (Visintin et al., 2003). Activation of the MEN is regulated in 
many additional ways. Cdc15 itself has a potent autoinhibitory C-terminal domain (Bardin 
et al., 2003), but its regulation remains elusive. The spatial segregation of the MEN 
components Lte1 and Tem1 also contributes to the temporal coordination of MEN 
activation, Fig. 1.15. 
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Figure 1.15 Localization of MEN components during the cell cycle 
(a) Lte1 is present throughout the cell during G1, localizes to the bud (mainly to the bud cortex) during S 
phase and mitosis and spreads into the cytoplasm of both the mother and the daughter cells after the nucleus 
has migrated into the bud. Tem1 and Bub2-Bfa1 localize to both spindle pole bodies (SPBs) at the time of 
SPB duplication (not shown) and, as the mitotic spindle forms, are found more concentrated at the daughter-
directed SPB. A small amount of Tem1 however is still present at the mother-bound SPB (not shown) while 
Bub2-Bfa1 completely disappears from the mother-bound SPB. During anaphase Cdc15 and Dbf2-Mob1 are 
recruited to SPBs. Nud1 functions as a scaffold for MEN components. Cdc5 localizes to the nucleus during S 
phase, metaphase and anaphase and is found also on SPBs and the site of cytokinesis during anaphase. Taken 
from Bardin and Amon, 2001. (b) Localization of Dbf2 during the cell cycle analyzed by indirect 
immunofluorescence (IF). Dbf2 localizes to SPBs during anaphase. 
 
 
Tem1 resides on the single spindle pole body in G1, gets distributed with similar 
amounts on both SPBs when they are duplicated and later on, at metaphase to anaphase 
transition, it becames concentrated at the daughter-directed SPB (dSPB; Bardin et al., 
2000; Molk et al., 2004; Pereira et al., 2000). However a small amount of Tem1 is still 
present on the mother cell SPB, also after anaphase (Molk et al., 2004; Pereira et al., 
2000). Bub2-Bfa1 subcellular localization follows essentially the same pattern, with the 
exception that the complex completely disappears from the SPB remaining in the mother 
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cell at the onset of anaphase (Molk et al., 2004; Pereira et al., 2000). Bub2-Bfa1 are 
required for the localization of Tem1 on SPBs during interphase and early mitosis, but not 
during anaphase (Pereira et al., 2000). The MEN activator Lte1 is confined in the bud 
(mainly at the bud cortex) throughout most of the cell cycle and spreads into the cytoplasm 
of both the mother and the daughter cells after the nucleus has migrated into the bud (Molk 
et al., 2004). The subcellular localization of many other MEN components is also cell 
cycle regulated. Cdc5 localizes on SPBs throughout the cell cycle except in G1 when it is 
degraded by the APC/CCdh1 (Shirayama et al., 1998; Song et al., 2000), while the MEN 
components Cdc15, Dbf2 and Mob1 localize on the cytoplasmic face of the SPBs during 
anaphase (Molk et al., 2004; Menssen et al., 2001; Cenamor et al., 1999; Bardin et al., 
2000; Visintin et al., 2001). The SPB component Nud1 is thought to function as a scaffold 
for the Bub2-Bfa1-Tem1 complex and helps to recruit other MEN components onto the 
SPBs (Gruneberg et al., 2000). Cdc15 and Dbf2 localize to both SPBs, while, as previously 
said, Tem1 and the Bub2-Bfa1 complex associate preferentially with the daughter-bound 
SPB. Interestingly the future destination (daughter versus mother cell) rather then age of 
SPB (old versus newly synthesized) determines which SPB recruits the Tem1-Bub2-Bfa1 
complex (Pereira et al., 2001). The spatial segregation of Lte1 and Tem1 led to an 
appealing model for explaining how nuclear division is coupled with mitotic exit. 
According to this model, Tem1 is kept inactive at SPBs by Bub2-Bfa1 until the Tem1-
bearing SPB migrates into the bud at anaphase onset. Only in this case will Tem1 be 
exposed to its activator Lte1. Thanks to this spatial segregation, misaligned spindle would 
prevent MEN activation and delay mitotic exit until errors are corrected, thus ensuring the 
balanced chromosome partitioning between the mother and the daughter cells (Bardin et 
al., 2000; Pereira et al., 2000).  
This model would imply that the pool of Tem1 localized on the d-SPB would be 
responsible for triggering MEN activation and mitotic exit. However recent studies have 
highlighted an important role also for the pool of Tem1 localized on the SPB remaining in 
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the mother cell. This pool would control the timing of mitotic exit as persistence of Bub2-
Bfa1 at this SPB during anaphase prevents mitotic exit in cells where Tem1 activity is 
partially impaired (Fraschini et al., 2006). Consistent with this idea Bub2-Bfa1 is retained 
on both SPBs in anaphase cells with improperly positioned spindle (Pereira et al., 2001).  
The molecular mechanism through which MEN induces the release of Cdc14 from its 
inhibitor Cfi1 in late anaphase is still unknown. Some observations lead to the conclusion 
that MEN contributes to the dissociation of the phosphatase from its inhibitor by 
promoting phosphorylation of Cfi1. Indeed, a correlation exists between the release of the 
phosphatase and the phosphorylation of both Cdc14 and Cfi1. Overexpression of a 
hyperactive form of Cdc15, known to ectopically activate the downstream kinase Dbf2, 
induces the extopic phosphorylation of Cfi1 (Visintin et al., 2003). Furthermore Cfi1 has 
been identified as a putative Dbf2-substrate (Mah et al., 2005). The MEN pathway other 
than promote the release of Cdc14 it further promotes its accumulation in the cytoplasm. 
Responsible for this Cdc14-cytoplasmic localizationis the protein kinase Dbf2 that by 
phosphorylating two residues of Cdc14 close to its nuclear localization signal (NLS) (Mohl 
et al., 2009) allows for cytoplasmic retention of the phosphatase. 
 
Inactivation of FEAR network and MEN 
The inactivation of Cdc14 after mitotic exit has been completed is as important for 
succesfull cell division as its activation during anaphase. This is illustrated by the severe 
growth defects exhibited by cells with unconstrained Cdc14 activity (Visintin et al., 1998). 
Therefore, it is important that FEAR network and MEN are inactivated once mitotic exit 
has been completed and cells have entered G1. FEAR network activity appears to be 
restricted to a very brief time during early anaphase, as Cdc14 becomes re-sequestered into 
the nucleolus during late anaphase in cells lacking a functional MEN (Pereira et al., 2002; 
Stegmeier et al., 2002; Yoshida et al., 2002). How the activation of the FEAR network is 
restricted to the duration of early anaphase is unknown. However the mechanisms that 
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regulate FEAR and MEN inactivation at the end of mitosis are well understood. 
Interestingly, Cdc14 itself plants the seeds for its own demise. The most important 
substrate of Cdc14, once fully activated by the MEN pathway, is the APC/CCdh1. By 
dephosphorylating Cdh1, and thus activating the APC/CCdh1 complex, Cdc14 promotes its 
own re-sequestration. The most important APC/CCdh1 target at this time is Cdc5, the key 
factor for Cdc14 release and maintainance. Thus, since Cdc5 is a component of the FEAR 
network and activator of the MEN its degradation leads to the silencing of both the two 
pathways (Visintin et al., 2008). Cdc5 degradation represents the major mechanism 
responsible for Cdc14 inactivation at the end of mitosis. Beside Cdc5, another APC/CCdh1 
substrate that once degraded contributes to FEAR network silencing is the small nuleolar 
protein Spo12. Indeed, the phosphorylation of two serine residues of Spo12 by Clb2-Cdk 
is required for FEAR network function. Given that these phosphorylation sites conform to 
Cdc14 consensus, it is possible that Cdc14 itself quenches FEAR network activation by 
dephosphorylating Spo12 (Shah et al., 2001; Stegmaier et al., 2004). Regarding MEN 
inactivation, Cdc14 dephosphorylates both Bfa1 and Lte1, thus presumably restoring the 
GAP-activity of Bub2-Bfa1 complex towards Tem1 (Geymonat et al., 2003; Pereira et al., 
2002) and triggering the release of Lte1 from the bud cortex. The cortical release of Lte1 
decreases its concentration in the bud, which is believed to be required for efficient Tem1 
activation (Bardin et al., 2000; Jensen et al., 2002).  
 
Signals controlling FEAR network and MEN activity 
Many mitotic processes, such as the onset of sister-chromatid separation, mitotic 
spindle disassembly and cytokinesis are irreversible. Therefore, to ensure the successful 
completion of mitosis, it is essential that mitotic exit is tightly coordinated with other cell 
cycle events. Different works have identified some of the cellular signals that control the 
activation of the FEAR network and the MEN, shedding light onto the mechanisms 
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whereby Cdc14 activation and hence the coordination of late mitotic events is 
accomplished. 
 
Coordination of chromosome segregation and exit from mitosis through the FEAR 
network 
Faithful chromosome segregation requires that exit from mitosis is temporally 
coordinated with partitioning of the genetic material between the progeny. The fact that 
two important regulators of sister-chromatid separation, the separase Esp1 and the polo-
kinase Cdc5, also promote the release of Cdc14 as part of the FEAR network, provides a 
molecular explanation as to how cells ensure that exit from mitosis does not occur prior to 
the onset of sister-chromatid separation (Stegmeier et al., 2002; Sullivan and Uhlman, 
2003). Conversely, the fact that FEAR network-induced Cdc14 activation promotes the 
segregation of telomeres and rDNA regions (described in detail below) ensures that sister-
chromatid separation is completed before cells exit from mitosis (D’Amours et al., 2004).  
 
Preventing mitotic exit in response to microtubule and DNA damage through inhibition 
of MEN and FEAR network 
In presence of mitotic spindle or DNA damage, cells have to delay sister-chromatid 
separation and mitotic exit in order to provide time for error correction. Two surveillance 
mechanisms, known as the spindle assembly chechpoint (SAC) and the DNA damage 
checkpoint monitor defects in the attachment of microtubles to kinetocores and DNA 
damage, respectively (Nyberg et al., 2002; Lew et al, 2003). The target of both checkpoints 
is the securin Pds1. By preventing degradation of Pds1 they prevent sister chromatid 
separation and the activation of the FEAR network and furthermore antagonize MEN 
function. The spindle assembly checkpoint components Mad1, Mad2, Mad3, Bub1 and 
Bub3 are the one responsible for the inhibition of Pds1 degradation via APC/CCdc20 
inhibition (reviewed in Lew et al., 2003), whereas Bub2 and Bfa1 are the components 
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involved in preventing MEN activation in response to spindle damage. It has been 
proposed that the activation of the spindle checkpoint prolongs the inhibitory function of 
the Bub2-Bfa1 complex on MEN cascade activation, possibly influencing Bub2-Bfa1 
GAP-activity (Hu and Elledge, 2002). Furthermore it has been also proposed that the Bub2 
and Bfa1 SAC components are needed to prevent MEN activation in response to any 
mitotic checkpoints (Lee et al., 2001b). 
Regarding the DNA damage checkpoint, the DNA damage effector protein Chk1 
directly phosphorylate Pds1, protecting it from APC/CCdc20 ubiquitilation (Sanchez et al., 
1999; Wang et al., 2001); Rad53 inhibits the interaction between Cdc20 and the securin 
Pds1 itself (Agarwal et al., 2003), and the c-AMP-dependent protein kinase PKA directly 
phosphorylate Cdc20 blocking its interaction with the substrates (Searle et al., 2004), 
thereby all inhibiting the metaphase anaphase transition and sister-chromatid separation in 
presence of DNA damage to preserve genomic stability. 
 
Preventing mitotic exit in response to incorrect spindle position through regulating 
MEN activity 
In order to ensure that each daughter cell receives exactly one DNA complement 
during cell division, the division site must bisect the mitotic spindle. In fission yeast and 
higher eukaryotes, the division site is determined by the position of the mitotic spindle and 
signalling between the cell membrane and the mitotic spindle apparatus is likely to be 
important to coordinate chromosomes segregation and cytokinesis in space. In S. 
cerevisiae the division site is pre-determined and therefore the proper orientation of the 
spindle apparatus through the mother-bud neck prior to mitotic spindle disassembly and 
cytokinesis is crucial for the fidelity of chromosomes segregation. It thus come as no 
surprise that mechanisms exist that prevent exit from mitosis until the bud, the future 
daughter cell, receives a complete DNA complement. The activity of a surveillance 
mechanism termed “the spindle orientation checkpoint”: (SPOC) blocks exit from mitosis 
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until the spindle is correctly oriented. One mechanism that helps prevent exit from mitosis 
in cells with a mis-positioned mitotic spindle is the spatial segregation of MEN 
components through which cell senses the position of the spindle. Indeed, the MEN 
activator Lte1 becomes sequestered at the bud cortex during bud formation while Tem1 
resides specifically on the daughter-bound SPB (Bardin et al., 2000; Pereira et al., 2000). 
Thus, delivery of Tem1 bearing SPB into the bud, that occurs only if the mitotic spindle is 
correctly oriented, is likely to promote Tem1 and thus MEN activation during anaphase 
(Bardin et al., 2000; Pereira et al., 2000). When the spindle is not correctly aligned, Tem1 
is not exposed to Lte1 and thus mitotic exit is prevented. This idea is consistent with the 
finding that overexpression of LTE1, which causes the protein to be present in the mother 
cell as well as the daughter cell, allows cells with mis-oriented spindles to exit from 
mitosis (Bardin et al., 2000). In the same way, when the maintenance of Lte1 in the bud is 
disrupted by the inactivation of septins, which form a diffusion barrier for membrane 
associated proteins (Barral et al., 2000; Hofken et al., 2002), cells with a mis-positioned 
nucleus exit from mitosis (Castillion et al., 2003).  
Spatial restriction of Lte1 and Tem1 is not the only mechanism that prevents cells 
with misaligned spindles from exiting mitosis. Indeed, it has been shown that BUB2 and 
BFA1 deletion allows cells to exit from mitosis even if in presence of an improperly 
aligned spindle (Pereira et al., 2000). Interestingly, the phosphorylation of Bfa1 and its 
asymmetric localization to the daughter bound SPB are regulated in response to spindle 
orientation (Hu et al., 2001). Responsible for this regulating phosphorylation on Bub2-
Bfa1 complex, in response to improper spindle positioning, is the protein kinase Kin4, a 
component of the SPOC (D’Aquino et al., 2005; Pereira and Schiebel, 2005). During an 
unperturbed cell cycle for most of the time Kin4 localizes through the mother cell cortex, 
while during anaphase it is concentrated in the bud neck. It associates with the mother-
bound SPB mirroring the localization of Bub2-Bfa1 (D’Aquino et al., 2005; Pereira and 
Schiebel, 2005). 
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However, in cells with mis-positioned spindles both Kin4 and Bub2-Bfa1 associate 
with both SPBs during anaphase allowing Kin4 to phosphorylate Bfa1. This 
phosphorylation prevents Bfa1 from Cdc5 inhibitory phosphorylation, thus freezing the 
Bub2-Bfa1 complex in an active state and preventing the activation of the MEN 
(D’Aquino et al., 2005; Pereira and Schiebel, 2005; Maekawa et al., 2007). Recent studies 
highlighted that the protein phasphatase PP2ARts1 and the protein kinase Elm1 are essential 
for the function of Kin4 in the SPOC (Caydasi et al., 2010; Chan et al., 2009). Based on 
the restriction of Kin4 to the mother cell cortex and Lte1 to the bud cortex, it has been 
proposed that Kin4 establishes a domain of MEN inhibition in the mother cell and Lte1 
creates a domain of MEN activation in the bud (Bardin et al., 2000; Chan and Amon, 
2010; D'Aquino et al., 2005; Pereira et al., 2000). According to this “zone model”, the 
Tem1-bearing SPB has to escape the zone of inhibition and enter in the zone of activation 
for MEN to become active and to promote exit from mitosis (Chan and Amon, 2010; Chan 
and Amon, 2009). 
 
The multiple roles of Cdc14 during late stages of mitosis 
In the last years it became clear that Cdc14 not only promotes mitotic Cdks 
inactivation and exit from mitosis, but also a variety of other cellular events, including 
rDNA and telomere segregation, mitotic spindle dynamics and cytokinesis. Remarkably, 
the execution of these diverse events relies on Cdc14 activated by different regulatory 
networks, Fig. 1.16. 
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Figure 1.16 Functions of Cdc14 released by the FEAR network and the MEN 
Cdc14 orchestrates the anaphase events. FEAR released Cdc14 regulates many aspects of chromosome 
movement. The phosphatase promotes rDNA segregation by inducing the silencing of rDNA transcription by 
RNA PolI, which results in the recruitment of condensins to rDNA. Cdc14 stabilizes the anaphase spindle by 
dephosphorylating several microtubule-binding proteins such as Ask1 and Fin1. Cdc14 promotes the 
localization of the microtubule-bundling protein Ase1 and the chromosomal passenger complex Ipl1-Sli15 to 
the spindle midzone and controls nuclear position. Cdc14 also stimulates the MEN, which is required to 
maintain Cdc14 in a released state during late anaphase. Once activated, the MEN further promotes Cdc14 
activity. Cdc14 released by MEN bring about exit from mitosis by dephosphorylating Cdh1, Swi5 and Sic1, 
which results in mitotic Cdk inactivation. 
 
 
Functions of Cdc14 released by the FEAR network 
Although Cdc14 activated by the FEAR network is not essential for cell 
proliferation, it helps to coordinate several mitotic events, thereby contributing to the 
maintenance of genomic stability. The importance of the FEAR network is highlighted by 
the dramatic loss of viability exhibited by cells that progress through anaphase in its 
absence (D’Amours et al., 2004). Cdc14 released by the FEAR network promotes the 
completion of chromosomes segregation. Indeed, it has been observed that cells lacking 
FEAR network activity are impaired in the segregation of telomeres and rDNA array 
sequences. Given that cells lacking MEN activity do not exhibit such defects, it appears 
that the transient activation of Cdc14 by the FEAR network is sufficient for the separation 
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of these late segregating chromosomal regions. rDNA arrays and sister-chromatid’s 
telomeres are linked by cohesin-independent linkages (D’Amours et al., 2004; Sullivan et 
al., 2004). Cdc14 released by the FEAR network is responsible for the dissolution of these 
cohesin-independent linkages. Several observations point to the possibility that Cdc14 
mediates rDNA segregation by promoting the enrichment of condensins, which are protein 
complexes required for chromosomes condensation (Bhalla et al., 2002; Hirano, 2000), at 
the rDNA locus. First, cells carrying mutation in subunits of the condensin complex 
exhibit nucleolar segregation defects similar to that of a Cdc14 loss of function mutant 
(Bhalla et al., 2002; Freeman et al., 2000). Secondly, CDC14 overexpression induces 
ectopic enrichment of condensins at the rDNA locus and ectopic rDNA segregation 
(D'Amours et al., 2004). Lastly, the inactivation of condensins prevents rDNA segregation 
in CDC14 overexpressing cells (D'Amours et al., 2004). Furthermore, recently it has been 
shown that Cdc14 released by the FEAR network promotes the removal of RNA PolI 
subunit from the nucleolus, thereby inhibiting the transcription of rDNA in anaphase 
(Clemente-Blanco et al., 2009; Tomson et al., 2006). The silencing of rDNA genes during 
anaphase is thought to be necessary for allowing condensin’s access to rDNA chromatin 
(Clemente-Blanco et al., 2009). The observation that Cdc14 induces the sumoylation of the 
condensin subunit Ycs4 during anaphase raises the interesting possibility that Cdc14 
targets condensins to the rDNA by promoting Ycs4 sumoylation. How Cdc14-dependent 
condensation facilitates rDNA segregation remains unclear. 
 An additional function of FEAR-released Cdc14 is to control nuclear positioning. 
In budding yeast, the nucleus is positioned at the bud neck during metaphase. At anaphase 
onset microtubule motor proteins associated with the cytoplasmic microtubules emanating 
from the daughter-bound SPB pull the nucleus into the bud. Concomitantly, microtubule 
motor proteins associated with the mitotic spindle push the two SPBs apart. The 
combination of these microtubule-associated forces results in the equal partitioning of the 
genetic material between the mother and the daughter cells. Cdc14 released by the FEAR 
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network has been implicated in the generation of the mother-directed cytoplasmic-
microtubule pulling forces which contribute to the equal distribution of the duplicated 
chromosomes between the mother and the daughter cells. In cells lacking separase function 
sister-chromatids are not segregated and the undivided nucleus is pulled into the bud (Ross 
et al., 2004). How Cdc14 promotes the generation of these forces remains unknown. 
 Cdc14 released by the FEAR network induces the stabilization of the anaphase 
mitotic spindle, which is essential for the correct segregation of sister-chromatids in a wide 
variety of processes. Cdc14 dephosphorylates several microtubule-interacting proteins 
such as Fin1 and Ask1, which allows them to interact with and thus stabilize the elongating 
spindle (Woodbury et al, 2007; Higuchi et al, 2005). Cdc14 contributes to the stabilization 
of the spindle midzone by regulating the subcellular localization of the chromosomal 
passenger proteins (Pereira et al., 2003). The spindle midzone is a very fragile site of the 
anaphase spindle, where interpolar microtubules overlap. FEAR-released Cdc14 promotes 
the translocation of the chromosomal passenger proteins Ipl1 and Sli15 (Aurora B kinase 
and INCENP in higher eukaryotes, respectively) to the mitotic spindle and spindle 
midzone, ensuring stabilization of the anaphase spindle. Other than dephosphorylating 
Sli15, Cdc14 also dephosphorylates the microtuble-bundling protein Ase1, translocating it 
to the spindle midzone. The Ipl1-Sli15 complex and Ase1 then recruit other factors which 
stabilize the elongating spindle, critical among them being Esp1-Slk19 complex 
(Khmelinskii et al., 2007). 
 Lastly, the activation of Cdc14 by the FEAR network contributes to the MEN 
activation (Stegmeier et al., 2002). First, Cdc14 released by the FEAR network promotes 
the dephosphorylation of Cdc15 kinase, thus enhancing Cdc15’s mitotic exit function 
(Jaspersen et al., 2000; Stegmeier et al., 2002). The mechanism by which 
dephosphorylation of Cdc15 promotes its mitotic exit function remains unknown. 
Dephosphorylation may enhance its interaction with the upstream Tem1, its localization on 
SPBs or antagonize the inhibitory function of Cdc15’s C-terminal domain. Secondly, 
 61 
Cdc14 has been proposed to inactivate the Bub2-Bfa1 complex in a phosphatase-
independent manner during early anaphase (Pereira et al., 2002). Shortly after its release 
from the nucleolus, Cdc14 binds Bub2 at the daughter SPB, inactivating Bub2-Bfa1 
complex activity (Pereira et al., 2002; Yoshida et al., 2002a). While the binding of Cdc14 
released by the FEAR network to the Bub2-Bfa1 complex would inactivate its GAP 
activity in early anaphase, dephosphorylation of Bub2 by Cdc14 during late mitosis would 
re-activate the GAP-complex (Geymonat et al., 2003; Pereira et al., 2002). However 
further investigations are needed to better understand the nature of this phosphatase-
independent function of Cdc14 and the mechanism that prevents Cdc14 from 
dephosphorylating Bub2 in early anaphase. Notably, during early anaphase Cdc14 
dephosphorylates its targets despite the presence of high mitotic Cdks activity throughout 
the cell. Therefore, regions within the cell that contain a high local concentration of Cdc14 
during early anaphase, such as kinetochores, the mitotic spindle and SPBs are most likely 
to harbour yet unidentified targets of Cdc14 released by the FEAR network. 
 
Functions of Cdc14 released by the MEN 
Cdc14 released by the MEN is mainly responsible for promoting exit from mitosis, 
as this transition does not occur in absence of MEN function (Jaspersen et al., 1998; 
Surana et al., 1993). Several observation, however, indicate that Cdc14 and MEN also 
regulate cytokinesis, independently of their mitotic exit function. When the need for MEN 
function in mitotic exit is bypassed, either by weakening the Cdc14/Cfi1 interaction or by 
overexpression of the Cdk inhibitor Sic1, severe cytokinesis defects become apparent 
(Jimenez et al., 1998; Lippincott et al., 2001). The notion that MEN regulates cytokinesis 
is also consistent with the translocation of the MEN components Cdc15, Dbf2, Mob1 and 
Cdc5 to the bud neck (the site of actomyosin ring constriction in budding yeast) at the time 
of cytokinesis (Frenz et al., 2000; Xu et al., 2000). Furthermore, the cytokinesis function of 
at least some MEN components appears to require Cdc14 function, as is the case for the 
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accumulation of Dbf2 and Mob1 at the bud neck (Frenz et al., 2000; Yoshida et al., 2001). 
It is possible therefore that, after the MEN promoted Cdc14 activation, Cdc14 itself 
dephosphorylates Cdk consensus site in MEN components to promote their localization to 
the bud neck, where they will then regulate cytokinesis.  
 
Cdc14 function and regulation in other eukaryotes 
Homologues of Cdc14 exist in most if not all eukaryotes nevertheless their 
biochemical similarities, their function and regulation significantly differ among the 
species, Fig. 1.17. 
Fission yeast Like its cousin in S. cerevisiae, the fission yeast ortholog Clp1 (also known 
as Flp1), antagonizes mitotic Cdk activity. Furthermore, the activity of Clp1 is at least in 
part regulated by a signal pathway (SIN-septation initiation network) homologous to the 
MEN. Despite these similarities, the mechanism whereby Clp1 and Cdc14 accomplish 
mitotic Cdk inactivation and the cellular processes regulated by these two phosphatases 
appear to be quite different. In contrast to Cdc14, Clp1 is not essential for cell cycle 
progression and mitotic exit, but rather controls mitotic entry and coordinates cytokinesis 
with entry in the next cell cycle (Cueille et al., 2001; Trautmann et al., 2001). The most 
important role of Clp1 seems to be to maintain low mitotic Cdk activity during G2 in 
response to a cytokinesis checkpoint. Indeed, activation of the cytokinesis checkpoint in 
fission yeast leads to a cell cycle arrest in G2. This cell cycle arrest requires the continuous 
inhibition of mitotic Cdks, which is mediated by Clp1 (Cueille et al., 2001; Trautmann et 
al., 2001). The observation that Clp1 localizes in the nucleolus during some cell cycle 
stages and it is released during others raises the possibility that some aspect of Cdc14 and 
Clp1 regulation are shared between the two yeasts. During G1 and S phase, Clp1 localizes 
predominantly to the nucleolus, but in contrast to its budding yeast counterpart a small 
portion resides at SPBs (Cueille et al., 2001; Trautmann et al., 2001). Furthermore, while 
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Cdc14 is released from the nucleolus during anaphase, Clp1 is released from the nucleolus 
as cells enter in mitosis localizing to the mitotic spindle and to kinetochores, and later it is 
found to the medial ring, site of cytokinesis (Cueille et al., 2001; Trautmann et al., 2001). 
Kinetocores-localized Clp1 has been proposed to function together with Aurora B kinase 
to repair mono-orientation of sister-chromatids, thus ensuring their correct segregation 
(Trautmann et al., 2004). Similarly to the budding yeast Cdc14, Clp1 regulates the spindle 
midzone stability by dephosphorylating several midzone-binding proteins such as Ase1 
and the kinesin 6-motor protein Klp9 (Fu et al., 2009; Khmelinskii et al., 2009). Whether 
Clp1 is bound to an inhibitor when it resides in the nucleolus is at present unclear. 
However, a regulatory network homologous to the MEN termed the septation-initiation 
network (SIN) appears to control Clp1 localization in a manner similar to the MEN 
(Bardin et al., 2001; Cueille et al., 2001; Trautmann et al., 2001). Although SIN does not 
regulate Clp1 localization during an unperturbed cell cycle, this signalling network is 
required to maintain Clp1 in a released state when the cytokinesis checkpoint has been 
activated (Cueille et al., 2001; Trautmann et al., 2001). Thus, maintainance of Cdc14 and 
Clp1 in its released state relies on conserved pathways. How Clp1 is initially released from 
the nucleolus remains unclear but this release does not depend on homologues of the 
FEAR network (Chen et al., 2006). 
C. elegans Depletion of Cdc14 by RNA interference (RNAi) in C. elegans has been 
reported to causes cytokinesis defects, most likely due to a failure to form an intact central 
spindle, leading to multinucleated cells and causing embryonic lethality (Gruneberg et al., 
2002). A different study, however, showed that null CeCDC14 worms were viable and 
lacked mitotic and cytokinetic defects (Saito et al., 2004). How CeCdc14 would promote 
the central spindle formation is unknown, but it is noteworthy that the phosphatase is 
required for the localization of Zen-4, a kinesin-related motor protein required for central 
spindle formation, to the mitotic spindle (Gruneberg et al., 2002). Consistent with a role in 
cytokinesis and central spindle function, CeCdc14 localizes to the central spindle (spindle 
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midzone) during anaphase and to the midbody during telophase, similar to S. pombe Clp1, 
but the phosphatase has neither been detected in the nucleolus nor on centrosomes 
(Grunberg et al., 2002). Whether CeCdc14 is regulated by signaling pathways homologous 
to the MEN and SIN is also unclear. RNA interference of several potential MEN and SIN 
homologues in C. elegans did not lead to embryonic lethality (Gruenberg et al., 2002). It is 
possible that the RNAi-mediated depletion was incomplete or that redundant factors exist 
in C. elegans. Alternatively, the MEN/SIN components may not be necessary during 
embryonic division or these pathways evolved to fulfill functions specific to yeast. 
Human The human genome encodes two Cdc14 homologues, hCdc14A and hCdc14B. The 
roles of these two phosphatases are poorly understood, but an involvement in mitotic exit 
and cytokinesis is possible. In vitro studies have shown that hCdc14, just like its yeast 
counterpart, has a clear preference for substrates of proline-directed kinases (Visintin et al., 
1998; Trautmann et al., 2001; Kaiser et al., 2002), which is further supported by the crystal 
structure of the core domain of hCdc14A (Gray et al., 2003). Furthermore hCdc14A can 
dephosphorylate APC/CCdh1 in vitro (Bembenek et al., 2001). Although this finding 
indicates that hCdc14 can bring about mitotic Cdks inactivation, this Cdc14 isoform 
appears to primarily regulate centrosomes function in vivo. Indeed, overexpression of 
hCdc14A leads to premature centriole splitting in S-phase and formation of an excessive 
number of aberrant mitotic spindles (Kaiser et al., 2002; Mailand et al., 2002). Conversely, 
depletion of hCdc14A by RNAi leads to centrosomes duplication, mitotic and cytokinetic 
defects (Mailand et al., 2002). Consistent with its proposed role in regulating centrosome 
function, hCdc14A localizes to this organelle (Bembenek et al., 2001; Kaiser; Mailand). 
Much less is known about the function of hCdc14B. Intriguingly, however, hCdc14B 
localizes to the nucleolus during interphase and is dispersed at the onset of mitosis 
(Bembenek and Kaiser, 2002). Based on RNAi depletion experiments hCdc14B has been 
implicated in the regulation of mitotic spindle assembly, centriole duplication, mitotic exit 
and the G2 DNA damage checkpoint (Basserman et al., 2008; Cho et al., 2005; Wu et al., 
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2008). Interestingly, it has been recently found that in response to DNA damage 
checkpoint activation hCdc14B becomes released from the nucleolus and it activates the 
APC/CCdh1, that in turn leads Plk1 to the proteosomal degradation (Bassermann et al., 
2008). Interestingly this is the same circuit activated by the yeast Cdc14, during exit from 
mitosis. More recent observations showed that deletion of both the hCdc14 isoforms does 
not cause growth or mitotic defects (Berdougo et al., 2008; Mocciaro et al., 2010). 
From the studies of Cdc14 functions in different eukaryotes emerged a picture 
where the mitotic function of the S. cerevisiae Cdc14 has not been conserved through the 
evolution. However, the finding that the introduction of both hCdc14A and hCdc14B into 
fission yeast and Cdc14B in budding yeast rescue respectively the clp1 and cdc14 loss of 
function phenotypes, suggests that at least some properties of these phosphatases have 
been conserved throughout the evolution (Vazquez-Novelle et al., 2005). Further studies 
are necessary to assess the regulation and physiological function of Cdc14 phosphatases in 
organisms other than yeasts. 
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Figure 1.17 Overview of Cdc14 orthologs 
Localization of Cdc14 orthologs during different stages of the cell cycle and possible functions of the 
phosphatase in each organism are shown. Concentrations of Cdc14 are shown in different shades of red, 
where dark red corresponds to high amount of Cdc14 and light red corresponds to low amount of Cdc14. 
DNA, light blue; S.cervisiae spindle pole bodies, dark blue rectangles; centrosomes, dark blue circles; 
microtubules, black lines. From Mocciaro & Schiebel, 2010. 
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2. Materials and Methods 
Plasmids, primers and strains 
Plasmids and Primers 
Plasmids and primers used in this study are listed in Table 2.1 and Table 2.2, 
respectively. 
 
Bacterial strains 
The genotypes of all the bacterial strains used as hosts for plasmid amplification and 
construction are listed in Table 2.3. Cells were provided chemically competent for 
transformation. 
 
Yeast strains 
All the strains are derivatives of W303 (ade2-1, can1-100, trp1-1 leu2-3, 112, his3-
11, 15, ura3). The relevant genotypes of all the yeast strains used in this study are listed in 
Table 2.4. The majority of the strains used in this study was generated by dissecting 
sporulated heterozygous diploid strains obtained by crossing haploid strains of opposite 
sexes (see below for procedure).  
 
Construction of CDC14 mutants 
Plasmids pFM1, pFM2, pFM3, pFM4, pFM5, pFM6, pFM7, pFM8, pFM9, pFM10, 
pFM11, pFM12, pFM13, pFM14, pFM15, pFM16, pFM17, pFM18, pFM20, pFM21 
carrying CDC14 alleles encoding for versions of the protein in which the T10, T140, S260, 
T391, S471 and T517 have been mutated, alone or in combination to alanine (A) or 
aspartate (D) were generated by PCR-based site-directed mutagenesis as described below. 
Integrative plasmid Rp49 (YIplac204) containing a HindIII 3HA-CDC14 fragment under 
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the control of its own promoter were used as template in the amplification reaction. The 
obtained plasmids were first sequenced to confirm the presence of the desired mutations 
with primers listed in Table 2.2 and then digested with Bsg1 so to direct the integration of 
these mutant alleles of CDC14 at the TRP1 locus of the yeast strain Ry1 (wild type), 
Ry1219 (a heterozygous diploid deleted in CDC14- cdc14!). Amounts of wild-type and 
mutated Cdc14 proteins were checked by Western Blot, in order to identify strains that 
have the same amount of integrants, and concomitantly the amount that ensures the 
physiological levels of Cdc14 as compared to wild type. Diploids obtained were selected, 
sporulated and dissected. 
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Media and growth conditions  
Media for E.coli. 
LB (DIFCO)    1% Bactotryptone 
     0.5% Yeast extract 
     1% NaCl 
     pH 7.25 
 
LB agar    LB + 2% agar (DIFCO) 
 
LB amp    LB + 50 µg/ml ampicillin 
 
Strains were grown at 37°C. 
 
Media for S. cerevisiae 
YEP     1% Yeast extract 
     2% bactopeptone 
     0.015% L-tryptophan 
     pH 5.4 
 
YEP agar    YEP + 2% agar (DIFCO) 
 
Before using, YEP was supplemented with 2% glucose (YEPD) or 2% raffinose (YEPR) 
or 2% raffinose and 2% galactose (YEPRG) and 300 µM adenine. 
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Minimum media: SC 0.15% yeast nitrogen base (YNB, DIFCO) without 
amino acids and ammonium sulfate 
0.5% ammonium sulfate 
200 nM inositol  
 
SC agar    SC + 2% agar 
 
Before using SC was supplemented with 2% glucose or 2% raffinose or 2% raffinose and 
2% galactose and amino acids as required. Strains were grown at room temperature 
(23°C).  
 
Procedures 
DNA manipulation techniques 
Enzymatic restriction of DNA 
DNA samples were digested with the appropriate restriction enzymes using 
conditions described in (Sambrook, 1989) or the own provider’s instructions (NEB).  
For diagnostic DNA restriction 0,5-2 µg of plasmid DNA was digested for 2 hrs at 37°C 
with 1-10 units of the appropriate restriction enzyme. The volume was made up depending 
on the DNA volume and concentration to 20-50 µl with the appropriate buffer and ddH2O. 
For preparative DNA restriction, 5-10 µg of plasmid DNA were incubated for 2 hrs 
at 37°C with 1-10 units of restriction enzyme. The enzymes sensitive to heat inactivation 
were inactivated at 65°C for 20’. The enzymes not sensitive to heat inactivation and the 
restrictions preparative for yeast transformation were inactivated at 65°C for 5’ with 6 mM 
EDTA pH 8. The DNA was then precipitated adding 1/10 volume 3 M NaAc and 3 
volumes 100% isopropanol and then pelleted at 13000 rpm for 15’. The pellet was washed 
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with 200 µl of 70% ethanol and finally resuspended in 10 µl ddH2O in the case of 
integrative plasmids to be transformed into yeast.  
Purification of DNA inserts from agarose gel 
Cut DNA was loaded into an agarose gel and DNA fragments were separated by 
electrophoresis"! The DNA fragment of interest was excised from the agarose gel with a 
sharp scalpel. DNA extraction was performed with QIAquick Gel Extraction Kit (Quiagen) 
following the manufacturer’s instructions. DNA fragments were eluted in 30-50 µl of 
ddH2O.  
 
Ligation 
50 ng vector DNA was ligated with a 3- and 6-fold molar excess of insert DNA in the 
following conditions: 
 10X T4 DNA ligase buffer   1 µl 
 T4 DNA ligase    1 µl 
 ddH2O     up to 10 µl 
 
Reactions were incubated ON at 16°C. After incubation the entire ligation reaction was 
used to transform E.coli. 
 
DNA amplification 
DNA was amplified using polymerase chain reaction (PCR). PCR was performed 
using genomic yeast DNA or plasmid DNA as template. Amplification of a DNA fragment 
requires two oligonucleotides flanking the region of interest, working as primers for the 
DNA polymerase. Phusion DNA polymerase (Finnzymes) and ExTaq (TaKaRa) DNA 
polymerase were used. 
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The reaction mix : 
  
 template DNA     1 µl 
 5X/10X Buffer    1X 
 dNTPs      0.2 mM 
 forward primer    1 µM 
 reverse primer     1 µM 
 DNA polymerase     1-2 units 
 ddH2O     to 20 µl 
 
DNA amplification was performed with a Biometra T3000 Thermocycler with the 
following parameters: 
 
 1. heat shock step    5’  at 95°C 
 2. denaturation step    1’  at 95°C 
 3. annealing step    1’  at 50-55°C  
 4. extension step    1’/kb  at 72°C 
 5. repeat 25 times steps from 2 to 4  
 6. extension step    10’  at 72°C 
 7. end      hold  at 4°C 
 
Transformation 
Escherichia coli transformation 
50 µl of fresh chemically competent DH5alpha cells were thawed on ice for 
approximately 10 minutes prior to the addition of plasmid DNA or the ligation mixture. 
Cells were incubated with DNA on ice for 30 minutes and then subjected to a heat shock 
for 30-45’’ at 37° C. After the heat shock, cells were returned to ice for 2’. Finally 950 µl 
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of LB medium was added to the reaction tube. Cell suspension was incubated on a shaker 
at 37°C for 45’ before plating onto LB plates containing the appropriate antibiotic. Plates 
were incubated overnight at 37°C.  
 
Yeast transformation 
Yeast cells were grown ON in 50 ml of YEPD or of the appropriate medium 
allowing them to reach the stationary phase. Next morning the cell culture was diluted to 
OD600 = 0.2 and allowed to grow several cycles until it had reached an OD600 of 0.5-0.8. 
Cells were then harvested at 3000 rpm for 3’ and washed with 50 ml of sterile double-
distilled (dd) H2O. The pellet was then transferred to an eppendorf tube with 1 ml of 
ddH2O and washed with 1 ml 1X TE/1X LiAc solution. Cells were then resuspended in 
250 µl 1X TE/1X LiAc solution. Aliquots of 50 µl of competent cells were used for each 
transformation reaction. 
 
Transformation mix: 
 cell suspension    50 µl 
 PEG/TE/LiAc solution (40% PEG, 1X TE, 1X LiAc) 300 µl  
 10 mg/ml single-stranded salmon sperm denatured DNA 5 µl  
 DNA   “x” µl (max up to 10 µl) 
 
After gentle mixing, the transformation reaction was incubated on a rotating wheel 
for 30’ at RT. Cells were heat-shocked at 42°C for 15 min and then centrifuged for 3’ at 
3000 rpm. The pellet was resuspended in 200 µl of 1X TE and the cell suspension was 
plated on appropriate selective medium.  
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Solutions: 
 10 mg/ml single-stranded salmon sperm denatured DNA 
 10X LiAc (1.0 M, pH 7.0) 
 50% PEG 4000 
 10X TE (0.1 M Tris-HCl pH 7.5, 10 mM EDTA) 
 
DNA extraction 
Plasmid DNA isolation from E. coli (mini prep) 
Clones picked from individual colonies were used to inoculate 2 ml LB 
supplemented with 50 µg/ml ampicillin and grown ON at 37°C. Bacterial cells were 
transferred to micro-centrifuge tubes and pelleted for 5’ at 8000 rpm. Minipreps were 
performed with QIAprep Spin Miniprep Kit (Quiagen) following the manufacturer’s 
instructions. Plasmids were eluted in 30 µl ddH2O.  
 
Plasmid DNA isolation from E. coli (maxi prep) 
Plasmid-containing cells were inoculated in 100 ml LB amp and they were grown at 
37°C ON. Cells were then recovered by centrifuging 10 min at 5000 rpm. Maxipreps were 
performed with QIAprep Spin Maxiprep Kit (Quiagen) following the manufacturer’s 
instructions. Plasmids were eluted in 500 µl ddH2O. 
 
Smash and Grab yeast genomic DNA isolation 
Cells picked from an individual colony were inoculated in 200 µl of Lysis buffer. 
200 µl of phenol/chlorophorm/isoamyl alcohol and 1 volume of glass beads were added to 
the cell suspensions and the tube was shaked 10’ on Vxr Ika-Vibrax shaker. The tube was 
centrifuged 4’ at 13000 rpm and the upper aqueous layer was transferred to a new tube. 
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This step was repeated another time. 1 ml ice-cold 100% ethanol was added to precipitate 
DNA. After gently mixing, the tube was centrifuged 4’ at 13000 rpm. Supernatant was 
removed, the pellet was air-dried and DNA resuspended in 50 µl of 1X TE. 
 
Solutions 
Lysis buffer:   2% Triton X-100  
   1% SDS, 100 mM NaCl  
   10 mM Tris-HCl pH 8.0  
   1 mM EDTA pH 8.0 
 
phenol/clorophorm/isoamyl alcohol 25:24:1 (SIGMA) 
 
10X TE:   0.1 M Tris-HCl pH 7.5  
   10 mM EDTA  
 
Teeny genomic yeast DNA isolation 
Yeast cells of the desired strain were grown in 10 ml YEP containing the appropriate 
sugar to stationary phase. Cells were collected by centrifuging and then washed with 1 ml 
of a solution containing 0.9 M sorbitol, 0.1 M EDTA pH 7.5. Pellet was then transferred 
into 0.4 ml of a solution containing 0.9 M sorbitol, 0.1 M EDTA pH 7.5 and 14 mM #-
mercaptoethanol. After mixing, 0.1 ml of a 2 mg/ml solution of Zymoliase 100T were 
added and the tube was incubated at 37°C up to spheroplasts formation (20’-30’), checked 
by optical microscopy. After 30’’ of centrifugation, the pellet was carefully resuspended in 
0.4 ml TE 1X (10 mM Tris-HCl pH 8, 1 mM EDTA pH 8). After addition of 90 µl of a 
solution containing 1.5 ml of EDTA pH 8.5, 0.6 ml of Tris base and 0.6 ml 10% SDS, the 
tube was mixed and incubated 30’ at 65°C. 80 µl of 5M potassium acetate (KAc) were 
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added and then the tube was incubated on ice for at least 1 hour. The tube was then 
centrifuged 15’, the supernatant was transferred in a new tube and DNA was then 
precipitated and washed with 100% ethanol. Dried pellet was carefully resuspended in 0.5 
ml of TE 1X. 25 µl of 1 mg/ml RNAse was added to the tube and the solution was 
incubated 20’ at 37°C. DNA was then precipitated by addition of 0.5 ml of isopropanol 
and then centrifuged. Pellet was washed with 70% cold ethanol, air-dried and finally 
resuspended in 50 µl of TE 1X.  
 
Site-directed mutagenesis of CDC14 
CDC14 was mutagenized according to the QuickChange Site-Directed mutagenesis 
kit (Stratagene) instructions. Plasmid Rp49 containing CDC14 open reading frame (ORF) 
under the control of its endogenous promoter was used as template in the amplification 
reactions. Primers listed in Table 2.2 were used to introduce the specific mutations. The 
mutagenesis mix contained 5 µl buffer, 3 µl quick solution, 10 ng DNA template 125 ng 
for each primer, 1 µl dNTP mix, 1 µl Pfu Turbo DNA polymerase and water up to 50 µl. 
The template DNA was next eliminated with DpnI digestion, a restriction enzyme that 
cleaves only methylated DNA. 2µl of the mixture was used to transform XL10-Gold 
bacterial cells in order to recover and amplify the mutated plasmids. The plasmids were 
next sequenced to ascertain that the only mutation they carried was the one we intended to 
insert. The primers used in the sequencing reaction are listed in Table 2.2. Plasmids pFM3, 
pFM4, pFM9, pFM10, pFM13, pFM14 were used as templates for another round of 
mutagenesis to generate plasmids containing multiple mutations to A or to D in CDC14. 
Amplification of mutated CDC14 was performed with the following PCR parameters: 
 
 1. heat shock step    30’’  at 95°C 
 2. denaturation step    30’’  at 95°C 
 3. annealing step    1’  at 55°C 
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 4. extension step (2’/Kb)   17’  at 68°C 
 5. repeat 18 times steps from 2 to 4  
 6. extension step    7’  at 68°C 
 7. end      hold  at 4°C 
 
Agarose gel electrophoresis 
Following the addition of 1/5 volume of bromophenol blue (BPB) solution, DNA 
samples were loaded on 0.8% -1% agarose gels along with DNA markers. Gels were made 
in 1X Tris-Acetate-EDTA (TAE) buffer containing 10 µg/ml ethidium bromide and run at 
80-120 volts (V) until desired separation was achieved. DNA bands were visualized under 
a UV lamp (radiation wavelength 260 nm).  
 
Solution: 
BPB solution: 0.2% BFB in 50% glycerol 
 
10X TAE buffer:  0.4 M Tris acetate 
    0.01 M EDTA 
 
Protein techniques 
Protein extraction 
10 ml of a cell culture at OD600 = 0.2-1 were collected and centrifuged for 2’ at 
maximum speed. The resulting pellet was washed with 1 ml of cold 10 mM Tris-HCl pH 
7.5, transferred to 2 ml Sarstedt tubes and frozen in liquid nitrogen in order to better 
preserve protein integrity. The pellet was then resuspended in 100 µl of lysis buffer 
supplemented with complete protease inhibitor cocktail (Roche) and phosphatases 
inhibitors (60 mM "-glycerol phosphate, 0.1 mM Na orthovanadate, 5 mM NaF, 15 mM p-
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Nitrophenylphosphate). An equal volume of acid-washed glass beads (Sigma) was added 
(leaving a layer of supernatant over the beads) and the tubes were subjected to 3 rounds of 
Fast Prep (speed 6.5 for 45’’) at 4°C in order to break the cells. Cell breakage was checked 
under the optical microscope. Lysed cells were transferred to a fresh tube. In order to 
quantify the protein content, 10 µl of the lysate were diluted 1:3 with cold 50 mM Tris-
HCl pH 7,5/ 0,3 M NaCl and 3 µl were used in the Biorad protein quantification assay. 
The absorbance was read at #= 595 nm. 50 µl of 3x SDS blue loading buffer was then 
added to each sample. The samples were boiled at 95ºC for 5’, centrifuged at 13000 rpm 
for 3’ and the supernatant, containing the final protein extract, was collected in a new 
microcentrifuge tube. Extracts were stored at -20°C. 
 
Solutions: 
Lysis buffer:   50 mM Tris-HCl pH 7,5  
   1 mM EDTA pH 8 
   50 mM DTT 
3X SDS blue loading buffer:   9% SDS  
     30% glycerol 
     0.05% Bromophenol blue 
     6% "-mercaptoethanol 
     0.1875 M Tris-HCl pH 6.8 
 
Protein extraction from TCA treated yeast cells 
10 ml of a cell culture at OD600 = 0.2-1 were collected and centrifuged for 2’ at 
maximum speed. The resulting pellet was resuspended in an equal volume of ice-cold 5% 
trichloroacetic acid (TCA) and incubated 10’ on ice. After centrifuging 2’ at maximum 
speed at 4°C, the pellet was transferred with 1 ml 5% TCA to a 2 ml Sarstedt tube. The 
 79 
tube was centrifuged at 4°C and the supernatant discarded. The pellet was frozen in liquid 
nitrogen in order to better preserve protein integrity. Pellet was then washed with 1 ml 
room temperature absolute acetone and air-dried. The pellet was next resuspended in 100 
µl of lysis buffer supplemented with complete protease inhibitor cocktail (Roche) and 
phosphatases inhibitors (60 mM "-glycerol phosphate, 0.1 mM Na orthovanadate, 5 mM 
NaF, 15 mM p-Nitrophenylphosphate). An equal volume of acid-washed glass beads 
(Sigma) was added (leaving a layer of supernatant over the beads) and the tubes were 
subjected to 3 rounds of Fast Prep (speed 6.5 for 45’’) at 4°C in order to break the cells. 
Cell breakage was checked under the optical microscope. 50 µl of 3X SDS blue loading 
buffer was then added to each sample. The samples were boiled at 95ºC for 5’, centrifuged 
at 13000 rpm for 3’ and the supernatant, containing the final protein extract, was collected 
in a new microcentrifuge tube. Extracts were stored at -20°C.  
 
Solutions: 
Lysis buffer:     50 mM Tris-HCl pH 7,5  
    1 mM EDTA pH 8  
    50 mM DTT 
 
3X SDS blue loading buffer:   9% SDS  
     30% glycerol  
     0.05% Bromophenol blue 
     6% "-mercaptoethanol  
     0.1875 M Tris-HCl pH 6.8 
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Immunoprecipitation and phosphatase assay 
50 ml of a cell culture were treated as described in Material and Methods-TCA yeast 
protein extraction. Cell breakage was checked under the optical microscope. SDS to a final 
concentration of 1% was added and the sample was boiled 5’ at 95°C. 9 volumes of NP40 
buffer containing 2 mg/ml BSA were added, the tube was gently mixed and then 
centrifuged 10’ at 13000 rpm at 4°C. After centrifugation, the supernatant was transferred, 
avoiding the debris on the bottom of the tube, into a new eppendorf tube. This step was 
repeated another time. Rabbit anti-Clb2 antibodies (Santa Cruz) were added at a dilution of 
1:50 to 500 µl of protein extract and samples were incubated on a rotating wheel for 1 hour 
at 4°C. 50 µl of Protein G-conjugated agarose beads (PIERCE) suspension pre-incubated 
(at least 30’ on the rotating wheel at 4°C) with 5 mg/ml BSA, were next added to each 
sample. The samples were then incubated on the rotating wheel at 4°C for 2 hours. After 
incubation with the beads, the beads bound to the protein of interest were washed: 
  
2x 1 ml of NP40 buffer 
1x 1 ml of NP40 buffer + 1% "-mercaptoethanol 
2x 1 ml of NP40 buffer 1% "-mercaptoethanol + 2 M Urea 
1x 1 ml of 10 mM Tris-HCl pH 7.5  
  
During each wash: 
• samples were centrifuged for 1’ at 3000 rpm at 4°C 
• supernatant was removed paying attention at not disturbing beads 
After the last wash, 1 ml 1X calf intestinal phosphatase (CIP) buffer (NEB) was added to 
the beads, the tube was gently agitated and the suspension was centrifuged at 3000 rpm. 
After discarding the supernatant 45 µl of 1X CIP buffer were added to the sample together 
with 5 µl of CIP. 50 µl of 1X CIP buffer were added to a control sample. Samples were 
incubated at 37°C for 30’. Samples were then washed twice with 1 ml NP40 buffer. After 
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the last wash, samples were centrifuged at 3000 rpm and supernatants were removed. 30 µl 
of 3X SDS blue loading buffer were added, samples were boiled 5’ at 95°C and then 
loaded on SDS-PAGE. 
 
SDS polyacrylamide gel electrophoresis 
Proteins were separated based on their molecular weight on 6%, 8% or 10% 
polyacrylamide gels. Gels were prepared from 30%, 30:0.8 acrylamide:bisacrylamide mix 
(Sigma) and 4X Separating buffer or 4X Stacking buffer and an appropriate amount of 
ddH2O. As polymerization catalysts ammonium persulphate (APS) and TEMED (BDH) 
were used. Gels were run in SDS-PAGE Running buffer at 50-150 V for 2-3.5 hrs. For 
Phos-tag gels, 40 µM of Phos-tag (NARD Institute, Ltd) and 80 µM MnCl2 were added to 
the separating gel. Before transfer to nitrocellulose the gels were incubated in 1X Western 
Transfer Buffer supplemented with 1 mM EDTA for 10’, in order to chelate the Mn ions, 
and then  washed in 1X Western Transfer Buffer  for 10’. 
Solutions: 
30%, 30:0.8 acrylamide:bisacrylamide mix (Sigma).  
 
4X Separating buffer:   1.5 M Tris base pH 8.8 with glacial acetic acid  
     0.4% SDS 
 
4X Stacking buffer:    0.25 M Tris base pH 6.8 with glacial acetic acid 
     0.2% SDS 
 
10X SDS-PAGE Running buffer:  2 M glycine  
     0.25 M Tris-HCl  
     0.02 M SDS, pH 8.3 
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Western blot hybridization 
Proteins were transferred in western transfer tanks to nitrocellulose (Protran, 
Whatman) in 1X Western Transfer buffer at 30 V ON or 100 V for 1.5-2 hrs. Ponceau S 
staining was used to roughly reveal the amount of protein transferred onto the filters.  
Membranes were blocked with: 
• 3% milk in PBS-T for Western blots using anti-HA, anti-Myc, anti-GFP, anti-Clb2 and 
anti-Pgk1 antibodies, 1 hour at RT 
• 5% ovalbumin in PBS-T for Western blots using anti-Cdc14 and anti-Cdc5 antibodies, 
5 hours at RT 
• 5% milk in TBS-T for Western blots using anti-Clb5 antibodies, 3 hours at RT 
 
After blocking, membranes were incubated with the primary antibody: 
• 1:1000 mouse anti-Myc (Covance, 9E10), 1:1000 mouse anti-HA (Covance), 1:5000 
mouse anti-Pgk1 (Invitrogen), 1:1000 rabbit anti-Clb2 (Santa Cruz), 1:1000 mouse anti-
GFP (Chemicon), diluted in 1% milk/ 1% BSA/ PBS-T for 2 hrs at RT or ON at 4˚C 
• 1:1000 goat anti-Cdc14 (Santa Cruz), 1:1000 goat anti-Cdc5 (Santa Cruz) diluted in 1% 
ovalbumin/ PBS-T, ON at 4°C 
• 1:1000 goat anti-Clb5 (Santa Crutz) diluted in 5% milk/TBS-T, 3 hrs at RT or ON at 
4°C 
 
Membranes were then washed 3 x 15’ in PBS-T or TBS-T, after which they were 
incubated with the horseradish-peroxidase-conjugated secondary antibody: 
 
• 1:10000 anti-mouse, 1:10000 anti-rabbit in 1% milk/ 1%BSA/ PBS-T for 1 hour 
• 1:5000 anti-goat in 1% ovalbumin/ PBS-T or TBS-T for 1 hours 
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After incubation with the secondary antibody, the membrane was washed 3 x 15’ in PBS-T 
or TBS-T and the bound secondary antibody was revealed using ECL (Enhanced 
Chemiluminescence, Amersham).  
 
Solutions: 
1X Western Transfer buffer:   0.2 M glycine  
     0.025 M Tris base  
     20% methanol 
 
10X PBS buffer:    1.37 M NaCl  
     27 mM KCl  
     14.7 mM KH2PO4  
     80 mM Na2HPO4  
 
PBS-T buffer: 0.1% Tween, 1X PBS 
 
Kinase Assays 
Cdc5 kinase assay 
25 ml of a cell culture at OD600: 0.5 were treated as described in (Charles et al., 
1998). 
Cells were centrifuged for 2’ at maximum speed. The resulting pellet was transferred with 
1 ml Tris-HCl pH 7.4 to a 2 ml Sarstedt tube. The tube was centrifuged at 4°C and the 
supernatant discarded. The pellet was frozen in liquid nitrogen in order to better preserve 
protein status. Pellet was then resuspended in 100-150 µl of LLB breakage buffer 
supplemented with complete protease inhibitor cocktail (Roche) and phosphatases 
inhibitors (60 mM "-glycerol phosphate, 0.1 mM Na orthovanadate, 5 mM NaF, 15 mM p-
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Nitrophenylphosphate). An equal volume of acid-washed glass beads (Sigma) was added 
(leaving a layer of supernatant over the beads) and the tubes were subjected to 3 rounds of 
Fast Prep (speed 6.5 for 45’’) at 4°C in order to break the cells. Cell breakage was checked 
under the optical microscope. The samples were centrifuged twice at maximum speed at 
4°C for 10’ to clean up the extract. Supernatant was transferred to a new tube avoiding 
cellular debris at the bottom and lipid layer at the top. Protein concentration was 
determined by Bradford Assay (see TRIS protein extraction for details). 500 ug of extract 
were used for the immunoprecipitation. An appropriate volume of LLB breakage buffer 
was added to each tube so that all tubes are at the same volume. Mouse anti-HA antibodies 
(Covance) were added at a dilution of 1:50 and samples were incubated on a rotating 
wheel for 30’ at 4°C. 20 µl of slurry Protein A-conjugated agarose beads (PIERCE) were 
next added to each sample. The samples were then incubated on the rotating wheel at 4°C 
for 1 hour. After incubation with the beads, the beads bound to the protein of interest were 
washed: 
 
2x 1 ml of LLB 
1x 1 ml of High-Salt QA 
1x 1 ml of 5KB 
2x 1 ml of KB 
 
During each wash: 
 
• samples were centrifuged for 1’ at 2000 rpm at 4°C 
• supernatant was removed paying attention at not disturbing beads 
 
Beads bound to the protein of interest were resuspended with 30 ul of Reaction mix and 
incubated for 15’ at RT. Then 15 ul of 3X sample buffer was added to stop the reaction 
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and samples were boiled for 3’ at 95°C. Samples were spun down at maximum speed for 
5’ and then loaded on a 12.5% gel. The gel was fixed in 10% Ac. Acetic, 10% MeOH for 
20-30’, dryed for 1-3 hrs depending on the size and then exposed. 
 
Solutions: 
LLB buffer:    50 mM HEPES pH 7.4  
    0.1% NP40  
    5 mM NaF  
    5 mM "-glycerol phosphate  
    1 mM MgCl2  
    1 mM DTT  
    75 mM KCl 
 
LLB Breakage Buffer:  LLB  
    1X protease inhibitor cocktail (PIC, Roche)  
    100 mM PMSF  
    0,1 M Na orthovanadate 
 
High-Salt QA buffer:   20 mM Tris-HCl pH 7.6  
    250 mM KCl  
    1 mM MgCl2  
    1 mM DTT 
 
5KB buffer:    50 mM HEPES pH 7.4  
    200 mM KAc  
    10 mM MgCl2  
    5 mM MnCl2  
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    1 mM DTT 
KB buffer:    50 mM HEPES pH 7.4  
    60 mM KAc, 10 mM MgCl2, 5 mM MnCl2 
 
Kinase reaction mix: 
   
 1 mg/ml Casein (Sigma) in KB buffer   29.6 µl 
 10 mM ATP       0.15 µl 
 6000 Ci/mmol gamm-ATP    0.25 µl 
 
Dbf2 kinase assay 
15 ml of a cell culture at OD600: 0.5 were collected and centrifuged for 2’ at 
maximum speed. The resulting pellet was transferred with 1 ml Tris-HCl pH 7.4 to a 2 ml 
Sarstedt tube. The tube was centrifuged at 4°C and the supernatant discarded. The pellet 
was frozen in liquid nitrogen in order to better preserve protein status. Pellet was then 
resuspended in 100-150 µl of NP40 buffer supplemented with complete protease inhibitor 
cocktail (Roche) and phosphatases inhibitors (60 mM "-glycerol phosphate, 0.1 mM Na 
orthovanadate, 5 mM NaF, 15 mM p-Nitrophenylphosphato). An equal volume of acid-
washed glass beads (Sigma) was added (leaving a layer of supernatant over the beads) and 
the tubes were subjected to 3 rounds of Fast Prep (speed 6.5 for 45’’) at 4°C in order to 
break the cells. Cell breakage was checked under the optical microscope. The samples 
were centrifuged twice at maximum speed at 4°C for 10’ to clean up the extract. The 
supernatant was transferred to a new tube avoiding cellular debris at the bottom and lipid 
layer at the top. Protein concentration was determined by Bradford Assay (see TRIS 
protein extraction for details). 300 ug of extract were used for the immunoprecipitation. An 
appropriate volume of LLB breakage buffer was added to each tube so that all tubes had 
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the same volume. Mouse anti-Myc antibodies (Covance) were added at a dilution of 1:50 
and samples were incubated on a rotating wheel for 1 hour at 4°C. 20 µl of slurry Protein 
A-conjugated agarose beads (PIERCE) were next added to each sample. The samples were 
then incubated on the rotating wheel at 4°C for 2 hours. After incubation with the beads, 
the beads bound to the protein of interest were washed: 
 
4x 1 ml of NP40 buffer 
2x 1 ml of 25 mM mops  
 
During each wash: 
• samples were centrifuged for 1’ at 2000 rpm at 4°C 
• supernatant was removed paying attention at not disturbing beads 
 
Beads bound to the protein of interest were resuspended with 6 ul of HBII buffer and 
incubated for 15’ at RT. 10 ul of kinase reaction mix was added to the samples. Samples 
were incubated for 15’ at RT. Then 10 ul of 3X sample buffer was added to stop the 
reaction. Samples were spun down at maximum speed for 5’ and then loaded on a 12.5% 
gel. The gel was fixed in 10% Ac. Acetic, 10% MeOH for 20-30’, dryed for 1-3 hrs 
depending on the size and then exposed. 
 
Solutions: 
NP40 buffer:   150 mM NaCl  
   50 mM Tris-HCl pH 7.5  
   1% NP40 
HBII buffer:   60 mM "-glycerol phosphate  
   15 mM Mops  
   15 mM MgCl2  
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   5 mM EGTA  
   1 mM DTT  
   1X protease inhibitor chocktail (PIC- Roche)  
   0.1 mM Na orthovanadate  
   15 mM p-Nitrophenylphosphate 
 
Kinase reaction mix:  
equal volume of SOL1 and SOL2 
SOL1: 
 100 mM cold ATP      1.1 µl 
 6000 Ci/mmol gamm-ATP     3 µl 
 H2O        275 µl 
 
SOL2:  
 4 mg/ml Histon H1 in 50 mM Mops 
 
Clb2 kinase assay  
Same as for Dbf2. Rabbit anti-Clb2 (SantaCrutz) were addedat a dilution of 1:50. 
 
Yeast procedures 
Tetrad dissection and analysis 
MATa and MAT" strains were mixed on the appropriate solid medium and 
incubated overnight at permissive conditions. The next day, cells from the cross mixture 
were streaked to single colonies on selective medium and incubated at the appropriate 
temperature, allowing for selection of diploid cells. Single colonies grown under selective 
conditions were next amplified on rich media for 1 day. This step greatly increases the 
efficiency of sporulation. The next day diploids were patched onto sporulation plates (1% 
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KAcetate, all amino acids at 1/4 of the normal concentration) to induce meiosis and 
sporulation by starvation. After ~ three days diploids have efficiently sporulated and 
maturated and tetrads can now be dissected. 
In order to separate individual spores the wall of the ascus or tetrad is removed by 
enzymatic digestion. 
 
Digestion conditions: a toothpick full of tedrads is resuspended into: 
        
   200 µl  ddH2O 
   2 µl 10 mg/ml zymolase 100T (Seikagaka, Biobusiness) 
 
The digestion mixture was then incubated at 30°C for 5’ in order to enzymatically digest 
the asci sac. Then, 1 ml ddH2O was added to dilute the mix and 20 µl were dripped in a 
line onto the appropriate agar plate. Individual tetrads were dissected using the Nikon 
dissection microscope. Spores were left to grow at RT for 3-5 days. Colonies were replica 
plated onto selective media to define their genotype. 
 
BAR-test/alpha factor sensitivity 
The BAR1 gene (BARrier to the "-factor response) encodes for a protease that is 
secreted into the periplasmic space of MATa cells (Sprague, 1981). This protease cleaves 
and inactivates the "-mating factor pheromone allowing cells to recover from "-factor-
induced cell cycle arrest. Transcription of BAR1 in MAT" haploids and MATa/MAT" 
diploids is repressed. BAR1 is a MATa specific gene, whose transcription is stimulated by 
the presence of "-factor (Kronstad et al., 1987; Manney et al., 1983). MATa cells that lack 
the Bar1 protein are supersensitive to an "-factor-induced G1 arrest (Sprague, 1981). 
When assessing the genotype of yeast strains, the presence or absence of the Bar1 protein 
is assessed with what we call the “BAR-test”. 
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MATa cells (one streak through a patch) were resuspeded in 50 µl of the appropriate 
medium. An appropriate volume of the appropriate medium containing 0.8% agarose was 
boiled. When cooled down, 3 ml of agarose/medium were mixed with the cell suspension 
mixture and poured into a small Petri dish. The Petri dish was put on ice until the mixture 
was solid. A small dot of MAT" tester strain was put in the center of the dish. The dish was 
incubated at RT for 1-2 days. bar1 mutant strains, being highly sensitive to the presence of 
"-factor, do not grow in proximity of the MAT" cells and produce a halo around the tester 
strain.  
 
Synchronization experiments 
Cells were grown ON in the appropriate volume of YEPD or YEPR at 23°C in a 
water shaking bath. The day after, cells were diluted to OD600 = 0.2 in fresh medium and 
left to grow for 2 hrs.  
 
G1 arrest and release: 
In order to synchronize cells in G1-phase, cell cultures were then diluted again to 
OD600 = 0.2 and added with 5 µg/ml !-mating factor synthetic peptide (Primm). After 90’ 
incubation, 2.5 µg/ml !-factor was re-added to the culture. The G1 arrest was considered 
complete when more than 90% of the cells have shmoo. For G1 arrest experiments, to 
maintain cells in G1, 2.5 µg/ml !-factor was added every 90’ until the end of the 
experiment. For synchronization experiments, after the arrest was complete, cells were 
released from the G1 block. !-factor was washed out by filtration, using between 5 to 10 
volumes of medium without the pheromone. Cells were next released into the appropriate 
fresh medium in the absence of the pheromone.  
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S phase and Metaphase arrests and releases: 
For S phase or metaphase arrest experiments: cells were first pre-synchronized in 
G1 by addition of !-factor and next released in a medium containing 10 mg/ml 
hydroxyurea (HU, Sigma) or 15 µg/ml nocodazole (NOC, Sigma) dissolved in DMSO, 
respectively. In the case of a nocodazole arrest, 7.5 µg/ml nocodazole was re-added to the 
culture after 90’ incubation.  
For synchronization experiments, after the arrest was complete, cells were released from 
blocks. Drugs were washed out by filtration, using between 5 to 10 volumes of medium 
without the without them, in the case of nocodazole releases 1% of DMSO was added to 
the washing media. Cells were next released into the appropriate fresh medium.  
Note: when releasing from nocodazole it is advisable to add 1% DMSO also in the flask of 
release.  
 
Special treatments: 
• Expression of genes under the control of the GAL1-10 promoter, was achieved by 
adding 2% galactose to the medium.  
• Repression of genes under the control of the MET3 promoter, was achieved by 
adding 8mM of fresh methionine to the medium (re-add 4mM methionine every 
hours).  
• ATP analogue-sensitive alleles (cdc15-as1 and cdc28-as1) were inactivated by 
adding 5µM 1NM-PP1 to the cell culture (Bishop et al., 2001).  
• The ATP analogue-sensitive allele cdc5-as1 (Zhang et al., 2005), was inactivated 
by adding 5 µM CMK to the medium.  
• Temperature sensitive alleles were inactivated by incubating the colture to the 
restrictive temperature. 
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Reagents: 
Purified !-factor synthetic peptide (Primm), 5 mg/ml stock dissolved in ddH2O 
Hydroxyurea (Sigma), powder 
Nocodazole (Sigma), 15 mg/ml stock dissolved in DMSO 
1NM-PP1 (Toronto Research Chemicals), 20 mM stock in DMSO 
CMK (Accenda Tech), 10 mM stock in DMSO 
 
In situ indirect immunofluorescence 
1.5 ml of a cell culture at OD600 = 0.2-0.4 were collected by centrifugation and 
incubated 10’ at RT or ON at + 4°C in 1 ml fixative solution (3.7% formaldehyde in 0.1 M 
KPi pH 6.4). Cells were pelleted and washed 3 times with 1 ml of 0.1 M KPi pH 6.4 
followed by a wash with 1 ml of sorbitol-citrate solution. Cells were then resuspended in 
200 µl of digestion solution and incubated at 30°C in order to enzymatically digest the cell 
wall, creating spheroplasts. Spheroplasts are osmotically fragile and lyse in a hypotonic 
solution; 1.2 M sorbitol maintains an isotonic environment in order to avoid cell lysis. The 
low pH helps in slowing down the endogenous cell proteolytic activity. Digestion was 
checked by looking for burst spheroplasts when mixed with an equal volume of 1% SDS 
under an optical microscope. When the digestion was complete, the obtained spheroplasts 
were pelleted at 2000 rpm for 2’ and washed with 1 ml of sorbitol-citrate solution. The 
pellet was then resuspended in an appropriate volume of sorbitol-citrate solution (from 10 
to 50 µl, depending on the pellet size). 5 µl of the resuspended spheroplasts were then 
loaded on a 30-well slide previously coated with 0.1 % polylysine (Sigma). To further fix 
cells, the slide was then put in cold methanol for 3’, followed by 10’’ in cold acetone. Cells 
were then incubated, in a humid dark incubation chamber, with primary antibody/ies at the 
following conditions: 
 
• 1:100 rat anti-tubulin (Oxford-Biotechonology) in PBS-BSA for 90’ 
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• 1:150 mouse anti-HA (Covance) in PBS-BSA for 90’ 
• 1:300 goat anti-Cdc14 (Santa Cruz) in PBS-ovalbumin for 2 hours 
• 1:500 mouse anti-Nop1 (EnCor Biotechnology) in PBS-BSA for 90’ 
 
After incubation, cells were washed 5x with PBS-BSA or PBS-ovalbumin and incubated 
with secondary antibody at the following conditions: 
 
• 1:100 FITC-conjugated anti-rat in PBS-BSA for 90’ 
• 1:1000 Cy3-coniugated anti-mouse in PBS-BSA for 90’ 
• 1:500 Cy3-coniugated anti anti-goat in PBS-ovalbumin for 2 hours 
• 1:500 Cy3-coniugated anti-mouse in PBS-BSA for 90’ 
 
Cells were then washed 5x with PBS-BSA or PBS-ovalbumin and then treated with a 
DAPI mount solution. The slide was covered with a coverslip and sealed with nail polish. 
Immunofluorescence was analysed with a Leica DMR HC BIOMED fluorescence 
microscope using a 100X immersion-oil objective. 
 
Solutions: 
0.1 M KPi buffer pH 6.4:  27.8 ml 1 M K2HPO4  
    72.2 ml 1 M KH2PO4  
    900 ml ddH2O 
 
Fixative solution:   3.7% formaldehyde  
    0.1 M KPi pH 6.4 
 
Sorbitol-citrate solution:  1.2 M Sorbitol  
    0.1 M phospho-citrate pH 5.9 
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Digestion solution:   1.2 M sorbitol-citrate  
    10% glusulase  
    0.1 mg/ml zymolase  
 
PBS-BSA:    1% crude BSA (Sigma)  
    0.04 M K2HPO4  
    0.01 M KH2PO4  
    0.15 M NaCl  
    0.1% NaN3 
 
PBS-ovalbumin:   1% crude ovalbumin 
    0.04 M K2HPO4  
    0.01 M KH2PO4 
    0.15 M NaCl  
    0.1% NaN3 
 
DAPI mount solution:  0.04 M K2HPO4  
    0.01 M KH2PO4  
    0.15 M NaCl  
    0.1% NaN3  
    0.05 µg/ml DAPI  
    0.1% p-phenylenediamine  
    90% glycerol 
 
Percentage of budded cells (budding index) 
1 ml of culture was collected and incubated 10’ at RT in 1 ml fixative solution 
(3.7% formaldehyde in 0.1 M KPi pH 6.4). Cells were next washed 1x with 0.1 M KPi pH 
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6.4. Fixed cells were sonicated and a 5 µl aliquot was scored under the light microscope 
for the presence or absence of the bud. 200 cells were scored for each sample.  
 
Fluorescence-activating cell sorting (FACS) 
1.5 ml of a cell culture at OD600 = 0,2 - 0,4 were collected by centrifugation and 
suspended in a Tris-HCl/ethanol solution for 15’. Cells were then washed with 1 ml of 50 
mM Tris-HCl pH 7.4 and suspended in the same buffer containing 1 mg/ml of RNase. 
Samples were incubated ON at 37°C. The day after the cells were collected by 
centrifugation and washed with 1 ml FACS buffer and stained in the same buffer 
containing 55 µg/ml propidium iodide (Fluka). Samples were then diluted 10-fold in 50 
mM Tris-HCl pH 7.4 and analyzed using a Becton Dickinson FACScan. 
 
Solutions: 
 Tris-HCl/Ethanol solution:  250 mM Tris-HCl pH 7.4  
     70% ethanol 
50 mM Tris-HCl pH 7.4  
 
FACS buffer:     200 mM Tris-HCl pH 7.4  
     200 mM NaCl  
     78 mM MgCl2 
 
 
Nuclei staining (DAPI staining) 
1 ml of a cell culture at OD600 = 0.2-0.4 were collected by centrifugation and 
incubated 10’ at RT in 1 ml of 70% ETOH. Cells were pelleted and then resuspended in 20 
µl of DAPI 0.001 mg/ml.  
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Plasmid Template Primers Mutated AA 
pFM1 YIplac204-3HA-CDC14 FM56-FM57 T10A 
pFM2 YIplac204-3HA-CDC14 FM58-FM59  T10D 
pFM3 YIplac204-3HA-CDC14 FM9-FM10 T140A 
pFM4 YIplac204-3HA-CDC14 FM11-FM12 T140D 
pFM5 YIplac204-3HA-CDC14 FM1-FM2 S260A 
pFM6 YIplac204-3HA-CDC14 FM3-FM4 S260D 
pFM7 YIplac204-3HA-CDC14 FM13-FM14 S391A 
pFM8 YIplac204-3HA-CDC14 FM15-FM16 S391D 
pFM9 YIplac204-3HA-CDC14 FM5-FM6 S471A 
pFM10 YIplac204-3HA-CDC14 FM7-FM8 S471D 
pFM11 YIplac204-3HA-CDC14 FM-60-FM61 T517A 
pFM12 YIplac204-3HA-CDC14 FM62-FM63 T517D 
pFM13 pFM3 FM56-FM57 T10A-T140A 
pFM14 pFM4 FM58-FM59 T10D-T140D 
pFM15 pFM13 FM1-FM2 T10A-T140A-S260A 
pFM16 pFM14 FM3-FM4 T10D-T140D-S260D 
pFM17 pFM9 FM13-FM14 FM60-FM61 T391A-S471A-T517A 
pFM18 pFM10 FM15-FM16 FM62-FM63 T391D-S471D-T517D 
pFM19 pFM13 + pFM17 N/A T10A-T140A- S391A-S471A-T517A 
pFM20 pFM14 + pFM18 N/A T10D-T140D-S391D-S471D-T517D 
pFM21 pFM19 FM1-FM2 T10A-T140A-S260- S391A-S471A-T517A 
pFM21 pFM20 FM3-FM4 T10D-T140D-S260-S391D-S471D-T517D 
 
Table 2.1: Plasmids used in this study. 
N/A applies to plasmid obtained by cloning rather then via PCR directed-mutagenesis.  
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Name Sequence (5’-3’) Purpose 
FM1 ggtacatgtcctgatcttgccattgtaaaaaactttgttgg Cdc14 mutagenesis 
FM2 ccaacaaagttttttacaatggcaagatcaggacatgtacc Cdc14 mutagenesis 
FM3 ggtacatgtcctgatcttgacattgtaaaaaactttgttggtgc Cdc14 mutagenesis 
FM4 gcaccaacaaagttttttacaatgtcaagatcaggacatgtacc Cdc14 mutagenesis 
FM5 gcaacaactcagatgacgaagccatgcatgataccaacg Cdc14 mutagenesis 
FM6 cgttggtatcctgcatggcttcgtcatctgagttgttgc Cdc14 mutagenesis 
FM7 gcaacaactcagatgacgaagacatgcaggataccaacg Cdc14 mutagenesis 
FM8 cgttggtatcctgcatgtcttcgtcatctgagttgttgc Cdc14 mutagenesis 
FM9 gcggatttcgaaatcgcaattcaagatgtggtttatgg Cdc14 mutagenesis 
FM10 ccataaaccacatcttgaattgcgatttcgaaatccgc Cdc14 mutagenesis 
FM11 gcggatttcgaaatcgatattcaagatgtggtttatggcg Cdc14 mutagenesis 
FM12 cgccataaaccacatcttgaatatcgatttcgaaatccgc Cdc14 mutagenesis 
FM13 ggtgaattaagagatttagccatgacgccgc Cdc14 mutagenesis 
FM14 gcggcgtcatggctaaatctcttaattcacc Cdc14 mutagenesis 
FM15 ggtgaattaagagatttagacatgacgccgccatcc Cdc14 mutagenesis 
FM16 ggatggcggcgtcatgtctaaatctcttaattcacc Cdc14 mutagenesis 
FM56 ggagtgtatacctcgacaacgcgatcgagttcc Cdc14 mutagenesis 
FM57 ggaactcgatcgcgttgtcgaggtatacactcc Cdc14 mutagenesis 
FM58 ggagtgtatacctcgacaacgacatcgagttcctgc Cdc14 mutagenesis 
FM59 gcaggaactcgatgtcgttgtcgaggtatacactcc Cdc14 mutagenesis 
FM60 ccgcagatgatgccatactaagacaactattgcc Cdc14 mutagenesis 
FM61 ggcaatagttgtcttagtatggcatcatctgcg Cdc14 mutagenesis 
FM62 ccgcagatgatgacatactaagacaactattgcc Cdc14 mutagenesis 
FM63 ggcaatagttgtcttagtatgtcatcatctgcgg Cdc14 mutagenesis 
FM45 ggatttcggtcccatgaacattgg Cdc14 sequencing 
FM46 gccggttattctaatgcgg Cdc14 sequencing 
FM47 ccgctaacgagtgtattggc Cdc14 sequencing 
FM48 gacgacaagagggttgcgc Cdc14 sequencing 
FM49 catctgcatcgaccagacaacg Cdc14 sequencing 
FM50 gatgtccaatgttcatgggac Cdc14 sequencing 
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FM51 gagaattcaaccttaccac Cdc14 sequencing 
FM52 cgtaatccaacttcccatgc Cdc14 sequencing 
FM53 ggaagcttttattcgaaatccgcattaga Cdc14 sequencing 
FM54 gtggtataagaaaaataagtggctc Cdc14 sequencing 
FM55 cggggtaccaattatttcttgatggagccac Cdc14 sequencing 
 
Table 2.2: Primers used in this study. 
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Name Genotype 
E. coli DH5!TM  F
-#80 dlacZ !M15 !(lacZYA-argF) U169 deoR recA1 endA1 hsdR17 (rK-, mK+) 
supE44 $- thi-1 qyrA96 relA1  
E. coli XL10-
Gold$(Stratagene) 
TetR !(mcrA)183 !(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac Hte [F´ proAB lacIqZ!M15 Tn10 (TetR) Amy CamR] 
 
Table 2.3: Bacterial strains used in this study. 
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Strain Relevant Genotype 
Ry1 MATa, ade2-1, leu2-3, ura3, trp1-1, his3-11,15, can1-100, GAL, psi+ 
Ry278 MATa, CDC14-3HA 
Ry394 MATa, CFI1-3MYC, CDC14-3HA 
Ry430 MATa, GAL-CLB2dBdel::URA3, CDC14-3HA 
Ry446 MATa, clb5::URA3, CDC14-3HA 
Ry448 MATa, GAL-CLB2dBdel::URA3, CFI1-3MYC, CDC14-3HA 
Ry798 MATa, 1xGAL-CDC5(dN70aa)-HA::URA3 
Ry995 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-LEU2, CFI1-3MYC, CDC14-3HA 
Ry1132 MATa, cdc15::CDC15-as1(L99G)::URA3, CDC14-3HA 
Ry1324 MATa, ura::GAL-3Myc-CDC5::URA3, cdc15::CDC15-as1(L99G)::URA3, CDC14-3HA, CFI1-3MYC 
Ry1325 MATa, ura::GAL-3Myc-CDC5::URA3, CDC14-3HA, CFI1-3MYC 
Ry1345 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750 –HIS3, leu2::CDC15-HA3-LEU2, 1xGAL-CDC5(dN70aa)-HA::URA3, CFI1-3MYC, CDC14-3HA 
Ry1353 
MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-
LEU2, 1xGAL-CDC5(dN70aa)-HA::URA3, cdc28d::cdc28-as1, CFI1-
3MYC, CDC14-3HA 
Ry1356 MATa, 1xGAL-CDC5(dN70aa)-HA::URA3, cdc28d::cdc28-as1, CFI1-3MYC, CDC14-3HA 
Ry1358 MATa, 1xGAL-CDC5(dN70aa)-HA::URA3, CFI1-3MYC, CDC14-3HA 
Ry1387 MATa, GAL-CLB2dBdel::URA3 
Ry1388 MATa, GAL-CLB2dBdel::URA3,  sic1::TRP1 
Ry1392 MATa, GAL-CLB2dBdel::URA3, cdc5::KanMX6, ura3::CDC5dBdel::URA3, CDC14-3HA 
Ry1393 MATa, GAL-CLB2dBdel::URA3, cdc5-1, CDC14-3HA 
Ry1394 MATa, GAL-CLB2dBdel::URA3, cdc15::CDC15-as1(L99G)::URA3, CDC14-3HA 
Ry1428 MATa, GAL-CLB2dBdel::URA3, cdc14::CDC14-yEGFP::KanMX 
Ry1452 MATa, GAL-CLB2dBdel::URA3, cdc23-1, CDC14-3HA 
Ry1457 MATa, GAL-CLB2dBdel::URA3, cdc20-3, CDC14-3HA 
Ry1466 MATa, GAL-CLB2dBdel::URA3, cdh1::HIS3, CDC14-3HA 
Ry1510 MATa, cdc5-ad1(L251W) 
Ry1538 MATa, MET3-CDC20::URA3, pds1::URA3, cdc15::CDC15-as1(L99G)::URA3, clb5::URA3, CDC14-3HA 
Ry1545 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-LEU2, 1xGAL-CDC5(dN70aa)-HA::URA3, CFI1-3MYC,   CDC14-3HA 
Ry1547 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-LEU2, GAL-CLB2dBdel::URA3, CDC14-HA 
Ry1558 MATa, MET3-CDC20::URA3, pds1::URA3, cdc15::CDC15-as1(L99G)::URA3, CDC14-3HA 
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Ry1573 MATa, cdc14-1 
Ry1575 MATa, GAL-CLB2dBdel::URA3, cdc14-1 
Ry1588 MATa, clb5::URA3, cdc15::CDC15-as1(L99G)::URA3, CDC14-3HA 
Ry1606 MATa, GAL-CLB2dBdel::URA3, cdc14-1, cdc5L158G 
Ry1607 MATa, GAL-CLB2dBdel::URA3, cdc5L158G 
Ry1687 MATa, GAL-CLB2dBdel::URA3, CDC5::Venus 
Ry1695 MATa/MATalpha, CDC14/cdc14-1-6HA::kanMX6 
Ry1708 MATa, GAL-CLB2dBdel::URA3, tof2::kanMX6, CDC14-3HA 
Ry1710 MATa, GAL-CLB2dBdel::URA3, cfi1::URA3, CDC14-3HA 
Ry1715 MATa, GAL-CLB2dBdel::URA3, net1::his5, net1-6Cdk-TEV-myc9::TRP1, cdc15::CDC15-as1(L99G)::URA3 
Ry2016 MATa, ura::GAL-3Myc-CDC5::URA3, CLB2-3HA 
Ry2020 MATa, CLB2-3HA 
Ry2248 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-LEU2, 1xGAL-CDC5(dN70aa)-HA::URA3, DBF2-3MYC 
Ry2254 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-LEU2, DBF2-3MYC 
Ry2257 MATa, 1xGAL-CDC5(dN70aa)-HA::URA3, DBF2-3MYC 
Ry2446 MATa, cdc5L158G 
Ry3536 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-LEU2, dbf2-2 
Ry3540 MATa, cdc15::TRP1-GAL-GFP-CDC15(1-750)-HIS3, leu2::CDC15-HA3-LEU2, cdc5L158G 
 
Table 2.4: Yeast strains. The table includes strains made and use in this work. 
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3. Results 
An overview: What do we know about Cdc14 release?  
Several observations suggest that the release of Cdc14 from its inhibitor Cfi1 (also 
known as Net1) is mediated by phosphorylation. In vitro studies suggest that 
phosphorylation triggers the dissociation of Cdc14 from its inhibitor Cfi1  (Shou and 
Deshaies, 2002; Shou et al., 1999). Furthermore, in vivo the release of Cdc14 correlates 
with an increased phosphorylation of Cdc14 and Cfi1 (Visintin et al., 2003). In agreement 
with the idea that phosphorylation controls the dissociation of the Cdc14-Cfi1 complex is 
the observation that the most downstream components of the networks that control Cdc14 
release (FEAR and MEN) are kinases. Indeed the Polo-like kinase Cdc5, Clb2-Cdk and the 
most-downstream MEN kinase Dbf2 have all been implicated in this process (Azzam et 
al., 2004; Geymonat et al., 2003; Hu and Elledge, 2002; Hu et al., 2001; Mohl et al., 2009; 
Pereira et al., 2002; Queralt et al., 2006; Stegmeier et al., 2002; Visintin et al., 2003; 
Yoshida and Toh-e, 2002). More specifically, work from Azzam and colleagues (Azzam et 
al., 2004) supports the idea that the Clb2-Cdk kinase is responsible for Cfi1 
phosphorylation. Phoshorylation that lead to the dissociation of Cdc14 from its inhibitor 
during early anaphase (Azzam et al., 2004; Sullivan et al., 2004). The authors showed that 
recombinant Clb2-Cdk could disrupt the Cdc14-Cfi1 complex in vitro (Azzam et al., 
2004). Moreover, they identified several residues in Cfi1 that appears to be phosphorylated 
by Cdk1 in vivo. Interestingly, yeast strains carrying an allele of Cfi1 where these sites 
were replaced by alanine (an amino acid that cannot be phosphorylated) exhibited a kinetic 
of Cdc14 release reminiscent of the one characteristic of FEAR network mutants. This 
finding suggests that Clb2 is a FEAR network component and that Clb2-Cdk-mediated 
phosphorylation of Cfi1 is the mechanism via which the FEAR network controls the 
Cdc14-Cfi1 interaction (Azzam et al., 2004).  
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Of all the mitotic exit network components identified to date, the kinase Dbf2 is the 
most downstream acting and as such the most likely candidate for controlling the 
phosphorylation status of the Cdc14-Cfi1 complex in the later stages of anaphase. 
Although data in support of this hypothesis are still missing, Mohl and colleagues (Mohl et 
al., 2009) recently identified sites in Cdc14 whose phosphorylation by Dbf2 results in a 
cytoplasmic accumulation of the phosphatase. Whether Dbf2 is also responsible for 
phosphorylation events that trigger the dissociation of Cdc14 from Cfi1 is still unknown. 
Of the three kinases mentioned above, the Polo-like kinase Cdc5 seems to take the 
lion’s share. Cdc5 is part of the FEAR network and acts as an activator of the MEN 
(Stegmeier et al., 2002). It is unique among FEAR and MEN components in that it is 
required throughout anaphase for maintaining Cdc14 in its released state (Visintin et al., 
2008). When overexpressed, Cdc5 is capable of inducing a release of Cdc14 in stages of 
the cell cycle during which the phosphatase is normally sequestered (Visintin et al., 2003). 
Similarly, recombinant Cdc5 dissociates the Cdc14-Cfi1 complex in vitro (Shou et al., 
2002). Both in vitro and in vivo, the ability of Cdc5 to disrupt the interaction between 
Cdc14 and Cfi1 is associated with the ability of the protein to induce directly or indirectly 
phosphorylation of both Cdc14 and Cfi1 (Shou et al., 2002; Visintin et al., 2003). 
Although we have established a framework of how mitotic exit is controlled in budding 
yeast, important questions remain to be addressed. For instance, the molecular mechanism 
that regulates the Cdc14-Cfi1 interaction remains unclear and how the three kinases 
interact to induce a timely and complete release of Cdc14 is still unknown. 
My PhD aimed to provide answers to those questions. More specifically I wished to 
reveal the mechanism(s) underlying the phospho-driven (dis)association of Cdc14 with its 
inhibitor Cfi1. 
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Cdc5 and one between Clb-Cdks and MEN are required for Cdc14 
release 
To evaluate the minimal requirement for mitotic kinases Clb2-Cdk, Cdc5 and Dbf2 
to promote the release of Cdc14, we analyzed the consequences of modulating the activity 
of these kinases either alone or in mutual combination in the G1 and S phases of the cell 
cycle. In these phases, both endogenous Clbs and Cdc5 are absent (G1-phase) or just start 
to accumulate (S-phase), MEN is inactive and there is no contribution of other mitotic 
regulators; thus Cdc14 is maintained sequestered in the nucleolus. 
Ectopic expression of the kinases Cdc5 and Clb2 was obtained by placing their 
coding sequence under the control of the galactose-inducible and glucose-repressible 
promoter GAL1-10. As for Dbf2, its ectopic activation was achieved by modulating the 
expression of an allelic variant of MEN kinase Cdc15 (CDC15(1-750)), truncated of its 
auto-inhibitory loop.  Overexpression of this hyperactive allele of Cdc15 was shown to 
result in the ectopic activation of Dbf2 (Bardin et al., 2003; Visintin et al., 2003). As for 
Clb2 and Cdc5, the coding sequence of this allele of CDC15 was placed under the control 
of the GAL1-10 promoter. 
We started to assess the ability of Cdc5 and Cdc15 to release Cdc14 from the 
nucleolus in G1 arrested cells. As Cdc5 is a target of the APC/CCdh1 and the APC/CCdh1 is 
active in G1 (Shirayama et al., 1998), we analyzed the contribution of Cdc5 in this phase 
of the cell cycle, by overexpressing an allele of CDC5 that is resistant to degradation by 
the APC/CCdh1 (Shirayama et al., 1998). APC/C substrates carry recognition motifs known 
as destruction boxes and KEN boxes. The core sequence of destruction-box motifs is 
RxxLxxxxN, while the KEN box comprises four essential ammino acids, KENxxxN 
(Harper et al., 2002). These sequences contain sufficient information to confer APC/C-
dependent ubiquitination on a protein. Cdc5 contains two destruction boxes at its N-
terminus, which are essential for the protein’s degradation during exit from mitosis 
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(Charles et al., 1998; Shirayama et al., 1998). To determine whether overexpression of 
CDC5 was sufficient to trigger the release of Cdc14 in G1, we examined the consequences 
of expressing an allele of Cdc5 that lacks the first 70 amino acids of the protein. This 
fragment contains both Cdc5’s destruction boxes (CDC5!N70, henceforth CDC5dB!) 
(Shirayama et al., 1998). 
Cells carrying one integrant of the GAL-CDC5dB! construct, the GAL-CDC15(1-
750) and both GAL-CDC5dB! and GAL-CDC15(1-750) were arrested in G1. When the 
arrest was complete, as judged by more than 90 percent of cells having shmoos, the 
pheromone was re-added to the medium to maintain the cells blocked in G1 together with 
galactose to drive ectopic overexpression of CDC5 and CDC15. Cdc14 localization was 
analyzed by indirect immunofluorescence (IF) using anti-Cdc14 antibodies. We found that 
in G1 arrested cells, neither the overexpression of a non-degradable form of Cdc5 (GAL-
CDC5dB!), nor of a hyperactive version of Cdc15 (GAL-CDC15(1-750)) was able to 
promote the release of Cdc14 from the nucleolus. In contrast, the concomitant GAL1-10 
driven expression of non-degradable Cdc5 and hyperactive Cdc15 induced a Cdc14 
release, Fig. 3.1a. We conclude that Cdc5 and MEN interact, directly or indirectly, to 
induce the ectopic release of Cdc14 in G1 arrested cells. 
As overexpression of Clb-Cdk complexes quickly push yeast cells into S-phase, the 
contribution of Clb2-Cdk on Cdc14 release was analyzed in S-phase arrested cells. To 
obtain an S-phase arrest, we treated cells with hydroxyurea (HU), a drug that inhibits the 
ribonucleoside reductase and prevents DNA synthesis. GAL-CLB2dB!, GAL-CDC15(1-
750), and GAL-CLB2dB! GAL-CDC15(1-750) cells were pre-synchronized in G1 and then 
released into growth medium containing HU. Once cells where homogeneously arrested in 
S-phase, as judged by more than 90 percent of cells having small buds, the media was 
supplemented with galactose to induce expression from the GAL-promoter. Here, neither 
the overexpression of an allele of Clb2 resistant to degradation (GAL-CLB2dB!) nor of the 
hyperactive form of Cdc15 (GAL-CDC15(1-750)) or the combined overexpression of Clb2 
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(GAL-CLB2dB!) and Cdc15 (GAL-CDC15(1-750)) induced a release of Cdc14, Fig. 3.1b. 
However, differently from the G1 phase, overexpression of Cdc5 succeeded in releasing 
Cdc14 in S-phase arrested cells, Fig. 3.1b. 
As our G1 data suggest that Cdc5 is not sufficient to induce Cdc14 release on its own 
we searched for the kinase that cooperates with Cdc5 to release Cdc14 in S phase arrested 
cells. Previous work has shown that the ability of Cdc5 to ectopically release Cdc14 in this 
cell cycle phase does not require MEN activity (Visintin et al., 2008). As endogenous Clb-
Cdk complexes start to accumulate in this phase of the cell cycle we hypothesized that 
these complexes could cooperate with Cdc5. We tested our hypothesis by asking whether 
CDC5dB! could release Cdc14 in S phase-arrested in the absence of Clb-Cdks activity. To 
inactivate Clb-Cdk complexes we took advantage of an allele of CDC28 (the sole Cdk in 
budding yeast) that is sensitive to the ATP analogue NM-PP1 (cdc28-as1; (Bishop et al., 
2001)). Of note, we refer to Clb-Cdk complexes rather then Clb2-Cdk because by 
inactivating directly CDC28, we inhibited all the complexes that the kinase forms at this 
specific phase (Clb5-Cdk, the S-phase predominant species; Clb2-Cdk, the mitotic 
predominant species). Interestingly we observed that Cdc5dB% is no more able to induce 
Cdc14 when Clb-Cdk complexes are inhibited. Thus, in agreement with our hypothesis we 
found that the release of Cdc14 by high levels of Cdc5 in S phase-arrested cells requires 
Clb-Cdks activity, Fig. 3.1c. As for the cells arrested in G1, the concomitant expression of 
Cdc5 (GAL-CDC5dB!) and MEN (GAL-CDC15(1-750)) rendered the presence of the Clb-
Cdks activity dispensable, Fig. 3.1c.  
Taken together, our results show that the ectopic release of Cdc14 from the nucleolus 
requires the combined activity of two kinases, Cdc5 and either Clb-Cdks or the MEN 
kinase Dbf2. We refer to this double kinase requirement as the “two-hit” model  (Fig. 3.2a, 
(Manzoni et al., 2010)). 
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Figure 3.1 Cdc5 requires a partner kinase for promoting Cdc14 release 
(a) GAL-CDC5dB! (Ry1358, GAL-CDC5DN70), GAL-CDC15(1-750) (Ry995) and GAL-CDC5dB! GAL-
CDC15(1-750) (Ry1345) cells were arrested in G1 by !-factor in YEPR. When arrest was complete the 
media was supplemented with 2% galactose (YEPR+G) to induce the expression of CDC5dB! and 
CDC15(1-750). The percentage of cells with Cdc14 released from the nucleolus was determined at the 
indicated times. (b) GAL-CDC5dB! (Ry1358, GAL-CDC5DN70), GAL-CDC15(1-750) (Ry995), GAL-
CLB2dB! (Ry448) and GAL-CDC15(1-750) GAL-CLB2dB! (Ry1547)  cells were arrested in G1 with !-
factor in YEPR and released in YEPR fresh media supplemented with HU to induce a synchronous arrest in 
S phase. Once cells were arrested, the media was supplemented with 2% galactose (YEPR+G) to induce the 
expression of CDC5dB!, CLB2dB! and CDC15. The percentage of cells with Cdc14 released from the 
nucleolus was determined at the indicated times. (c) GAL-CDC5dB! ((Ry1358, GAL-CDC5DN70), GAL-
CDC5dB! cdc28-as1 (Ry1356), GAL-CDC5dB! GAL-CDC15(1-750) cdc28-as1 (Ry1353) cells were 
treated and analyzed as described in (b), with the difference that concomitantly with galactose addition, cells 
were supplemented with 5µM of 1NM-PP1 analog 9 (Bishop et al., 2001) to inhibit Cdc28 activity. 
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Mitotic exit requires the power of two kinases: Cdc5 and either Clb-Cdks 
or MEN 
The observation that Cdc5 requires Clb-Cdks or MEN activity to release Cdc14 in 
phases other than anaphase suggests an appealing interpretation to explain how the correct 
timing of Cdc14 activation is achieved during a normal cell cycle. Moreover, it provides a 
nice explanation for a wide variety of mutants. At anaphase onset, the activation of the 
APC/CCdc20 results in the degradation of securin (Pds1 in budding yeast) and in the 
activation of separase (Esp1 in budding yeast). Active separase has been proposed to 
downregulate PP2ACdc55 phosphatase activity (Queralt et al., 2006) resulting in a first wave 
of Cdk-dependent Cfi1 phosphorylation (Queralt et al., 2006). As in this cell cycle stage 
Cdc5 and Clb-Cdks have reached their peak concentration it is conceivable to think that at 
anaphase onset Cdc5 and Clb2-Cdk would be responsible to initiate Cdc14 release, Fig. 
3.2a. At this stage, while Cdc5 and Clb2-Cdk are active, MEN is not (Stegmeier and 
Amon, 2004), as most of its components are inhibited by Clb-Cdks phosphorylation 
(Konig et al., 2010) and the GTPase Tem1 still resides in the mother cells, a space 
conceived as “MEN inhibitory zone” (Bardin et al., 2000; Chan and Amon, 2010). 
However, MEN is activated shortly thereafter (Stegmeier and Amon, 2004), when Clb2 is 
partially degraded by the APC/CCdc20 (Morgan, 2007). Hence it can maintain Cdc14 in its 
released state by taking over the role of Clb2-Cdk when the activity of the latter goes 
below a critical threshold. These events change the ratio of kinase/phosphatase activity in 
favor of the phosphatase thereby diminishing the rate of inhibitory phosphorylation on 
MEN components and ultimately leading to complete activation of the MEN, Fig. 3.2a 
(Bouchoux and Uhlmann, 2010; Konig et al., 2010).  
The “two-hit” model would also explain Cdc14 dynamics in mutants lacking MEN, 
in agreement with (Queralt et al., 2006). FEAR and MEN are not redundant. In MEN 
mutants, the release of Cdc14 brought about by the FEAR network is transient and limited 
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to the nucleus and hence is insufficient to complete exit from mitosis, Fig. 3.2b, and 
(Pereira et al., 2002; Stegmeier et al., 2002; Yoshida and Toh-e, 2002). Only by the 
additional contribution of MEN can the release of Cdc14 be prolonged in time resulting in 
Cdc14 spreading into the cytoplasm as well, Fig. 3.2c and (Mohl et al., 2009; Stegmeier 
and Amon, 2004). 
According to our model, the decrease of Clb2-Cdk activity is not compensated for in 
MEN mutants, and might be the reason why the FEAR-mediated Cdc14 release is transient 
(Manzoni et al. 2010) Fig. 3.2b. If this interpretation is correct then Cdc14 re-sequestration 
in MEN mutants should mirror the pattern of Clb2 degradation and it should be possible to 
make Cdc14 release permanent, even in the absence of MEN by stabilizing Clb2. 
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Figure 3.2 A “two-hit” mechanism underlies the release of Cdc14 
(a) Release of Cdc14 requires the activity of two kinases: Cdc5 always and one between Clb2-Cdk and MEN 
kinase Dbf2. This model provides a nice explanation for what happens in an unperturbed cell cycle. Here 
Clb2-Cdk and Cdc5 initiate the release of Cdc14 by the FEAR network. At the metaphase to anaphase 
transition Clb2 is partially degraded by the APC/CCdc20, while the MEN start to be activated. Thus the role of 
Clb2 is taken over by Dbf2 when its activity goes below a critical threshold, sustaining the release of Cdc14 
in the later stages of anaphase. (b-c) cdc15-as1 (b) and wild type (c) cells were arrested in G1 with !-factor 
in YEPD at 23°C and released in fresh YEPD media supplemented with the Cdc15-as1 inhibitor (1NM-PP1 
analog 9 (Bishop et al., 2001)). At the indicated time-points samples were taken to determine the percentage 
of metaphase spindles (closed squares), anaphase spindles (closed circles) as well as the percentage of cells 
with Cdc14 released from the nucleolus (open circles). 
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Cdc14 re-sequestration occurs concomitantly with Clb2 degradation in 
MEN mutants 
To test whether Clb2 degradation could be the reason why the release of Cdc14 
mediated by the FEAR network is transient, we compared the kinetics of Cdc14 release 
and Clb2 degradation in wild type and MEN mutant cells. To inactivate the MEN we used 
the ATP analog-sensitive allele of CDC15 (cdc15-as1), (Bishop et al., 2001). Wild type 
and cdc15-as1 cells were arrested in G1 and synchronously released in media lacking the 
pheromone, but containing the cdc15-as1 inhibitor. Cell cycle progression was assessed by 
scoring mitotic spindle formation. The dynamics of Cdc14 release and sequestration were 
followed by indirect in situ immunofluorescence. The levels and mobility of Clb2 were 
investigated by western-blot hybridization. In agreement with our hypothesis wild-type 
cells maintained Cdc14 released throughout anaphase, Fig. 3.3a; whereas MEN mutant 
cdc15-as1 (Bishop et al., 2001) cells re-sequestered Cdc14 into the nucleolus. They did so 
concomitantly with the reduction of Clb2 levels triggered by the APC/CCdc20, Fig. 3.3b 
(Mohl et al., 2009; Stegmeier and Amon, 2004).  
From this series of experiments we concluded that reduction in the levels of Clb2 
maybe the reason why the release of Cdc14 mediated by the FEAR network is transient. 
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Figure 3.3 Cdc5 is partially degraded in MEN mutant cells 
Wild type (Ry278, a) and cdc15-as1 (Ry1132, b) cells were arrested in G1 with !-factor in YEPD at 23°C 
and released in fresh YEPD media supplemented with the Cdc15-as1 inhibitor (1NM-PP1 analog 9 (Bishop 
et al., 2001)). At the indicated time-points samples were taken to determine the percentage of metaphase 
spindles (closed squares), anaphase spindles (closed circles) as well as the percentage of cells with Cdc14 
released from the nucleolus (open circles). Examples of Cdc14 localization for the 105 min. time-point are 
shown. Cdc14 is shown in red, tubulin in green and DAPI in blue. Bar, 3µm.  Clb5, Clb2, Cdc5 and Pgk1 
protein levels were analysed by western blot hybridization. Pgk1 protein was used as an internal loading 
control in immunoblots.  
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Clb2 stabilization is not sufficient to sustain Cdc14 release in the absence 
of MEN 
If this hypothesis is correct, it should be possible to release Cdc14 permanently, even 
in the absence of MEN, by stabilizing Clb2. 
To test this hypothesis, we tracked Cdc14 localization in a synchronous population 
of cells overexpressing a non-degradable form of Clb2 (GAL-CLB2dB!) that are impaired 
in MEN activity due to the ATP analog-sensitive allele of CDC15 (cdc15-as1) (Bishop et 
al., 2001). We expressed Clb2dB% at low and high doses to cover a wide range of Clb2 
concentrations. As for the low doses, we first determined the minimal galactose 
concentration necessary to arrest the cells in mitosis. GAL-CLB2dB! cells exit from 
mitosis when grown in media with 0.025% galactose, Fig. 3.4a, but are blocked in the 
presence of 0.05% galactose, Fig. 3.4b. We thus grew GAL-CLB2dB! cdc15-as1 cells in 
0.05% galactose to express what we call 'low doses' of non-degradable Clb2. For the 'high 
doses', we used 1% galactose. Nucleolar integrity was assessed by imaging the nucleolar 
protein Nop1 (Tollervey et al., 1991), Fig. 3.5 a, b, c. 
In the presence of non-degradable Clb2 expressed at high doses, more cdc15-as1 
mutant cells released Cdc14 as compared to the cdc15-as1 single mutant (compare the 
release at 135 minutes in Fig. 3.5a with the release at 105 minutes in Fig. 3.3b). 
Interestingly, we noticed that the spatial pattern of Cdc14 release changed from a nuclear 
FEAR-type to a nuclear and cytoplasmic release, resembling the one mediated by MEN 
(compare Fig. 3.5e (135 minutes) and Fig. 3.3b). However, this shift towards a MEN-type 
release was incomplete, as assessed by the fraction of cells that underwent release and by 
localization of Cdc14, because Cdc14 was not completely released in the cytoplasm in the 
entire anaphase population. Indeed, if the Cdc15 inhibitor was added 120 minutes after the 
release, Cdc14 release appeared more similar to that in wild-type cells, Fig. 3.5b. This 
result suggests that Clb2-Cdk and MEN have overlapping but not identical roles. This 
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notion is consistent with recent results obtained by Mohl and colleagues showing the need 
for Cdc14 phosphorylation by Dbf2 on its NLS for its cytoplasmatic retention (Mohl et al., 
2009). 
When non-degradable Clb2 was expressed at low doses, Cdc14 localization 
dynamics remained similar to those in cdc15-as1 cells for both the small fraction of 
anaphase cells with Cdc14 released, Fig. 3.5d, and the nuclear localization.  
Regardless of the presence of non-degradable Clb2, Cdc14 eventually re-entered the 
nucleolus in both cases. While with low doses it remained there, with high doses, Cdc14, 
after some time was released again. Noticeably, the alternation of sequestration and release 
of Cdc14 was not an isolated event, but occurred 3 to 4 times during the 5 hours of 
observation, Fig. 3.5a, and during each cycle Cdc14 was always fully released into the 
cytoplasm, Fig. 3.5e. 
In conclusion, our data suggest that the stabilization of Clb2 is not sufficient to 
maintain Cdc14 released in MEN mutants. 
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Figure 3.4 Identification of the minimal galactose concentration necessary for an homogeneous 
telophase arrest  
(a-d) GAL-CLB2dB! (Ry430) cells were arrested with !-factor in YEPR and released into medium 
supplemented with different concentrations of galactose (0,025%, a; 0,05%, b; 0,075%, c; 0,1%, d) to induce 
the expression of Clb2. The percentage of cells with metaphase spindles (closed squares), anaphase spindles 
(closed circles) as well as the percentage of cells with Cdc14 released from the nucleolus (open circles) was 
determined at the indicated times. 
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Figure 3.5 Non-degradable Clb2 promotes periodic cycles of Cdc14 release and sequestration 
(a,b,d) GAL-CLB2dB! cdc15-as1 (Ry1394) cells were arrested with !-factor in YEPR and released into 
medium supplemented with 1% (a,b) and 0,05% (d) galactose to induce the expression of Clb2.  5 µM 1NM-
PP1 analog 9 (Bishop et al., 2001) was added at the time of (a,c) or two hours after the release to inactivate 
the  cdc15-as1 allele. The percentage of cells with metaphase spindles (closed squares), anaphase spindles 
(closed circles) as well as the percentage of cells with Cdc14 released from the nucleolus (open circles) was 
determined at the indicated times. (c) At the indicated time-points the nucleolar protein Nop1 was stained to 
assess the integrity of the nucleolus during the course of the experiment. Nop1 is shown in red and DAPI in 
blue. (e) The localization of Cdc14 and the morphology of the mitotic spindle and nuclei for representative 
fields of cells from (a) are shown for various time-points. 
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Clb-Cdks stabilization maintains Cdc14 released in the absence of MEN 
If in MEN mutants Cdc14 is sequestered even in the presence of stable Clb2, what 
other mechanisms contribute to Cdc14 sequestration? We wished to verify whether other 
Clbs besides Clb2 could play a role in this process. This hypothesis is consistent with the 
results of our experiments in cells arrested in S-phase, where Cdc5 requires Clb-Cdks 
activity to release Cdc14, Fig. 3.1c, as by inactivating Cdc28 directly we inhibited all Clb-
Cdk complexes at once. To test whether stabilization of Clbs other than Clb2 maintains 
Cdc14 released in MEN mutants, we stabilized all Clbs at physiological levels by depleting 
Cdc20 in a strain lacking PDS1. Depletion of Cdc20 allows for cyclin stabilization, whilst 
Pds1 deletion allows for cohesin cleavage and passage into anaphase Fig. 3.6. 
More specifically, the coding sequence of Cdc20 was placed under the control of the 
methionine repressible MET3 promoter. To deplete Cdc20, MET-CDC20 pds1! cells were 
first arrested in G1, in a synthetic complete medium lacking methionine (SC-Met). In G1, 
the APC/CCdh1 targets Cdc20 for degradation. Cells depleted for Cdc20 were next 
synchronously released into the cell cycle into YEPD media added with methionine to 
repress the transcription of Cdc20, thereby preventing de novo Cdc20 synthesis. As Cdc20 
activity besides triggering Clbs degradation is also important for the degradation of 
securin, a process essential for sister chromatid separation, deletion of PDS1 in our mutant 
is necessary to allow cells depleted for Cdc20 to transit into anaphase, Fig. 3.6a, b. MET-
CDC20 pds1! cells, however, arrest in telophase, due to their inability to destroy cyclins, 
Fig. 3.6b. Interestingly, these cells arrest with Cdc14 released from the nucleolus, Fig. 3.6b 
and Fig. 3.7a and (Shirayama et al., 1999) and as such represent the perfect experimental 
set up to determine whether and which flavor of Clb has to be stabilized to render MEN 
activity dispensable for Cdc14 release. To address this question, we inactivated MEN via 
the cdc15-as1 allele in a MET-CDC20 pds1! background. Strikingly, we found that 
inactivation of MEN did not alter the kinetics of Cdc14 release observed in MET-CDC20 
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pds1! cells Fig.3.7b (compare with Fig. 3.7a), Fig. 3.7c. These results indicate that 
degradation of other Clbs besides Clb2 is the reason why Cdc14 is re-sequestered in MEN 
mutants.  
 119 
 
 
 
Figure 3.6 The metaphase to anaphase transition: Rationale for the experiment described in  
 (a) The metaphase to anaphase transition is triggered by the APC/CCdc20. In budding yeast the APC/CCdc20 
triggers the degradation of securin (Pds1), thereby allowing for sister chromatid separation; the degradation 
of S phase cyclin Clb5, a potent antagonist of phosphatase Cdc14, thereby allowing for activation of the 
phosphatase and progression through anaphase; and partial degradation of mitotic cyclin Clb2. (b) Cells 
depleted for Cdc20 that lack Pds1 deletion arrests in telophase with Cdc14 fully released. Cdc14 activity in 
this setting is opposed by kinase Clb5-Cdk. (c) The question we wish to address is whether endogenous 
stabilization of Clbs is sufficient to maintain Cdc14 release also in the absence of MEN.  
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Figure 3.7 Stabilization of S- and M-phase cyclins maintain Cdc14 released in MEN mutants 
MET-CDC20 pds1! cdc15-as1 (Ry1558, a-b) and cdc15-as1 (Ry1132, c) cells were arrested in G1 with !-
factor in a synthetic complete medium lacking methionine (SC-Met). When arrest was complete cells were 
released into YEPD media lacking the pheromone, but added with 8 mM methionine to repress the 
expression of Cdc20. 5 µM 1NM-PP1 analog 9 (Bishop et al., 2001) to inactivate the  cdc15-as1 allele was 
added to (b) and (c) . The percentages of cells with metaphase spindles (closed squares), anaphase spindles 
(closed circles) as well as the percentage of cells with Cdc14 released from the nucleolus (open circles) were 
determined at the indicated times. Clb5, Clb2 and Pgk1 protein levels were assessed by western blot 
hybridization (a, b). Pgk1 protein was used as an internal loading control in immunoblots. 
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Clb-Cdks stabilization maintains Cdc14 released in the absence of MEN 
As Clb5 is the predominant species among S-phase cyclins, and as it is degraded at 
the metaphase to anaphase transition, Fig. 3.3a, b, we set out to verify its contribution to 
Cdc14 release in the absence of MEN. To this aim, we analyzed the consequences of 
deleting CLB5 in a MET-CDC20 pds1! cdc15-as1 mutant. To our surprise we found that, 
in this mutant, Cdc14 was never released from the nucleolus, Fig. 3.8a. This result points 
to Clb5 being a novel member of the FEAR pathway. Indeed, the pattern of Cdc14 release 
in the MET-CDC20 pds1! cdc15-as1 clb5! mutant in the absence of the Cdc15 inhibitor, 
and as such with an active MEN, closely resembles the typical phenotype of FEAR 
mutants, Fig. 3.8b, where Cdc14 release is delayed during early anaphase. 
We conclude that the stabilization of both S phase and mitotic cyclins is sufficient to 
render full and stable the release of Cdc14. This result is consistent with the hypothesis 
that S-phase cyclin degradation contributes to Cdc14 sequestration.  
 
Clb5 is a bona fide FEAR network component 
The observation that deletion of CLB5 gene (clb5!) leads to: i) a delay in the release 
of Cdc14 in MEN competent cells (MET-CDC20 pds1! clb5!) Fig. 3.8b, and ii) a 
complete absence of Cdc14 release in cells lacking MEN activity (MET-CDC20 pds1! 
clb5! cdc15-as1), Fig.3.8a, point to Clb5 as a novel FEAR network component. Indeed, 
FEAR network mutants are impaired in the release of Cdc14 during early anaphase, when 
the mitotic spindle is between 3 and 7 µm, and exhibit a delay of about 10 minutes in 
mitotic exit (Stegmeier et al., 2002). To better assess if Clb5 plays a role in the FEAR 
network or if the phenotype we observe is caused by the genetic background in which we 
performed the experiment, we analyzed progression through the cell cycle of a 
synchronous population of cells carrying only a deletion of CLB5 (clb5!). To this aim, 
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wild-type, clb5! and clb5! cdc15-as1 cells first arrested in G1 and then synchronously 
released into the next cell cycle. We monitored cell cycle progression by following the 
kinetics of mitotic spindle formation. The contribution of Clb5 in promoting Cdc14 release 
was assessed by imaging Cdc14 by indirect IF. In wild-type cells Cdc14 was released from 
the nucleolus in the entire anaphase population, Fig. 3.8c, while clb5! cells showed a 
delay in Cdc14 release from the nucleolus during early anaphase, Fig. 3.8d. Moreover, 
similarly to all FEAR network mutants analysed to date, we found that a deletion of CLB5 
in combination with MEN inactivation (cdc15-as1) resulted in cells being impaired in 
releasing Cdc14, Fig. 3.8e. Taken together, we conclude that Clb5 is a bona fide member 
of the FEAR network. As Clb5 is degraded at the metaphase-anaphase transition, a role for 
the kinase in promoting Cdc14 release is difficult to envision. We believe that elucidating 
this mechanism will provide important information about cell cycle logic. 
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Figure 3.8 Clb5 is a FEAR network component 
(a, b) MET-CDC20 pds1! clb5!  cdc15-as1 (Ry1538) cells were arrested in G1 with !-factor in a synthetic 
complete medium lacking methionine (SC-Met). When arrest was complete cells were released into YEPD 
media lacking the pheromone, but added with 8 mM methionine to repress the expression of Cdc20 in the 
presence (a) or absence (b) of 5 µM Cdc15-as1 inhibitor (1NM-PP1 analog 9 (Bishop et al., 2001)).. The 
percentages of cells with metaphase spindles (closed squares), anaphase spindles (closed circles) as well as 
the percentage of cells with Cdc14 released from the nucleolus (open circles) were determined at the 
indicated times. (c-e) Wild type (Ry1, c), clb5! (Ry446, d) and clb5! cdc15as1 (Ry1588, e) cells were 
arrested with !-factor in YEPR and released into medium supplemented with 5 µM 1NM-PP1 analog 9 
(Bishop et al., 2001) to inactivate the  cdc15-as1 allele. Cell samples were analyzed as in (a, b). 
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Oscillations are impaired in the absence of both MEN and Clb2-Cdk-
mediated phosphorylation of Cfi1 
Although Cdc14 was re-sequestered in the presence of both high and low doses of 
non-degradable Clb2, oscillations occurred only in cells blocked in anaphase by high 
doses. It is possible that also in this setting Clb5 is required for Cdc14 release and 
accordingly that the first sequestration event is related with its degradation. However, at 
the metaphase-anaphase transition, the APC/CCdc20 is activated. As such, it is unlikely that 
Clb5 is present during the ensuing cycles of Cdc14 release and sequestration. Here, we can 
hypothesize that in MEN mutants high doses of non-degradable Clb2 can compensate for 
the lack of Clb5, and trigger an additional mechanism that leads to multiple cycles of 
Cdc14 release and sequestration. What is the molecular circuit underlying this oscillatory 
behavior? First, we asked whether the kinase requirement for Cdc14 release that we have 
identified above (i.e., the two-hit hypothesis whereby Cdc5 and either MEN or Clb-Cdks 
are necessary for Cdc14 release) was satisfied during the oscillations. According to our 
model, clear predictions can be made: 1) oscillations should persist in the presence of at 
least one between MEN and Clb2-Cdk, 2) should be abolished by the simultaneous 
removal of both MEN and Clb2-Cdk, 3) should occur when both are present, and 4) should 
be abolished by the inactivation of Cdc5. 
We thus moved to test the predictions. We have already shown that high doses of 
Clb2-Cdk can sustain oscillations in the absence of MEN, Fig. 3.5a, suggesting that Clb2-
Cdk, together with endogenous Cdc5 are sufficient to sustain the oscillations. We next 
wished to determine whether MEN and Cdc5, without the contribution of Clb2-Cdk, could 
sustain the oscillations. To test whether MEN alone can drive the oscillations, we 
interfered with the ability of Clb2-Cdk to release Cdc14 by using an allele of Cfi1 (cfi1-
6Cdk) lacking six Clb2-Cdk phosphorylation sites. This mutant is no longer 
phosphorylated by Clb2-Cdk. It shows a delay in releasing Cdc14 typical for FEAR 
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mutants (Azzam et al., 2004) and allows us to selectively eliminate the contribution of 
Clb2-Cdk to the release of Cdc14. In agreement with our prediction we found that in the 
presence of high doses of stable Clb2, in the cfi1-6Cdk mutant cells, although Cdc14 was 
released with a delay, oscillations arose nevertheless, Fig. 3.9a. 
The simultaneous removal of MEN and Clb2-Cdk can arrest the oscillatory behavior, 
as observed when cdc15-as1 was inhibited with the analog sensitive inhibitor in 
combination with the cfi1-6Cdk, both when the inhibitor was added before or after the 
initial release, Fig. 3.9b, c. Finally, we confirmed that oscillations arise when both MEN 
and Clb2-Cdk are present, Fig. 3.9d, e. So far, we have observed oscillations only in the 
presence of high levels of stabilized Clb2. Given that both Clb2-Cdk and MEN alone can 
sustain the oscillations, we asked whether the presence of MEN would allow low levels of 
stable Clb2-Cdk to undergo periodical cycles of Cdc14 release and re-sequestration. We 
found this to be the case, Fig. 3.9e. Because the release of Cdc14 in the simultaneous 
presence of Clb2-Cdk and MEN resembles that observed in wild-type cells, Fig. 3.10b 
compare to 3.10a, we decided to investigate the molecular nature of the oscillations in this 
setting, using both high and low doses of non-degradable Clb2.  
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Figure 3.9 Cdc14 oscillations fulfill the kinase requirement of the two-hit model 
(a-c) GAL-CLB2dB! cfi1-6Cdk (Ry1545) andGAL-CLB2dB! cfi1-6Cdk cdc15-as1 (Ry1715) cells were 
arrested with !-factor in YEPR and released into medium supplemented with 1% galactose to induce the 
expression of Clb2. 195 minutes into the release (a, b) or at the moment of the release (c) 5 µM of the 1NM-
PP1 analog 9 inhibitor (Bishop et al., 2001) was added to inactivate the cdc15-as1 allele. The percentage of 
cells with metaphase spindles (closed squares), anaphase spindles (closed circles) as well as the percentage of 
cells with Cdc14 released from the nucleolus (open circles) was determined at the indicated times.  The 
arrow indicates the time of inhibitor addition (+In; b)  (d, e) GAL-CLB2dB! (Ry430) cells were arrested in 
G1 with !-factor in YEPR and released into fresh medium supplemented with 1% (d) or 0.05% (e) galactose. 
Cell samples were analyzed as in (a).  
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Oscillations are impaired in Cdc5 mutants 
The final prediction of the “two-hit” model is that Cdc5 is continuously required to 
generate oscillations. If this is the case, then a loss-of-function allele of CDC5 should 
sequester Cdc14 without further release. To address this point we looked at the 
consequences of inhibiting Cdc5 on Cdc14 endocycles. GAL-CLB2dB! cdc5-1 cells where 
arrested in G1 and synchronously released in the next cell cycle in the presence of 
galactose. Since Cdc5 is required for the release of Cdc14, the allele was inactivated after a 
large fraction of the population had reached anaphase (as assessed by DAPI staining, 165 
minutes after release). The prediction was confirmed experimentally by using the 
temperature sensitive mutant cdc5-1, with no distinction between high and low doses, Fig. 
3.10c, d. The re-sequestration of Cdc14 was not a mere consequence of the temperature 
shift because the GAL-CLB2dB! single mutant strain showed oscillations at 37oC as well, 
3.10e.  
In conclusion, our data suggest that the periodical release and sequestration of Cdc14 
is in agreement with the kinase requirement as proposed by the “two-hit” model. 
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Figure 3.10 Modulating Cdc5 activity interferes with the oscillations 
(a-b) Wild type (Ry278, a) and GAL-CLB2dB! (Ry430, b) cells were arrested with !-factor in YEPR and 
released into fresh media. The percentage of cells with metaphase spindles (closed squares), anaphase 
spindles (closed circles) as well as the percentage of cells with Cdc14 released from the nucleolus (open 
circles) was determined at the indicated times. (c, d) GAL-CLB2dB! cdc5-1 (Ry1393) cells were arrested in 
G1 with !-factor in YEPR and released into fresh medium supplemented with 1% (c) or 0.05% (d) galactose. 
Cells were shifted at the restrictive temperature 165 minutes after the release. Cell samples were analyzed as 
in (a). (e) GAL-CLB2dB! (Ry430) cells were treated as in (a). Cells were shifted at the restrictive 
temperature 165 minutes after the release. Cell samples were analyzed as in (a). The arrow indicates the time 
of the shift to the restrictive temperature (c-e). 
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A negative feedback loop including Cdc5, Cdc14 and Cdh1 generates a 
Cdc14 oscillatory release 
 Having established that the oscillatory phenotype satisfies the kinase requirement 
that controls Cdc14 release in an unperturbed cell cycle, we moved to investigate the 
molecular nature of these oscillations in the GAL-CLB2dB! strain, both at high and low 
doses of non-degradable Clb2. We observed that either the simultaneous inactivation of 
MEN and Clb2-Cdk or Cdc5, Fig.3.9b, c and Fig 3.10c, d, interfered with the oscillatory 
phenotype. We set to understand which of these two activities is periodically regulated 
during the oscillations. A simultaneous and coordinated activation and inactivation of 
Clb2-Cdk and MEN is difficult to envision. A much easier explanation is that oscillations 
are driven by regulation of the Polo-like kinase Cdc5. Based on theoretical studies, 
oscillations are generated by a negative feedback loop. A negative feedback loop capable 
to give rise to oscillations is composed by at least three elements (Novak and Tyson, 
2008). At the end of mitosis, Cdc14 initiates a negative feedback loop composed of Cdc5-
Cdc14-APC/CCdh1-Cdc5 (Visintin et al., 2008). During exit from mitosis Cdc5 triggers the 
Cdc14 release; active Cdc14 dephosphorylates the APC/C cofactor Cdh1 leading to the 
formation (activation) of the APC/CCdh1 complex. APC/CCdh1 activation results in Cdc5 
degradation, and hence in Cdc14 re-sequestration, Fig 3.11. We asked whether this 
negative feedback loop could be responsible for the oscillatory behavior observed in the 
presence of high levels of stable Clb2. To answer this question we analyzed the 
involvement of these three components in the generation of the oscillations by interfering 
with their activity in the GAL-CLB2dB! setup. 
We already assessed the contribution of Cdc5 to the oscillatory phenotype. We 
reasoned that if Cdc5 takes part in the loop, and its function is to activate Cdc14, Cdc14 
itself should be part of the loop, giving rise to the oscillations. If Cdc14 belongs to the loop 
and is required for its own re-sequestration (Tomson et al., 2009; Visintin et al., 2008), we 
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predict that in a Cdc14 loss-of-function mutant the loop cannot be closed and Cdc14 
should always be released. We tested this hypothesis using the temperature-sensitive 
cdc14-1 mutant. Indeed, in this mutant Cdh1 should be inactive, Cdc5 stable and Cdc14 
constitutively released. Experimentally GAL-CLB2dB! cells carrying the cdc14-1 allele 
were pre-synchronized in G1 and then released in fresh media containing galactose. 180 
minutes after the release, when the cells had reached anaphase and had Cdc14 released, the 
double mutant was shifted to the restrictive temperature (37oC). We followed this strategy 
for every temperature sensitive mutant. In agreement with our hypothesis, we found that 
upon inhibition of Cdc14, the oscillations were lost and the phosphatase remained released 
from the nucleolus in the presence of both low and high levels of stable Clb2, Fig. 3.12a, b. 
As previously shown, this is not a mere consequence of the temperature shift because the 
GAL-CLB2dB! single mutant oscillated at 37oC as well, Fig. 3.10e. 
A possible caveat to this experiment is that the cdc14-1 mutant protein at the 
restrictive temperature could be misfolded and thus unable to bind to its inhibitor. In this 
case, we should observe Cdc14 constantly released, independently of Cdc5 stabilization. 
We tackled this problem in two manners. First, we assessed whether the cdc14-1 arrest was 
reversible once cells were shifted back to the permissive temperature (23oC) with the de 
novo protein synthesis inhibited. To this aim cdc14-1 mutant cells were arrested in G1 by 
!-factor pheromone and then released into fresh media lacking pheromone at the 
restrictive temperature (37oC). When the majority of cells had reached the telophase arrest 
as determined by nuclear morphology (DAPI staining, 3 hr into the release), the culture 
was shifted back to the permissive temperature in the presence of 1 mg/ml cycloheximide 
(inhibits de novo protein synthesis). We found that the cdc14-1 arrest was reversible, Fig. 
3.12c, because the already synthesized cdc14-1 mutant protein that suffered the thermal 
shock was able to be re-sequestered from its inhibitor. Second, we examined whether in 
presence of a wild type catalytically active copy of CDC14, the cdc14-1-6HA mutant 
protein could bind Cfi1 at the restrictive temperature. To address this question we 
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synchronized a heterozygous CDC14/cdc14-1-6HA diploid strain in S-phase with 10 
mg/ml hydroxyurea. When the arrest was complete, the cells were released in fresh media 
at the restrictive temperature (37oC). We observed that the mutant cdc14-1-6HA protein in 
this strain underwent release and sequestration at the restrictive temperature with wild-type 
kinetics Fig. 3.12d, e. We conclude that in our experimental set up Cdc14-1 stays released 
because it is enzymatically inactive. 
In the negative feedback loop, Cdc14 induces its own sequestration by indirectly 
destabilizing Cdc5. If the loop works as expected, we predict that stabilizing Cdc5 should 
abolish the oscillations. We tested this hypothesis using a non-degradable mutant of Cdc5 
(CDC5dB!) (Visintin et al., 2008), and indeed in this setting Cdc14 was always in a 
released state, for both high and low doses, Fig. 3.13a, b. Although it is possible that other 
mechanisms such as opposing phosphatases might also contribute to modulate Cdc5 
activity, the result is in agreement with the notion that the negative regulation occurs via 
Cdc5 degradation. This is not obvious, as in the presence of high levels of Clb2, 
APC/CCdh1 should be inhibited (Peters, 2006). We can explain this discrepancy supposing 
that the bulk of Cdh1 is phosphorylated and thus inhibited, but the spatial localization of 
the component of the circuit allows to a minor population of Cdh1 to be active. This 
possibility, however, allows a clear prediction: in a cdh1! strain, oscillations should be lost 
and Cdc14 fully released. We tested this prediction and confirmed that oscillations were 
lost, a result confirmed for both high and low doses, Fig. 3.13c, d. However the prediction 
was only partially confirmed since Cdc14 localization in anaphase cells was intermediate 
in nature. Indeed, in cells with high doses of non-degradable Clb2 (1% galactose), 
approximately half of the cells had Cdc14 released while the other half had Cdc14 
sequestered, Fig.3.13c. Cells with low doses of stable Clb2 (0.05% galactose) also had an 
intermediate phenotype, but more than 50% of anaphase cells had Cdc14 released, 
Fig.3.13d. Because cdh1! cells are difficult to arrest in G1, we reasoned that such an 
intermediate phenotype could be a consequence of poor synchronization and thus due to an 
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averaging out of the oscillations observed at the population levels. This possibility, 
however, is unlikely since wild-type cells released from a metaphase arrest induced by 
nocodazole, although poorly synchronous, show oscillations, while the cdh1! mutant 
confirmed the intermediate phenotype, Fig 3.13e, f. 
In detail, GAL-CLB2dB! cdh1! cells were first synchronized in G1 by 5 mg/ml of 
!-factor pheromone for 3 hr and then released into medium lacking pheromone 
supplemented with 15 mg/ml of the microtubule-depolimerizing drug nocodazole. 
Nocodazole treatment activates the spindle assembly checkpoint and results in a metaphase 
arrest. When the arrest was complete cells were released in growth medium lacking 
nocodazole supplemented with galactose to induce the expression of Clb2. GAL-CLB2dB! 
 cells, released from a metaphase block, showed oscillations in Cdc14 release and 
sequestration, Fig 3.13e whereas GAL-CLB2dB! cdh1! cells exhibited the same 
intermediate phenotype observed in the G1 synchronization experiment, Fig. 3.13f 
compare to 3.13c.  
Taken together, our data suggest that the oscillations in Cdc14 localization are driven 
by the same negative feedback loop that controls mitotic exit. This loop is composed of 
Cdc14, APC/CCdh1 and Cdc5. 
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Figure 3.11 Negative feedback loop generate oscillators 
Theoretical studies suggest that oscillators are generated by negative feedback loops.  Cdc14 activity at the 
end of mitosis is controlled by a negative feedback loop composed of Cdc5, Cdc14 and the APC/CCdh1. Here, 
Cdc5 triggers Cdc14 release and activation. Once active Cdc14 dephosphorylates Cdh1 promoting the 
formation of the APC/CCdh1 complex. APC/CCdh1 in turns ubiquitinates Cdc5 leading to the its proteosomal 
degradation. Cdc5 degradation in turns results in Cdc14 re-sequestration and closes the loop. We wondered 
whether this negative feedback loop is the one responsible for Cdc14 “endocycles”. 
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Figure 3.12 A Cdc14 loss-of-function mutant interferes with the oscillatory phenotype 
(a, b) GAL-CLB2dB! cdc14-1 (Ry1575) cells were arrested with !-factor in YEPR and released into 
medium supplemented with 1% (a) or 0.05% (b) galactose to induce the expression of Clb2. The percentage 
of cells with metaphase spindles (closed squares), anaphase spindles (closed circles) as well as the percentage 
of cells with Cdc14 released from the nucleolus (open circles) was determined at the indicated times. The 
arrow indicates the time of the temperature shift (180 minutes). (c) cdc14-1 (Ry1573) cells were arrested in 
G1 with !-factor (5$g/ml) in YEPD and then released into medium lacking pheromone at the restrictive 
temperature of 37oC. When the majority of cells reached the telophase arrest (3 hr into the release), the 
colture was shifted back to the permissive temperature in the presence of 1mg/ml cycloheximide to inhibit de 
novo protein synthesis. Cells were analysed as in (a-b). (d) Heterozygous diploid CDC14/cdc14-1-6HA 
(Ry1695) cells were arrested in S phase with 10 mg/ml hydroxyurea in YEPD. When arrest was complete 
cells were released in a fresh YEPD medium at the restrictive temperature of 37oC. Samples were taken at 
the indicated time points to analyze the percentage of metaphase spindles (closed squares), anaphase spindles 
(closed circles) as well as the percentage of cells with Cdc14-1-6HA released from the nucleolus (open 
circles). Representative cells of the 120 minute timepoint are shown in (e). Cdc14-1-6HA is shown in red, 
tubulin in green and DAPI in blue.  
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Figure 3.13 Cdc5 stabilization and Cdh1 depletion interfere with the oscillatory phenotype 
(a-d) GAL-CLB2dB! CDC5dB! (Ry1392, a, b) and GAL-CLB2dBD cdh! (Ry1466, c, d) cells were arrested 
with !-factor in YEPR and released into medium supplemented with 1% (a, c) or 0.05% (b, d) galactose to 
induce the expression of Clb2. (e, f) GAL-CLB2dB" (Ry430, e) and GAL-CLB2dB% cdh1% (Ry1466, f) cells 
were pre-synchronized in G1 with !-factor (5$g/ml) and then released into medium lacking pheromone 
supplemented with 15$g/ml nocodazole to arrest cells in metaphase. When the arrest was complete cells 
were released into a medium lacking nocodazole supplemented with 1% galactose to induce the expression 
of Clb2 and 1% DMSO. The percentage of cells with metaphase spindles (closed squares), anaphase spindles 
(closed circles) as well as the percentage of cells with Cdc14 released from the nucleolus (open circles) was 
determined at the indicated times. 
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APC/CCdh1 is not the only form of the APC/C capable of degrading Cdc5 
Puzzled by the observation that GAL-CLB2dB! cdh1!, and GAL-CLB2dB! 
CDC5dB! mutants behave differently, and having established that the intermediate 
phenotype of the GAL-CLB2dB! cdh1! strain was not due to an averaging out of the 
oscillations resulting from poor synchronization, we further examined the contribution of 
Cdc5 degradation to Cdc14 “endocycles”, by analyzing the pattern of Cdc14 localization 
in cells carrying a temperature sensitive allele of CDC23 (cdc23-1), a core component of 
the APC/C (reviewed in (Peters, 2006)). Since the APC/C is required for the metaphase-
anaphase transition, being responsible, together with its cofactor Cdc20, for separase 
(Esp1) activation, the cdc23-1 allele was inactivated after a large fraction of the population 
had reached anaphase (180 minutes after the release from the G1 block). In agreement with 
our interpretation, oscillations were lost in GAL-CLB2dB! cdc23-1 mutant. In these cells, 
both at high and low doses of Clb2dB%, Cdc14 did not oscillate but, contrarily to cdh1!, it 
was released in the entire anaphase population, Fig. 3.14a, b. This finding is in agreement 
with the possibility that APC/C-dependent degradation of Cdc5 promoted by Cdc14 is 
required for the oscillatory behavior. We confirmed the role of protein synthesis and 
degradation in the generation of oscillations by blocking protein synthesis with 
cycloheximide 180 minutes after having overexpressed non-degradable Clb2. In these 
conditions Cdc14 was sequestered and was never released, Fig.3.14e. 
This observation led us to hypothesize that other forms of the APC/C could be 
responsible for Cdc5 degradation. Thus, we verified whether the periodic release of Cdc14 
was affected by Cdc20, the other co-factor of the APC/C (Peters, 2006). When CLB2dB! 
was overexpressed in a cdc20-3 mutant, we observed periodic sequestration and release of 
Cdc14 regardless of the expression levels of non-degradable Clb2, Fig.3.14c, d, thus 
showing that Cdc20 is not implicated in generating the oscillatory loop. This result 
together with what we observed in the cdc23-1 and cdh1! mutants strongly points to a role 
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for Cdh1 in the generation of oscillations. This finding raises the possibility that the spatial 
localization of the components of this circuit allows Cdc14 to activate a subset of Cdh1, 
even in the presence of high levels of Clb2-Cdk. 
As for the distribution of Cdc14 in cdh1! cells, we hypothesized that although in this 
strain Cdc5 is degraded in an APC-dependent manner, the negative feedback loop was 
destroyed and thus oscillations were lost. As for the APC-dependent and Cdh1-
independent mechanism that drives Cdc5 degradation, our results hinted to a possible role 
for Cdc20. In cdc15-as1 cells, APC/CCdh1 is not activated because Cdc14 is only 
transiently released from the nucleolus early in anaphase, and thus Cdc20, a substrate of 
APC/CCdh1, is stabilized. Here, Cdc5 levels decreased with the same kinetics as Clb2, Fig. 
3.3b, suggesting that similarly to Clb2, Cdc5 could also be partially degraded in an 
APC/CCdc20-dependent manner. This possibility is plausible as GAL-Clb2dB! cdh1! cells 
accumulate Cdc20. Indeed, on one hand Cdc20 is continuously synthesized, being part of a 
cluster of genes whose expression depends on Clb2-Cdk activity (the Clb2 cluster), on the 
other hand it is stabilized by the lack of Cdh1, which is responsible for its degradation, Fig. 
3.15a. As such we can envision that in this context, Cdc5 synthesis (Clb2-CDK-dependent 
(Darieva et al., 2003)) and Cdc5 degradation (APC/C-dependent, reviewed in (Peters, 
2002)) find an equilibrium, Fig 3.15a. This intermediate value of Cdc5 could result in 
some cells having Cdc14 sequestered and others released. 
The observation that Cdc20 does not affect the oscillations if Cdh1 is present is 
consistent with the fact that in wild-type cells the synthesis of Cdc20 is counterbalanced by 
its APCCdh1-dependent degradation, Fig 3.15a. In conclusion, our results support the 
hypothesis that APC/CCdh1-dependent degradation of Cdc5 provides the main contribution 
to the generation of our oscillations and that oscillations in Cdc14 localization are driven 
by the negative feedback loop which includes Cdc14, Cdh1 and Cdc5 and controls Cdc14 
re-localization at the end of mitosis (Visintin et al., 2008). 
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Figure 3.14 APC/C dependent degradation and de novo protein synthesis are required for Cdc14 
endocycles 
(a-d) GAL-CLB2dB! cdc23-1 (Ry1452, a,b) and GAL-CLB2dB! cdc20-3 (Ry1457, c, d) cells  were arrested 
with !-factor in YEPR and released into fresh medium supplemented with 1% (a, c) or 0.05% (b, d) 
galactose to induce the expression of Clb2. Cells were shifted at the restrictive temperature 180 minutes after 
the release (arrow). The percentages of cells with metaphase spindles (closed squares), anaphase spindles 
(closed circles) as well as the percentage of cells with Cdc14 released from the nucleolus (open circles) were 
determined at the indicated times. (e) GAL-CLB2dB! (Ry430) cells were arrested and released as in (a). 180 
minutes after the release the cultures were added with 1 mg/ml of cycloheximide (arrow) to stop protein 
synthesis. Samples were analyzed as in (a). 
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Figure 3.15 A model for Cdc14 endocycles 
(a) How do Cdc14 endocycles arise? In our experimental set up Cdc5 is continuously synthesized being part 
of the Clb2 cluster genes. In GAL-CLB2dB! cdh1% cells oscillations are lost due to the involvement of Cdh1 
in the loop, and the intermediate phenotype can be explained by an equilibrium between Cdc5 Clb2-
dependent synthesis and Cdc5 APC/CCdc20-dependent degradation, the latter being stabilized by the lack of 
Cdh1. In GAL-CLB2dB!, where Cdh1 is active Cdc20 is degraded. Thus oscillations can occur. (b) 
Hypothesis 1: “Cdc5 stabilization model”: Cdc14 does not induces Cdc5 degradation indirectly activating 
APC/CCdh1 complex, but also directly dephosphorylating Cdc5 making the kinase a good substrate for the 
degradation. (c) Hypothesis 2: “Cfi1 dephosphorylation model”: besides triggering Cdc5 degradation Cdc14 
dephosphorylates other substrate, of which Cfi1 is a good candidate, that once dephosphorylated contributes 
to the re-sequestration of Cdc14 itself. 
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Cdc5 undergoes cycles of synthesis and degradation in the presence of 
high levels of stable Clb2 
Cycles of Cdc14 release and sequestration should be mirrored by cycles of 
phosphorylation and de-phosphorylation of Cdh1, and by cycles of synthesis and 
degradation of Cdc5. As changes in the phosphorylation status can be difficult to 
appreciate we focused our attention on Cdc5. As mentioned, Cdc5 is essential for Cdc14 
release. Hence, its degradation mediated by the APC/CCdh1 should be opposed by its re-
synthesis for a new cycle of Cdc14 release to occur. We already showed, Fig. 3.14e, that 
de-novo protein synthesis is required for the oscillation. That this synthesis concerns Cdc5 
is a likely possibility as Cdc5 belongs to the Clb2-cluster gene (Peters, 2006). We can 
hypothesize that in our setting the presence of Clb2 at high levels sustains Cdc5 re-
synthesis after the kinase is degraded. To visualize changes in the levels of Cdc5 in our 
experimental set up we employed different strategies. Population analysis of Cdc5 levels 
by western blot hybridization gave only partial answers, likely because of the 
heterogeneity of the cells in the population. Of note, the sensitivity of this technique is not 
able to assess differences in the 2-fold range of magnitude. 
To avoid complications due to population analysis we addressed the problem of 
Cdc5 degradation with a real-time single cell analysis. Before analyzing Cdc5 kinetics at 
single cell level, we established the right imaging conditions to identify oscillations in 
Cdc14 release and re-sequestration. For this purpose, a GAL-CLB2dB! strain carrying a 
GFP-tagged version of Cdc14 in combination with Cherry-tagged tubulin was grown in 
Sc-medium with 2% Sucrose and arrested in G1 by adding !-factor pheromone. When 
arrest was complete cells were loaded in a microfluidic chamber, and released in Sc-
medium with 2% Sucrose and 2% Galactose to induce the expression of GAL-CLB2dB!. 
Time-lapse imaging was performed at 30°C and frames were taken every 15 minutes. In 
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agreement with what we found during our population studies, Cdc14 endocycles where 
visible also at single cell level (data not shown).  
Having established the right conditions for oscillations to be reproduced, we moved 
to visualize over time an allele of Cdc5 tagged with Venus characterized in the laboratory 
of Dr. Yves Barral. This allele was shown to have wild-type kinetics of synthesis and 
degradation. GAL-CLB2dB! CDC5-Venus cells were grown in Sc-medium with 2% 
Sucrose and imaged in Sc-medium with 2% Sucrose and 2% Galactose to induce the 
expression of GAL-CLB2dB!. Cells were then loaded into a microfluidic chamber and the 
time-lapse imaging was performed at 30°C taking frames every 20 minutes. These 
experiments were performed in collaboration with Fabrice Coudron, a Post-Doc in the 
laboratory of Yves Barral. In agreement with our hypothesis in the presence of high levels 
of non-degradable Clb2 we observed fluctuations in the Cdc5 levels, as judged by the 
disappearance and re-appearance of the Cdc5 signal (data not shown).  
Taken together our experiments support the notion that cycles of Cdc5 synthesis and 
degradation underlie the Cdc14 endocycles. We conclude that once Cdc14 is fully 
released, due to a combination of FEAR and MEN, the negative feedback loop is 
operational: Cdc14 activates Cdh1, APC/CCdh1 degrades Cdc5 and Cdc5 degradation 
induces Cdc14 re-sequestration. In the presence of physiological levels of degradable 
Clb2, this event can occur only once, because upon APC/CCdh1 activation, Clb2 is also 
degraded and cells exit from mitosis. Instead, in our GAL-CLB2dB! system Clb2dB% is 
not degraded. Furthermore it behaves as a transcription factor for the Clb2 cluster gene, of 
which Cdc5 is part, thereby continuously stimulating Cdc5 transcription. Thus, Cdc5 is 
continuously synthesized, initiating new loops of release and re-sequestration. 
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Cdc14 promotes its own sequestration in multiple ways 
Having established the role of Cdc5 degradation in setting the oscillations we wished 
to understand another inconsistency found during our analyses. Our results showed that 
GAL-CLB2dB! cdc23-1, Fig. 3.14a, b, and GAL-CLB2dB! cdc14-1, Fig. 3.12a, b, mutants 
share the same phenotype, having Cdc14 permanently released, contrarily to GAL-
CLB2dB! cdh1! cells, Fig. 3.13c, d, where Cdc14 is only partially released. The 
observation that GAL-CLB2dB! cdc14-1, Fig. 3.12a, b, and GAL-CLB2dB! cdh1! cells 
Fig. 3.13c, d, behave differently cannot be explained by the minimal circuit we proposed 
so far (Cdc14 & Cdh1 '| Cdc5 & Cdc14). In this setting the only role played by Cdc14 is 
to activate Cdh1. This discrepancy suggests that Cdc14 could perform additional roles to 
induce its own sequestration. Given that both the inactivation of Cdc14 and of the APC/C 
(i.e., cdc23-1) cause a complete release of Cdc14, one possibility is that the cdc14-1 
mutant stabilizes Cdc5 as efficiently as the cdc23-1 mutant. We can envision one scenario 
that we called “the Cdc5 stabilization hypothesis” whereby Cdc5 is stabilized by 
phosphorylation (possibly by Clb2-Cdk) while its dephosphorylation, catalyzed by Cdc14, 
makes the kinase a good substrate for both the APC/CCdc20 and APC/CCdh1. Thus Cdc14 not 
only induces Cdc5 degradation indirectly activating APC/CCdh1 complex, but also directly 
dephosphoryates Cdc5 making the kinase a good substrate for degradation, Fig. 3.15b. 
Alternatively, the different phenotypes of cdh1! and cdc14-1 could be explained if 
Cdc14 would induce its own sequestration, besides triggering Cdc5 degradation, via 
dephosphorylating other substrates, of which Cfi1 is a good candidate. Once 
dephosphorylated Cfi1 contributes to the re-sequestration of Cdc14 itself (as previously 
proposed by Tomson and colleagues (Tomson et al., 2009)), Fig. 3.15c. We refer to it as 
“Cfi1 dephosphorylation model”. To discriminate between these two models we analyzed 
the consequences of inactivating Cdc14 and Cdc5 simultaneously. According to the Cdc5 
stabilization model, the GAL-CLB2dB! cdc14-1 cdc5-1 double mutant should phenocopy 
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a GAL-CLB2dB! cdc5-1 single mutant, Fig. 3.10c, d, re-sequester Cdc14 and never release 
it again because the inactivation of Cdc5 itself should overcome its own stabilization due 
to the lack of Cdc14 activity. In contrast, the Cfi1 phosphorylation model predicts that the 
double mutant should phenocopy the GAL-CLB2dB! cdc14-1 mutant with Cdc14 
permanently released because Cfi1 phosphorylation could not be increased but also not 
decreased, Fig. 3.12a, b. Thus, GAL-CLB2dB!, GAL-CLB2dB! cdc14-1, GAL-CLB2dB! 
cdc5-1 and GAL-CLB2dB! cdc14-1 cdc5-1 cells were arrested in G1 by !-factor 
pheromone and then synchronously released in the presence of galactose to induce Clb2 
expression. When the majority of the cells reached anaphase, 180 minutes after the release, 
the culture was shifted to the restrictive temperature (37oC). In agreement with the Cfi1 
dephosphorylation hypothesis Cdc14 was always released in the double mutant Fig. 3.16d. 
We conclude that Cdc14 induces its own re-sequestration in additional ways besides 
contributing to the destabilization of Cdc5 mediated by the APC/CCdh1. 
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Figure 3.16 Cdc14 re-sequestration requires both Cdc5 inactivation and Cdc14 phosphatase activity 
(a-d) GAL-CLB2dB! (Ry430,  a)  GAL-CLB2dB! cdc14-1 (Ry1575, b), GAL-CLB2dB! cdc5-as1 
(cdc5L158G, Ry1607, c (Snead et al., 2007; Zhang et al., 2005)) and GAL-CLB2dBD cdc14-1 cdc5-as1 
(cdc5L158G, Ry1606, d) cells were arrested with !-factor (5 µg/ml). After 3 hr cells were released into 
medium lacking pheromone supplemented with 1% galactose to induce the expression of Clb2. 180 minutes 
after the release cells were shifted at 37°C and supplemented with 10 µM of the cdc5-as1 inhibitor (CMK) 
(Snead et al., 2007) (arrow). The percentages of cells with metaphase spindles (closed squares), anaphase 
spindles (closed circles) as well as the percentage of cells with Cdc14 released from the nucleolus (open 
circles) were determined at the indicated times. 
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The fraction of Cdc14 involved in the oscillatory phenotype is the one 
that specifically binds Cfi1 
Having identified the molecular circuit responsible for generating Cdc14 endocycles, 
we decided to elucidate the pool of Cdc14 that is responsible for this phenotype. Cdc14 
phosphatase is sequestered in the nucleolus in a complex termed RENT (REgulator of 
Nucleolar silencing and Telophase exit) consisting of Cdc14 itself, Cfi1 and the silencing 
factor Sir2 (Huang and Moazed, 2003; Shou et al., 1999; Visintin et al., 1999). A recent 
protein interaction analysis identified Tof2 as physically interacting with RENT complex 
components (Huang and Moazed, 2006). Furthermore it directly binds to Cdc14 in vitro 
and genetically interacts with the phosphatase in vivo (Geil et al., 2008; Waples et al., 
2009). Interestingly, Cfi1 and Tof2 shear a significant homology at their N-terminus, and it 
has been shown that this Tof2 N-terminal domain, as for Cfi1, is the one responsible for 
the Tof2/Cdc14 interaction (Waples et al., 2009). Similar to Cfi1, Tof2 localizes to the 
nucleolus and remains nucleolar during anaphase. It was recently proposed that also Tof2, 
next to Cfi1, affects Cdc14 localization (Waples et al., 2009). As such, we decided to 
investigate which fraction of Cdc14 is involved in the periodic release, the one sequestered 
by Cfi1 or the one sequestered by Tof2. To this aim we looked at the consequences of 
deleting Tof2 and Cfi1 in our oscillatory system. GAL-CLB2dB! tof2! and GAL-
CLB2dB! cfi1! cells were arrested in G1 by !-factor pheromone and synchronously 
released into the next cell cycle into fresh media containing galactose to induce Clb2 
expression. Although it is possible that the interaction between Tof2 and Cdc14 is affected 
during the periodical cycles of Cdc14 release/re-sequestration, we found that deleting Tof2 
did not affect the oscillations, Fig. 3.17a. On the contrary, the interaction with Cfi1 is key 
for the oscillations, as GAL-CLB2dB! cfi1! strain in the presence of high levels of stable 
Clb2 did not oscillate, but released constantly Cdc14, Fig. 3.17b. Thus, we demonstrated 
that the pool of Cdc14 involved in the oscillations is the one regulated by Cfi1.
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Figure 3.17 The pool of Cdc14 involved in the oscillations is the one bound to Cfi1 
(a, b) GAL-CLB2dB! tof2! (Ry1708, a)  and GAL-CLB2dB! cfi1! (Ry1710, b) cells were arrested with !-
factor in YEPR and released into medium supplemented with 1% galactose to induce the expression of Clb2. 
The percentage of cells with metaphase spindles (closed squares), anaphase spindles (closed circles) as well 
as the percentage of cells with Cdc14 released from the nucleolus (open circles) was determined at the 
indicated times. 
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What is the molecular significance of the two-hit model? 
Having identified the circuit responsible for the oscillation we wished to better 
understand the molecular significance of this double-kinase requirement. Different 
scenarios can be envisioned. The observation that the activity of Cdc5 is always required 
for Cdc14 release suggests an attractive hypothesis. Polo-like kinases (Plks), of which 
Cdc5 is the unique member in budding yeast, possess a conserved C-terminal polo-box 
domain (PBD; (Elia et al., 2003a; Lee and Erikson, 1997; Lee et al., 1998). The PBD 
interacts with Plk substrates or docking proteins after undergoing phosphopriming by 
another kinase (Elia et al., 2003b). The binding of Plk to these proteins results in Plk 
localization in the vicinity of its substrates and thus allows Plk-dependent phosphorylation 
events. It is therefore possible that priming by Clb-Cdks or Dbf2 is required to build up 
Cdc5 activity. Phosphorylation of Cdc14 and/or Cfi1 by Cdc5 could then promote the 
dissociation of Cdc14 from its inhibitor. Reinforcing this hypothesis are six Clb2-Cdk-
dependent phospho-residues that were identified in Cfi1 (Azzam et al., 2004). Cells 
carrying an allele of CFI1 encoding a version of the protein in which these residues have 
been mutated to alanine (cfi1-6Cdk), a non-phosphorylatable amino acid, display defects in 
releasing Cdc14 during early anaphase. Remarkably, one of these residues (Thr 212) is part 
of an optimal phospho-binding motif recognized by PBD (Elia et al., 2003b). Alternatively 
Cdc5 and Clb-Cdk or Dbf2 could have parallel functions in phosphorylating Cfi1 and/or 
Cdc14 thereby promoting the release of Cdc14 from its inhibitor (Azzam et al., 2004; Mohl 
et al., 2009; Visintin et al., 2003; Yoshida and Toh-e, 2002). Lastly, the MEN kinase Dbf2 
and Clb-Cdk complexes could be required for Cdc5 activation and/or vice versa. 
Supporting this idea is that fact that the activation of Cdc5 requires the phosphorylation of 
a conserved threonine residue (Thr 242), located in its T-loop, by Cdc28 (Mortensen et al., 
2005), the only Cdk in budding yeast.  
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The fact that Cdc5, Clb-Cdks and MEN kinases are interdependent, as Cdc5 kinase 
activity requires Clb-Cdk, MEN activation requires Cdc5, and finally MEN activity (e.g. 
Cdc15 kinase) is antagonized by Clb-Cdks, renders the elucidation of the molecular 
mechanism underlying the “two-hit” model rather challenging. It is in fact likely that 
various regulatory mechanisms co-exist to ensure a tight control over the activity of these 
powerful multitasking mitotic regulators. To shed light onto this process I investigated 
each of these possibilities. 
 
Cdc14 and Cfi1 phosphorylation are important for Cdc14 release 
Data present in the literature (Azzam et al., 2004; Visintin et al., 2003) suggest that 
one important function of the kinase that co-operates with Cdc5 to promote Cdc14 release 
from the nucleolus (Clb-Cdks or the MEN) is to phosphorylate Cfi1. Supporting this 
conclusion, Azzam and colleagues showed that Clb2-Cdk is required for Cfi1 
phosphorylation during early anaphase while we found that overexpression of CDC15(1-
750) in both G1- and S phase-arrested cells resulted in the ectopic phosphorylation of Cfi1, 
Fig. 3.18b and Fig. 3.20b. Our data also support the idea that Cfi1 phosphorylation serves 
as a priming step to build up Cdc5 activity. Indeed, when expressed in G1, where neither 
Clb-Cdks nor MEN kinases are active, differently than in all other stages of the cell cycle, 
Cdc5 not only was not capable of triggering the ectopic release of Cdc14, but also did not 
induce the phosphorylation of Cdc14 and/or of Cfi1, Fig 3.19b. However, the concomitant 
overexpression of CDC5 and CDC15(1-750) re-established both the ectopic release of 
Cdc14, in agreement with (Manzoni et al., 2010), and changes in the electrophoretic 
mobility of both Cdc14 and its inhibitor, Fig. 3.20a. The observation that the pattern of 
Cfi1 phosphorylation in cells expressing only CDC15(1-750) or both CDC5 and 
CDC15(1-750) is similar, Fig. 3.20b and Fig. 3.20a, as evidenced by our Western blots, 
allows us to further speculate that the priming events serve to mediate Cdc14 
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phosphorylation by Cdc5. In support to this “priming” model we identified (unpublished 
data) by mass spectrometry a residue in Cfi1 that lies in a putative Dbf2 recognition 
sequence (Mah et al., 2005), which is specifically phosphorylated in anaphase and is part 
of a minimal PBD-phosphobinding motif (Elia et al., 2003b). To test our model we will 
assess the consequences, on the phosphorylation and release of Cdc14, of mutating this 
residue into alanine, a non-phosphorylatable amino acid, and to aspartic acid, which 
mimics constitutive phosphorylation. Similarly, we will mutate other putative Dbf2-
dependent phosphorylation sites within Cfi1 and putative Cdc5-dependent phosphorylation 
sites within Cdc14. The analysis of the phenotypes of cells conditionally expressing these 
different mutant proteins will provide further insight about the relevance of the priming 
model. Clear predictions as to the expected phenotypes can be made. For instance, if Cfi1 
phosphorylation functions exclusively as a mediator of Cdc5-dependent phosphorylation, 
we expect cells expressing a mutant variant of Cdc14, carrying all putative sites 
phosphorylated by Cdc5 mutated into aspartic acid (D), to have Cdc14 released from the 
nucleolus during the entire cell cycle. Interestingly, cells carrying a mutant allele of 
CDC14 encoding a form of the protein where six putative Cdc5-dependent 
phosphorylation sites have been mutated into aspartic acid exhibit an altered kinetic of 
Cdc14 release with the phosphatase released for most of the cell cycle (unpublished data). 
Vice versa, a mutant allele of Cdc14 where the same sites have been mutated into alanine 
is unviable (unpublished observation). We are currently testing the localization of these 
mutant Cdc14 proteins in a strain carrying the cdc14-1 temperature sensitive mutation. 
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Figure 3.18 Cdc15 overexpression results in Cfi1 phosphorylation in S phase arrested cells 
(a, b) Wild-type (Ry394, a) and GAL-CDC15(1-750) (Ry995, b) cells carrying a CDC14-3HA and a CFI1-
3MYC fusions were arrested in G1 with !-factor in YEPR (5 µg/mL) at 23°C. When the arrest was complete, 
cells were released into YEPR lacking pheromone but containing HU (10 mg/mL). When cells had arrested 
in S phase, 2% galactose was added to induce the expression of Cdc15. Samples were taken at the indicated 
times to determine the percentage of cells with Cdc14 released from the nucleolus and proteins levels and 
mobility in SDS-PAGE of Cdc14-3HA, Cfi1-3Myc and 3Myc-Cdc5. Pgk1 was used as an internal loading 
control in Western blot analysis.   
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Figure 3.19 Overexpression of CDC5dB! does not induce the ectopic phosphorylation of Cdc14 or Cfi1 
in cells arrested in G1 
(a, b) Wild-type (Ry394, a) and GAL-CDC5dB!-3HA (Ry1358, b) cells carrying a CDC14-3HA and a CFI1-
3MYC fusions were arrested in G1with !-factor (5 µg/ml) in YEPR at 23°C. When more than 90% of cells 
were unbudded, 2% galactose was added to induce the expression of Cdc5. To maintain the G1 block, !-
factor pheromone (2.5 µg/ml) was re-added to the media every 90 min after galactose addition. Samples were 
taken at the indicated times to determine the percentage of cells with Cdc14 released from the nucleolus and 
proteins levels and mobility in SDS-PAGE or in Phos-tag SDS-PAGE (*) of Cdc14, Cfi1 and Cdc5dB%. 
Pgk1 was used as an internal loading control in Western blot analysis.  
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Figure 3.20 The concomitant overexpression of Cdc5 and Cdc15 is sufficient to promote the ectopic 
phosphorylation of both Cdc14 and Cfi1 in G1-arrested cells 
(a, b) GAL-GFP-CDC15(1-750) (Ry995, a) and GAL-CDC5dB!-HA GAL-GFP-CDC15(1-750) (Ry1345, b) 
cells carrying a CDC14-3HA and a CFI1-3MYC fusions were arrested in G1 in YEPR with !-factor 
pheromone (5 µg/ml) at 23°C. When the arrest was complete, 2% galactose was added to induce the 
expression of Cdc5 and Cdc15. To maintain the G1 block, !-factor pheromone (2.5 µg/ml) was re-added to 
the media every 90 min after galactose addition. Samples were taken at the indicated times to determine the 
percentage of cells with Cdc14 released from the nucleolus and proteins levels and mobility in SDS-PAGE 
or in Phos-tag SDS-PAGE (*) of Cdc14, Cfi, Cdc15 and Cdc5dB%. Pgk1 served as an internal loading 
control in Western blot analysis.  
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Do Clb2 and Dbf2 modulate Cdc5 activity? 
Our data are also consistent with Clb-Cdks and the MEN kinase Dbf2 being required 
to directly activate Cdc5. Supporting this hypothesis is the observation that Cdc5 
activation requires the phosphorylation of a conserved threonine residue by Cdc28 
(Mortensen et al., 2005). We found a putative site for Dbf2 kinase phophorylation nearby 
in Cdc5 T-loop. We mutated this site into alanine and will analyse the consequences of this 
mutation on Cdc5 activity. Although we cannot exclude that this extra layer of regulation 
is involved in the process, the observation that cells expressing a mutant form of Cfi1 
lacking the 6 Cdk-dependent phosphorylation sites are defective in releasing Cdc14 from 
the nucleolus during early anaphase, when both Clb2-Cdk and Cdc5 are present, argues 
that Cfi1 phosphorylation by Clb-Cdks is essential to mediate Cdc14 release. It will be 
interesting to assess if in this mutant the phosphorylation of Cdc14 is delayed as well.  
  Moreover if it possible that the “partner” kinases contribute to full Cdc5 activation 
under physiological conditions, we do not think that this is the major contribution of Clb2 
and Dbf2 to Cdc14 release. Indeed, when we compared Cdc5 kinase activity at different 
cell cycle stages we found that, albeit with a delay and to a lesser extent than in S- and M-
phase, overexpression of Cdc5 resulted in an increase of its kinase activity also in G1 
arrested cells, but in this phase of the cell cycle Cdc5 is not capable of inducing ectopic 
release of Cdc14, Fig 3.21a compare to 3.21b, c. 
Nevertheless for completion we will investigate the contribution of Cdc5 “partner” 
kinases to Cdc5 activation itself by comparing the activity of Cdc5 in G1-arrested cells, 
when the kinase is expressed alone or in combination with the other kinases involved in 
the process. We will also test, in the different mutant backgrounds, the consequences of 
overexpressing a mutant allele of CDC5 encoding a Cdc5 protein that can no longer be 
activated by Clb-Cdks (Mortensen et al., 2005). This way we will assess not only the 
relevance of this activating phosphorylation in the process but also, in case the partner 
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kinases serve to activate Cdc5, if Clb-Cdks and MEN contribute to Cdc5 activation via the 
same molecular mechanism. 
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Figure 3.21 Cdc5 overexpression resulted in an increase of its activity also in G1 arrested cells 
(a) GAL-CDC5dB! (Ry798) cells were arrested in G1 in YEPR with !-factor pheromone (5µg/ml) at 23°C. 
When more than 90% of cells were unbudded, 2% galactose was added to induce the expression of Cdc5. To 
maintain the G1 block, !-factor pheromone (2.5 µg/ml) was re-added to the media every 90 min after 
galactose addition. Samples were taken at the indicated times to determine the percentage of cells with 
Cdc14 released from the nucleolus. (b-c) GAL-CDC5dB! (Ry798) were pre-synchronised in G1 as described 
in (a). When arrest was complete cells were released into 10mg/ml HU (b) and 15µM nocodazole, to achieve 
an S- and M-phase arrest respectively. Cdc5 kinase activity on Casein and western blot analysis of Cdc5 
protein level and mobility in SDS-PAGE are shown. Pgk1 was used as an internal loading control in Western 
blot analysis. 
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High levels of Cdc5 induce a post-translational modification on Clb2 
During the course of our experiments in which CDC5 was overexpressed we noticed 
a slower migrating form of Clb2 appearing concomitantly with ectopic release of Cdc14. 
This observation suggested the possibility that this Cdc5-dependent modification of Clb2 
rendered Clb2 competent to phosphorylate Cfi1 in the FEAR network context. To test this 
possibility we analyzed Clb2 modification in response to CDC5 overexpression in wild-
type and cdc15-as1 mutant cells, the latter allowing to alleviate the contribution of MEN, 
if any, in the process. Wild-type, GAL-CDC5 and GAL-CDC5 cdc15-as1 cells, were 
arrested in G1 by !-factor and synchronously released from the block in a medium 
containing HU and 1NM-PP1, to arrest cells in S phase and to inactivate the MEN, 
respectively. When the arrest was complete, as judged by more than 95 percent of the cells 
having a bud, CDC5 overexpression was induced by adding galactose to the medium. To 
assess post-translational modifications of Clb2 we analyzed Clb2 electrophoretic mobility 
on SDS-PAGE. Clb2 was visualized by Western blot analysis with anti-Clb2 antibodies. 
Our data showed that in wild-type cells Cdc14 was not released from the nucleolus and 
that the electrophoretic mobility of Clb2 did not change through the course of the 
experiment, excluding that this modification of Clb2 was simply accumulating as a result 
of a prolonged arrest in S phase, Fig. 3.22a. On the contrary, overexpression of CDC5 in 
wild-type cells induced a modification on Clb2 concomitantly with the release of Cdc14 
from the nucleolus both in the presence or absence of MEN activity, 3.22b-c. These 
observations suggest that Cdc5 induces in a MEN-independent manner, directly or 
indirectly, a post-translational modification on Clb2, which might be relevant for the role 
that Clb2 plays in Cdc14 release. 
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High levels of Cdc5 induce the ectopic phosphorylation of Clb2 
Having established that Cdc5 induces a post-translational modification of Clb2, we 
characterized the nature of this modification. Because Cdc5 is a kinase, the most obvious 
hypothesis was the modification of Clb2 to be phosphorylation. GAL-CDC5 cells were 
arrested in S phase by treatment with HU. When the arrest was complete, CDC5 
overexpression was induced. Clb2 was immunoprecipitated, using anti-Clb2 antibodies, 
from a protein extract obtained from GAL-CDC5 cells after three hours of CDC5 
induction. The immunoprecipitated Clb2 protein was incubated in the presence or absence 
of the Calf Intestinal Phosphatase (CIP). Clb2 mobility in SDS-PAGE was analyzed by 
Western blot using anti-Clb2 antibodies. While two differently migrating forms of Clb2 
were detectable when the protein was not treated with the CIP, only the faster migrating 
form was detectable when the protein was incubated with the phosphatase Fig. 3.22d. This 
finding indicated that high levels of Cdc5 are capable of inducing, directly or indirectly, 
Clb2 phosphorylation. 
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Figure 3.22 Overexpression of Cdc5 induces the phosphorylation of Clb2 
(a-c) Wild-type (Ry394, a), GAL-3MYC-CDC5 (Ry1325, b) and GAL-3MYC-CDC5 cdc15-as1 (Ry1324, c) 
cells carrying a CDC14-3HA and a CFI1-3MYC fusions were arrested in G1 in YEPR with !-factor 
pheromone (5µg/mL) at 23°C. When the arrest was complete, cells were released into YEPR lacking 
pheromone but containing HU (10mg/mL) and 1NM-PP1 (5µM) to arrest them in S phase and to inhibit 
Cdc15-as1, respectively. When the arrest was complete, galactose was added to induce the expression of 
Cdc5. Samples were taken at the indicated times to determine the percentage of cells with Cdc14 released 
from the nucleolus (top) and Clb2 and Cdc5 protein levels and mobility in SDS-PAGE (bottom). Pgk1 was 
used as an internal loading control in Western blot analysis. (d) GAL-3MYC-CDC5 (Ry1325) cells were 
arrested in S phase as described in (a). Two and a half hours after galactose addition, a sample was taken to 
perform Clb2 immunoprecipitation. A phosphatase assay with the calf intestinal phosphatase (CIP) was 
performed on the immunoprecipitated Clb2 protein. Western blot analysis of Clb2 protein level and mobility 
in SDS-PAGE is shown. 
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Clb2 is phosphorylated during early anaphase in wild-type cells 
To examine whether the phosphorylation of Clb2 by Cdc5 is relevant for Clb2 
function rather than being an artefact due to overexpression of CDC5, we analyzed the 
levels and pattern of Clb2 during an unperturbed cell cycle. If phosphorylated Clb2 is the 
active form of the protein within the FEAR network, a clear prediction can be made. 
Indeed we predict that the phosphorylated Clb2 will appear concomitantly with the release 
of Cdc14 during early anaphase and will disappear as cells progress through anaphase. 
Wild-type cells were arrested in G1 by treatment with !-factor and then synchronously 
released into the next cycle. The synchrony of the cell population was assessed by 
monitoring the kinetics of mitotic spindle formation. Cdc14 release from the nucleolus was 
analyzed by indirect IF. To examine Clb2 phosphorylation we performed conventional 
SDS-PAGE and Phos-tag SDS-PAGE, followed by Western blot analysis using anti-Clb2 
antibodies. We found that, as cells entered in anaphase, Cdc14 was released from the 
nucleolus and remained in the released state until the mitotic spindle was disassembled. 
Clb2 levels increased as cells progressed through the cell cycle, reached a peak during 
metaphase and the protein was degraded as cells exited from mitosis, Fig. 3.23a. Of note, a 
hyperphosphorylated form of Clb2 accumulated at anaphase onset (70 minute time point) 
concomitant with the early release of Cdc14 from the nucleolus and disappeared as cells 
progressed through anaphase (90 minute time point), Fig. 3.23a. This result shows that a 
correlation exists between Clb2 phosphorylation and the early release of Cdc14 mediated 
by the FEAR network, supporting the possibility that Clb2 phosphorylation is 
mechanistically involved in promoting Cdc14 release during early anaphase. 
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In a cdc5 FEAR-defective mutant Clb2 is not hyperphosphorylated 
during early anaphase  
To assess if this phosphorylation of Clb2 is in any way important for Clb2 function 
within the FEAR network, we analyzed progression trough the cell cycle and the Clb2 
phosphorylation state in a specific mutant of CDC5, cdc5-ad1 (adaptation defective). 
Besides their most defect in escaping from a checkpoint-mediated cell cycle arrest in the 
presence of irreparable double-strand breaks (a process called “adaptation”; (Toczyski et 
al., 1997), cdc5-ad1 cells have recently also display defects in the release of Cdc14 during 
early anaphase under unperturbed conditions (Jin and Wang, 2006; Toczyski et al., 1997). 
If, as we hypothesize, Cdc5 is required for the phosphorylation of Clb2 and if 
phosphorylated Clb2 is the FEAR network effector, we expect a lack of Clb2 
hyperphosphorylation during early anaphase in the FEAR-defective cdc5-ad1 mutant. To 
assess this hypothesis, wild-type and cdc5-ad1 cells were arrested in G1 with !-factor and 
then synchronously released into the next cell cycle. We monitored cell cycle progression 
by analyzing via FACS the kinetics of DNA replication and via indirect IF the kinetics of 
mitotic spindle formation. The pattern of Clb2 mobility was analyzed by performing 
conventional SDS-PAGE and Phos-tag SDS-PAGE followed by Western blot analysis 
with anti-Clb2 antibodies. We found that wild-type and cdc5-ad1 cells entered and 
progressed through the cell cycle up to the first stages of mitosis with similar kinetics but, 
in agreement with (Jin and Wang, 2006), cdc5-ad1 cells did not release Cdc14 from the 
nucleolus during early anaphase as is typical for FEAR network mutants. Fig.3.23b. 
Consistent with their defect in releasing Cdc14 during early anaphase, cdc5-ad1 cells 
displayed a 10 minute delay in exiting from mitosis compared to wild-type cells. Both in 
wild-type and cdc5-ad1 cells, Clb2 levels increased during progression through S phase up 
to metaphase whereas Clb2 was degraded as cells entered into the next cell cycle Fig. 
3.23b. In agreement with our hypothesis we found that, while in wild-type cells a 
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hyperphosphorylated form of Clb2 accumulated at anaphase onset concomitant with the 
release of Cdc14 during early anaphase (100 minute time point), in cdc5-ad1 cells this 
hyperphosphorylated form of Clb2 did not accumulate Fig.3.23b. This observation 
suggests that the Cdc5-dependent phosphorylation of Clb2 may be relevant for the function 
of Clb2 in promoting the release of Cdc14 from the nucleolus during early anaphase. This 
set of experiments were performed in collaboration with Guendalina Mimun another 
graduate student in the lab. 
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 Figure 3.23 Clb2 is not phosphorylated during early anaphase in cdc5-ad1 cells 
(a, b) Wild-type (Ry1, a) and cdc5-ad1 (Ry1510, b) cells were arrested in G1 in YEPD with !-factor 
pheromone (5 µg/mL) and next released in fresh YEPD lacking pheromone. !-factor pheromone was 
readded 90 min after release to prevent entry into a subsequent cell cycle. In each panel (a and b): the graph 
on the left shows the DNA content of the cell population measured by FACS analysis; the graph on the right 
shows the percentages of cells with metaphase spindles (closed squares), anaphase spindles (closed circles) 
and Cdc14 released from the nucleolus (open circles); Western blot analysis shows Clb2 protein levels and 
mobility in SDS-PAGE and in Phos-tag SDS-PAGE (*) at the indicated times. Pgk1 served as an internal 
loading control in Western blot analysis. * indicates hyperphosphorylated Clb2. 
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How is the post-translational modification affecting the Clb2-Cdk 
complex? 
To tackle the latter question we analyzed the consequences of these phosphorylation 
events on Clb2-Cdk activity. Clb2 activity was assessed using histone H1 as a substrate. 
We found that high levels of Cdc5 result in a decrease in Clb2-Cdk activity, Fig. 3.24a 
compare to Fig. 3.24b. This result is in agreement with our observation that Cdc5 
overexpression results in a general decrease of total levels of Clb2. Although 
overexpression of Cdc5 induces Clb-Cdk inactivation, we cannot exclude that in 
physiological conditions the Cdc5 kinase activity may contribute to Clb2-Cdk activity. To 
test this possibility we compared the kinetics of Clb2 activity between a wild type and a 
loss of function allele of CDC5. Wild type and cdc5-as1 cells were synchronously released 
from a G1 arrest into media containing the Cdc5 inhibitor. Clb2 kinase activity was 
assessed over histone H1. Our data indicate that Cdc5 activity is not required to modulate 
Clb2 kinase activity, Fig 3.25b compare to 3.25a. 
The hypothesis that we favor to explain these apparently conflicting observations is 
that Cdc5-mediated phosphorylation of Clb2, although necessary for Clb2 role within the 
FEAR network, likely by causing a relocation of the kinase, ultimately leads to its 
inactivation. We speculate that this may be the Clb2 pool degraded at the metaphase to 
anaphase transition. It will bw interesting to see if Cdc5 induces re-localization of Clb2, 
possibly in the nucleolus where it can reach its substrates Cfi1. 
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Figure 3.24 Cdc5 does not modulate Clb2 activity 
(a, b) Wild type (Ry2020, a) and GAL-CDC5dB! (Ry 2016, b) cells carrying a HA tagged version of Clb2, 
were arrested in G1 with !-factor in YEPR (5 µg/mL) at 23°C. When the arrest was complete, cells were 
released into YEPR lacking pheromone but containing HU (10 mg/mL). When cells had arrested in S phase, 
2% galactose was added to induce the expression of Cdc5. Samples were taken at the indicated times to 
determine the percentage of cells with Cdc14 released from the nucleolus (top) and to perform Clb2 
immunoprecipitation. A kinase assay was performed on the immunoprecipitated Clb2 protein. Western blot 
analysis of Clb2 and Cdc5 protein level and mobility in SDS-PAGE is shown. Pgk1 was used as an internal 
loading control in Western blot analysis.  
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Figure 3.25 Clb2 activity does not require active Cdc5 
(a, b) Wild type (Ry1, a) and cdc5-as1 (Ry 2446, b) cells were arrested in G1 with !-factor in YEPR (5 
µg/mL) at 23°C and released into fresh media lacking the pheromone but supplemented with 10 µM of the 
cdc5-as1 inhibitor (CMK) (Snead et al., 2007). The percentage of cells with metaphase spindles (closed 
squares) and anaphase spindles (closed circles) was determined at the indicated times. Immunoprecipitation 
and kinase assay was performed on Clb2 protein. Western blot analysis of Clb2 and Cdc5 protein level and 
mobility in SDS-PAGE is shown. Pgk1 was used as an internal loading control in Western blot analysis. 
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Cdc5 is not required to modulate Dbf2 activity 
Overexpression of the GAL-CDC15(1-750) allele in S phase was reported (Bardin et 
al., 2003) to induce ectopic activation of kinase Dbf2. We wished to determine whether 
this was true  also in cells arrested in G1. To this aim GAL-CDC15(1-750) cells carrying a 
DBF2-3Myc fusion were arrested in G1 and Dbf2 activity was assessed on histone H1 as 
substrate. Our data show that also in G1 arrested cells overexpression of hyperactive 
Cdc15 resulted in the ectopic activation of Dbf2, Fig 3.26a. To further investigate the 
contribution of Cdc5 alone or in combination with Cdc15 to this process GAL-CDC5dB!-
3HA and GAL-CDC5dB!-3HA GAL-CDC15(1-750) cells both carrying a DBF2-3Myc 
fusion were tested for Dbf2 activity, Fig. 3.26b, c. Our results suggest that Cdc5 does not 
contribute to Dbf2 activity, nor alone nor in combination with Cdc15 Fig. 3.26b, c.  
Similarly in S-phase arrested cells the ability of the GAL-CDC15(1-750) does not require 
Cdc5, Fig. 3.27a, b. However the ability of Cdc5 and Cdc15 to ectopically release Cdc14 
requires active Dbf2 as indicated by the observation that adding a loss of function allele of 
DBF2 to the GAL-CDC5dB!-3HA GAL-CDC15(1-750) cells, results in the inability of 
these constructs to induce the ectopic release of the phosphatase, Fig 3.27c, d.  
Taken together, our results exclude a role for Cdc5 in modulating its partner kinases. It 
will be interesting to see if Cdc5 induces a re-localization of Dbf2. 
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Figure 3.26 Cdc5 does not affect Dbf2 activity 
(a-c) GAL-CDC15(1-750)  (Ry2254, a),  GAL-CDC5dB!  (Ry2257, b) and GAL-CDC5dB! GAL-CDC15(1-
750) (Ry 2248, c) with a Myc-tagged version of Dbf2 cells were arrested in G1 with !-factor (5 µg/ml) in 
YEPR at 23°C. When more than 90% of cells were unbudded, 2% galactose was added to induce the 
expression of Cdc5. To maintain the G1 block, !-factor pheromone (2.5 µg/ml) was re-added to the media 
every 90 min after galactose addition. Samples were taken at the indicated times to determine the percentage 
of cells with Cdc14 released. Immunoprecipitation and kinase assay was performed on the Dbf2-3Myc 
protein. Western blot analysis of Cdc5 and Cdc15 protein level and mobility in SDS-PAGE is shown. Pgk1 
was used as an internal loading control in Western blot analysis.  
 
 168 
 
Figure 3.27 GAL-CDC15(1-750) does not require Cdc5 activity to mediate Dbf2 activation 
(a, b) GAL-CDC15(1-750) (Ry2254, a) and GAL-CDC15(1-750) cdc5-as1 (Ry3539, b) cells were arrested in 
G1 in YEPR with !-factor pheromone (5µg/ml) at 23°C. When the arrest was complete, cells were released 
into YEPR lacking pheromone but containing HU (10mg/mL) to arrest them in S phase. Once cells were 
arrested 2% galactose was added to induce Cdc15 overexpression and 10 µM of the cdc5-as1 inhibitor 
(CMK) (Snead et al., 2007) was supplemented to inhibit Cdc5. Samples were taken at the indicated times to 
determine the percentage of cells with Cdc14 released. Immunoprecipitation and kinase assay was performed 
on the Dbf2-3Myc protein. Western blot analysis of Cdc15 protein level and mobility in SDS-PAGE is 
shown. Pgk1 was used as an internal loading control in Western blot analysis. (c, d) GAL-CDC5dB! GAL-
CDC15(1-750) (Ry2248, c) and GAL-CDC5dB! GAL-CDC15(1-750) dbf2-2 (Ry3536, d) cells were pre-
synchronized in G1 in YEPR with !-factor pheromone (5µg/mL) at 23°C. and then released into YEPR 
lacking pheromone but containing HU (10mg/mL) to arrest them in S phase. When the arrest was complete, 
cells were shifted at the restrictive temperature to inactivate Dbf2. Samples were analyzed as in (a). 
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4. Discussion and future plans 
The studies presented in this thesis aim to characterize the molecular mechanisms 
that regulate the interaction between Cdc14, a key regulator of mitotic exit, and its 
inhibitor Cfi1. The activity of Cdc14 is controlled by changes in its cellular localization 
(Shou et al., 1999; Traverso et al., 2001; Visintin et al., 1999). From G1 up to metaphase, 
Cfi1 sequesters Cdc14 in the nucleolus. During nuclear division Cdc14 is released from 
Cfi1 and first spreads into the nucleus, subsequently into the cytoplasm (Jin et al., 2008; 
Shou et al., 1999; Visintin et al., 1999). This sequential release (and concomitant 
activation) of Cdc14 is mediated by the consecutive activation of two signalling cascades: 
the Cdc-Fourteen Early Anaphase Release (FEAR) network and the Mitotic Exit Network 
(Pereira et al., 2002; Shou et al., 1999; Stegmeier et al., 2002; Visintin et al., 1999; 
Yoshida and Toh-e, 2002). FEAR and MEN ensure a timely correct execution of mitotic 
events (Shou et al., 1999). Components of both cascades include various kinases 
suggesting that cell cycle-regulated phosphorylation may mediate the interaction between 
Cdc14 and Cfi1. A number of observations support this hypothesis. In vitro studies suggest 
that phosphorylation is responsible for the dissociation of Cdc14 from its inhibitor Cfi1 
(Shou et al., 2002; Shou et al., 1999). In addition, in vivo phosphorylation of Cfi1 and 
possibly also of Cdc14 correlates with the release of the latter from the nucleolus (Shou et 
al., 2002; Shou et al., 1999; Visintin et al., 2003; Yoshida and Toh-e, 2002). 
In this study we aimed to identify the minimal kinase requirement for induction of 
the ectopic release of Cdc14 from the nucleolus with the goal of elucidating the molecular 
mechanisms controlling the Cdc14/Cfi1 interaction. 
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Cdc14 release from its inhibitor requires the power of two kinases  
A role for Clb-Cdks, Cdc5 and the MEN effector kinase Dbf2 in the release of 
Cdc14 has already been proposed (Azzam et al., 2004; Geymonat et al., 2003; Hu and 
Elledge, 2002; Hu et al., 2001; Mohl et al., 2009; Pereira et al., 2002; Queralt et al., 2006; 
Stegmeier et al., 2002; Visintin et al., 2003; Yoshida and Toh-e, 2002). However, the 
molecular mechanism via which Cdc14 is released remains unknown. To tackle this issue 
we analyzed the consequences of modulating the above-mentioned kinases alone or in 
mutual combination in the G1 and S phase of the cell cycle. In both phases, the kinases of 
interest are either absent or just start to accumulate. In addition, there is no contribution of 
other mitotic regulators, and Cdc14 is sequestered in the nucleolus. Our results showed 
that the release of Cdc14 requires the activity of two kinases, Cdc5 plus  the Clb-Cdk 
complexes or the MEN effector kinase Dbf2. Interestingly, MEN and Clb2-Cdks appeared 
to have partially overlapping roles, up to the point that Clb2-Cdk can replace MEN activity 
if stably expressed at high levels. MEN, however, remained essential if Clb2-Cdk levels 
were low. Indeed, our data suggest that the S-phase cyclin Clb5, other than Clb2, is 
essential for the early anaphase release of Cdc14 in this setting and in physiological 
conditions. The involvement of Clb5 in Cdc14 release is at odds with the well-known role 
of Clb5 as an anaphase inhibitor. More studies will be required to elucidate the role of this 
cyclin during mitotic exit. We speculate that elucidating Clb5 function within the FEAR 
network will improve our understanding of how cells coordinate DNA replication with 
mitotic exit. 
 
Molecular interpretation of the “two-hit” model 
The molecular significance of this double-kinase requirement is still unknown, but 
different scenarios can be envisioned. The observation that the activity of Cdc5 is always 
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required for Cdc14 release suggests an attractive hypothesis. Polo-like kinases (Plks), of 
which Cdc5 is the unique member in budding yeast, possess a conserved C-terminal polo-
box domain (PBD) (Elia et al., 2003a; Lee and Erikson, 1997; Lee et al., 1998). The PBD 
interacts with Plk substrates or docking proteins after they have undergone 
phosphopriming by another kinase (Elia et al., 2003b). The binding of Plk to these proteins 
allows Plk-dependent phosphorylation events to occur.  It is therefore possible that priming 
by Clb-Cdk and Dbf2 is required to build up Cdc5 activity. Phosphorylation of Cdc14 
and/or Cfi1 by Cdc5 could then promote the dissociation of Cdc14 from Cfi1. Supporting 
this hypothesis is the observation that cells carrying an allele of CFI1 encoding for a 
version of the protein in which six Clb2-Cdk-dependent phospho-residues have been 
mutated to alanine (cfi1-6Cdk), a non-phosphorylatable amino acid, display defects in the 
release of Cdc14 during early anaphase (Azzam et al., 2004). Remarkably, one of these 
residues (Thr 212) is part of an optimal phospho-binding motif recognized by PBD (Elia et 
al., 2003b). An alternative model foresees that Cdc5 and Clb-Cdks or Dbf2 have parallel 
functions in phosphorylating Cfi1 and/or Cdc14, (Azzam et al., 2004; Mohl et al., 2009; 
Visintin et al., 2003; Yoshida and Toh-e, 2002). Finally, the MEN kinase Dbf2 and Clb-
Cdk complexes could be required for Cdc5 activation and/or vice versa. Supporting the 
latter idea is the observation that activation of Cdc5 requires Cdc28-mediated 
phosphorylation of a conserved threonine residue within its T-loop, (Thr 242). Cdc28 
(Mortensen et al., 2005) is the only Cdk in budding yeast. As we said the fact that Cdc5, 
Clb-Cdks and MEN kinases are known to be interdependent, renders likely the possibility 
that multiple mechanisms are involved. 
Phosphorylation data from our laboratory together with reports in the literature 
(Azzam et al., 2004; Visintin et al., 2003) suggest that one important function of the 
kinases that co-operate with Cdc5 (Clb-Cdks or the MEN) is to phosphorylate Cfi1. Azzam 
and colleagues showed that Clb2-Cdk is required for Cfi1 phosphorylation during early 
anaphase while we found that overexpression of CDC15(1-750) in both G1 and S phase-
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arrested cells resulted in the ectopic phosphorylation of Cfi1. Our data also support the 
idea that Cfi1 phosphorylation serves as a priming step to build up in Cdc5 activity. 
Indeed, when expressed in G1, where neither Clb-Cdks nor MEN kinases are active, Cdc5 
not only was incapable of triggering the ectopic release of Cdc14, but also did not induce 
the phosphorylation of Cdc14 and/or Cfi1. However, the simultaneous expression of 
CDC5 and CDC15(1-750) re-established the ectopic release of Cdc14 and phopshorylation 
of both Cdc14 and Cfi1. The observation that the pattern of Cfi1 phosphorylation in cells 
expressing only CDC15(1-750) or both CDC5 and CDC15(1-750) is similar, allows us to 
speculate that priming events serve ultimately to mediate Cdc14 phosphorylation by Cdc5. 
In support of this “priming” model we identified (unpublished data) by mass spectrometry 
a residue in Cfi1 (S259) that lies in a putative Dbf2 recognition sequence (Mah et al., 
2005), that is specifically phosphorylated in anaphase and is part of a minimal PBD-
phosphobinding motif (Elia et al., 2003b). To test the "priming model" we will next 
examine the consequences on the phosphorylation and release of Cdc14, of mutating this 
residue into alanine, an amino acid that can no longer be phosphorylated, and into aspartic 
acid, which mimics phosphorylation. In addition, putative Dbf2-phosphorylation sites 
within Cfi1, and putative Cdc5-dependent phosphorylation sites within Cdc14, identified 
by sequence analysis (PHOSIDA) will be mutated. The analysis of the phenotype of cells 
conditionally expressing these mutant proteins will provide additional insights into the 
relevance of the priming model. Clear predictions as to the expected phenotypes can be 
made. For instance, if Cfi1 phosphorylation functions exclusively as a mediator of Cdc5-
dependent phosphorylation, we expect that cells expressing a mutant variant of Cdc14 
whose putative Cdc5 phosphorylation sites were mutated into aspartic acid, to have Cdc14 
released from the nucleolus during the entire cell cycle. Interestingly, cells carrying a 
mutant allele of CDC14 encoding for a form of the protein where six putative Cdc5-
dependent phosphorylation sites have been mutated into aspartic acid, exhibit an altered 
kinetic of Cdc14 release. This phosphatase was released for most of the cell cycle. Vice 
 173 
versa, a mutant allele of CDC14 where the same sites were mutated into alanine is 
unviable (unpublished data). We are currently testing the localization of these mutant 
Cdc14 proteins in a yeast strain carrying the cdc14-1 temperature-sensitive mutation. Our 
results, besides supporting the “priming model”, are also consistent with Clb-Cdks and the 
MEN kinase Dbf2 being required to directly activate Cdc5. Supporting this hypothesis is 
the observation that Cdc5 activation requires the phosphorylation of a conserved threonine 
residue by Cdc28 (Mortensen et al., 2005). Although we cannot exclude that this extra 
layer of regulation is involved in the process, the observation that cells expressing a mutant 
form of Cfi1 lacking the 6 Cdk-dependent phosphorylation sites are defective in releasing 
Cdc14 from the nucleolus during early anaphase in presence of both Clb2-Cdk and Cdc5, 
argues that Cfi1 phosphorylation by Clb-Cdks is essential to mediate Cdc14 release. It will 
be interesting to see if in this mutant the phosphorylation of Cdc14 is delayed as well. The 
contribution of the Cdc5 “partner” kinases to Cdc5 activation will be taken into 
consideration as well. Although our preliminary data seem to exclude that the three kinases 
modulate each other's activities.  Nevertheless, we expect that the finalization of our 
analysis will finally unveil the molecular mechanism underlying the dissociation of Cdc14 
from its inhibitor. 
 
Clb2 is phosphorylated in a Cdc5-dependent manner 
The Clb2-Cdk mitotic complex has been proposed to phosphorylate Cfi1 during the 
early stages of anaphase, thereby triggering the initial release of Cdc14 from the nucleolus 
(Azzam et al., 2004). Our studies envision for the Clb2-Cdk complex within the FEAR 
network the same role played by the MEN kinase Dbf2 during the later stages of mitosis; 
that is to promote the phosphorylation of Cfi1. This result is in agreement with (Azzam et 
al., 2004). Indeed, the observation that (1) the ectopic release of Cdc14 in S phase-arrested 
cells brought about by high levels of Cdc5 was MEN-independent (Visintin et al., 2008) 
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but relied on the presence of Clb-Cdk complexes, (2) requirement for Clb-Cdk activity is 
dispensable if MEN is ectopically activated (Manzoni et al., 2010) and that (3) the ectopic 
activation of MEN triggers the ectopic phosphorylation of Cfi1 (Visintin et al., 2003), 
support the notion that the Clb2-Cdk complex in the FEAR network is required for 
phosphorylating Cfi1. If correct, one would expect that similarly to the hyperactivation of 
MEN, overexpression of CLB2 would result in the ectopic phosphorylation of Cfi1. So far, 
our result did not confirm this prediction (data not shown). Although we can not exclude 
that we were not able to detect phosphorylated Cfi1 due to technical limitations of the 
procedure used to analyze the phospho-state of the protein, this observation raises 
alternative possibilities. First Clb-Cdk complexes other than Clb2-Cdk promote the 
phosphorylation of Cfi1 as members of the FEAR network; in agreement with this 
possibility, Clb5 has been hypothesized to be a novel FEAR network component (Manzoni 
et al., 2010). Second, Clb2 needs to be regulated, by post-translational modification/s 
and/or interactions with specific partners, to promote Cfi1 phophorylation and Cdc14 
release from the nucleolus. The existence of an additional activation step required for 
Clb2-mediated function within the FEAR network is appealing because it could explain 
why, differently than all other FEAR network components, high levels of Clb2 are not able 
to induce Cdc14 release from the nucleolus when cells are arrested in metaphase using 
nocodazole (data not shown). This result is in conflict with what is described by Azzam 
and collaborators who showed that the ectopic expression of CLB2 induces the ectopic 
release of the phosphatase from the nucleolus in metaphase (Azzam et al., 2004). The 
reasons for this discrepancy are currently unclear, but we suspect they are due to the 
different experimental procedures employed. While Clb2-Cdk-dependent phosphorylation 
of Cfi1 is essential for the release of Cdc14 in early anaphase (Azzam et al., 2004), our 
findings with GAL-CLB2dB! cells suggests that high levels of Clb2 are not sufficient to 
induce this event. During the course of our experiments we noticed that overexpressing 
CDC5 induced an electrophoretic mobility shift of the Clb2 protein, which we later found 
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to be due to phosphorylation. This Cdc5-mediated phosphorylation of Clb2 did not require 
MEN activity. Interestingly, the appearance of phospho-Clb2 correlated with the kinetics 
of Cdc14 release from the nucleolus and the appearance of phospho-Cdc14 and phospho-
Cfi1. These observations made us wonder whether this Cdc5-mediated phosphorylation of 
Clb2 was relevant for the role of the Clb2-Cdk complex within the FEAR network. 
Supporting this idea are the findings that: (1) hyperphosphorylated Clb2 appears 
concomitantly with the release of Cdc14, during the early stages of anaphase in an 
unperturbed cell cycle of wild-type cells, (2) Clb2 is not hyperphosphorylated during early 
anaphase in cells carrying an allele of CDC5 encoding for a protein defective in its FEAR 
functions (cdc5-ad1), and (3) cells overexpressing a FEAR-defective allele of CDC5 
(GAL-cdc5-ad1) in S phase-arrested cells, are not only impaired in promoting the ectopic 
release of Cdc14 but also in triggering the ectopic phosphorylation of Clb2 (data not 
shown). Encouraged by these preliminary observations we decided to further investigate 
the significance of this cell cycle-regulated Clb2 phosphorylation. We searched for 
putative Cdc5-dependent phosphorylation sites in Clb2. We identified and mutated two 
Clb2 residues, both into alanine or aspartic acid. Next, we assessed the consequences on 
cell cycle progression and Cdc14 release of introducing these mutated alleles of CLB2 as 
the sole source of Clb2 cyclin in the cell. Our preliminary data showed that a modified 
Clb2 that cannot be phosphorylated (Clb2S181AS389A) is unable to rescue the FEAR defect 
associated with clb2! mutant cells. Regardless of the expression of the Clb2S181AS389A 
protein, cells deleted for CLB2 remained defective in releasing Cdc14 from the nucleolus. 
In agreement with our hypothesis, this mutant Clb2S181AS389A is never 
hyperphosphorylated. These data are consistent with a direct or indirect requirement for 
Cdc5 activity to phosphorylate Clb2 in one or both of the sites we identified. In contrast, 
the expression of a phospho-mimicking version of Clb2 (Clb2S181DS389D) restored the 
kinetics of Cdc14 release from the nucleolus and exit from mitosis of a clb2! mutant as 
observed in wild-type cells. The observation that this “hyperactive” Clb2 does not trigger 
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the release of Cdc14 in phases other than anaphase is consistent with the possibility that 
besides triggering Clb2-phospharylation, an additional role for Cdc5, such as 
phosphorylating Cdc14, exists. It will be important to determine whether this 
“hyperactive” Clb2 can ectopically phosphorylate Cfi1. 
To further assess the relevance of the Cdc5-mediated phosphorylation of Clb2 on these 
sites we will: (1) analyze the phosphorylation pattern of the non-phosphorylatable 
Clb2S181AS389A following overexpression of CDC5 in S phase-arrested cells. Given the 
phenotype exhibited by the mutant, we expect that overexpressing CDC5 will not induce 
an ectopic phosphorylation of this mutant version of Clb2; (2) analyze by Phos-tag SDS-
PAGE the mobility of Clb2 in various genetic combinations; (3) address how this post-
translational modification is affecting the Clb2-Cdk complex. To tackle the latter question 
we will analyze the consequences of these phosphorylation events on the fate of the 
protein, in terms of localization and substrate specificity. In particular, we will consider the 
hypothesis that phospho-Clb2 may accumulate into a specific cellular compartment. 
Indeed, phosphorylation of cyclin B1 (the human ortholog of CLB2) by Plk1 (the human 
ortholog of CDC5) on S133 (corresponds to S389 in S.c.Clb2) has been reported to induce 
the translocation of the protein from the cytoplasm into the nucleus, thus promoting the 
G2-M transition of the cell cycle (Yuan et al., 2002). We speculate that, similarly, 
phospho-Clb2 would migrate into (a) particular cellular compartment(s), for example into 
the nucleolus, where its target Cfi1 is located. To investigate this possibility we will 
analyze Clb2 localization on a genome-wide scale by ChIP-on-chip and specifically at the 
nucleolus by performing ChIP assays and indirect immunofluorescence on spread nuclei, a 
technique that allows the detection of variations in the concentration of a protein in 
specific subnuclear locations, before and after CDC5 overexpression. In parallel we are 
raising antibodies that recognize specifically phosphorylated Clb2. This will be a powerful 
tool to investigate the dynamics of a subpopulation of the Clb2-Cdk complex. 
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The “two-hit” model provides a nice explanation for cell cycle 
progression 
The two-kinase requirement for Cdc14 release explains Cdc14 dynamics in wild-
type and mutant cells. At anaphase onset, wild-type cells release Cdc14 by the concerted 
action of Cdc5 and Clb-Cdk complexes. Clb-Cdk includes both S- and M-phase cyclins of 
which Clb5 and Clb2 are the predominant species, respectively. Later in the cell cycle, 
after the APC/CCdc20 triggers the degradation of Clb5 and partially that of Clb2, the 
decrease in Clb-Cdk activity is compensated by the activation of the MEN. This stepwise 
mechanism of Cdc14 release ensures a faithful execution of the anaphase program. It also 
makes sure that either Clb-Cdk or MEN is always active during mitosis (Clb-Cdks before 
and MEN after) to sustain the release of Cdc14. Therefore in agreement with previous 
work (Visintin et al., 2008), it must be the degradation of Cdc5 by the APCCdh1 that causes 
the re-sequestration of Cdc14 at the end of mitosis. Indeed, both CDC5dB! and cdh1! 
strains have a very large fraction of cells with Cdc14 released. 
 
A model for Cdc14 dynamics at the exit from mitosis 
 We challenged the “two-hit” model by analyzing Cdc14 localization in the 
presence of non-degradable Clb2, expressed at high and low levels. In the presence of high 
doses, Clb2-Cdk has a double role: it prevents cells from exiting mitosis and induces the 
release of Cdc14 (together with MEN, which is nevertheless dispensable in this setting). 
The latter of clb2-Cdk role is shared with Cdc5 as both are required for the release of 
Cdc14. When Cdc5 is degraded, as a consequence of Cdc14 release and APC/CCdh1 
activation, Clb2-Cdk cannot promote the release of Cdc14 alone. As a consequence, Cdc14 
moves back into the nucleolus. Nevertheless, Clb2-Cdk manages to block cells in mitosis, 
allowing Cdc5 to be resynthesized and to induce a new round of Cdc14 release and 
sequestration. In this context, Clb2-Cdk likely plays an additional third role, namely the 
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promotion of CDC5 transcription. CDC5, together with CLB2 belongs to the “CLB2 
cluster genes”, a set of about 30 genes whose expression depends upon Clb2 (Darieva et 
al., 2003). 
  When the doses of non-degradable Clb2 are reduced, the presence of MEN 
becomes essential for full Cdc14 release similarly to a normal cell cycle. As Cdh1 is 
activated, Cdc5 degradation causes the re-sequestration of Cdc14, followed by MEN-
driven cycles of Cdc14 release and sequestration. In presence of both high and low doses 
of Clb2, the role of Clb5 is likely limited to the initial release of Cdc14, after which it 
becomes degraded. Its presence is dispensable at high levels of stable Clb2, whereas it 
becomes essential when Clb2 is stabilized at low doses in the absence of MEN. 
We were surprised to observe that APC/CCdh1 was required for the oscillations in the 
presence of non-degradable Clb2. This result is in contrast to the notion that Clb2-Cdk 
inhibits APC/CCdh1 (Nasmyth, 1996). Similarly, Clb2-Cdk has been reported to inhibit 
MEN (reviewed in (Stegmeier and Amon, 2004) and (Konig et al., 2010)). In our system, 
however, MEN seems to be active even in the presence of high levels of stable Clb2. When 
we used the cfi1-6Cdk mutant, we found that oscillation increased in a MEN-dependent 
manner in the presence of active Clb2-Cdk arresting cells in mitosis. At present, we cannot 
give an explanation for these results. Possibly, they point to the fact that the subcellular 
localization of the kinases and phosphatases, whose delicate balance controls Cdc14 
localization, cannot be neglected if we wish to understand the regulatory network that 
controls exit from mitosis. 
 179 
Final remarks 
The goal of my thesis research was to elucidate the molecular mechanisms that 
control the activity of Cdc14, a key regulator of mitotic exit in Saccharomyces cerevisiae. 
Although our picture is still incomplete, my work shed new light onto this process. We 
found that the combination of Cdc5 with either Clb-Cdks or Dbf2 is sufficient to promote 
Cdc14 release from the nucleolus. Our results provide an explanation of how the interplay 
of the above mentioned kinases results in the release of Cdc14 at the right time during the 
cell cycle. Moreover, we found that once fully released, Cdc14 triggers a negative 
feedback loop that, in the presence of stable levels of mitotic cyclins, triggers periodic 
cycles of Cdc14 release and sequestration. As similar oscillatory phenotypes have been 
described for yeast bud formation and centrosome duplication, our observations suggest a 
paradigm whereby events capable of repeating themselves multiple times are restrained to 
occur once per cycle by their coupling to the cyclin-Cdk engine. 
 
Why oscillations? 
Our results raise the question of the physiological significance of the oscillations in 
Cdc14 localization. We believe that what we report contributes to the understanding of the 
principles underlying the coordination between the cell cycle engine (i.e. cyclin-Cdk 
activities) and the events triggered by the engine itself. The oscillatory behavior reported 
here is not an isolated example, but resembles other cases of periodical phenotypes that 
emerge when the cell cycle engine is blocked. In budding yeast, the deletion of Clbs results 
in a periodical budding in G1 (Haase and Reed, 1999). In both budding yeast and 
Drosophila melanogaster, the deletion or knock down of mitotic cyclins arrests cells 
before mitosis, but centrosomes nevertheless undergo periodic rounds of divisions (Haase 
et al., 2001; McCleland and O'Farrell, 2008). Mutants for three major control mechanisms 
preventing DNA re-replication can be blocked in G2/M with high levels of Clb2-Cdk and 
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undergo multiple cycles of re-replication (Nguyen et al., 2001). These seemingly different 
systems share basic properties with themselves and with our system: they are all triggered 
by the cell-cycle engine and normally occur once per cell cycle. They show periodic 
behavior when the engine is blocked.  
Do these systems share properties at the molecular level? The molecular details of 
the circuits we have mentioned are not as well known as the circuit we analyzed here. 
However, their capability to oscillate implies that they all include at least one negative 
feedback loop. This fits with the need for these circuits to reset to their initial state after 
one cycle, thereby preparing for the forthcoming cell cycle. However, their capability to 
oscillate implies much stronger requirements than the simple negative feedback loop: they 
must have enough non-linearity, sufficient time-delays and proper balancing of the rate 
constants, all conditions required for oscillations (Novak and Tyson, 2008). All these 
conditions are not obvious, and indeed the oscillatory behavior in the presence of constant 
high levels of mitotic kinase came to us as a surprise. 
We thus believe that an important question to be asked is why events coupled to the 
cell cycle engine, that take place only once per cycle, have evolved to an oscillatory 
regime, normally hidden by their coupling to the cell cycle machinery. The answer to this 
question is unknown, but surely worth further investigations. Here we propose that an 
oscillatory dynamic guarantees a resetting of the molecular circuit to its initial conditions 
less dependent on the Cdk input than a simple negative feedback loop thus avoiding 
intermediate outcomes of the circuit. In the case of Cdc14, that would be a state with only 
a fraction of Cdc14 re-sequestered in the nucleolus at the end of mitosis, with the 
APC/CCdh1 only partially active and with intermediate levels of Clb2. Such a condition 
would leave cells in a state of unclear physiological condition, partially mitotic and 
partially G1. The oscillatory dynamics, even if limited to one cycle, makes sure that this is 
avoided. 
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